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room temperature
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triplet
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tetramethylsilane
tyrosine

vii

ABSTRACT
This thesis describes new approaches to the asymmetric synthesis of cyclic
non-proteinogenic a-amino acids ( N P A A s ) and amino acid derivatives
from (2/?)-3-benzoyl-4-methylene-2-phenyloxazolidin-5-one. In the first
Chapter, an overview of the strategies used for the synthesis of these
compounds and also their biological activities was provided. It was found
that for the preparation of cyclic a-amino acids in high enantiomeric
purity, starting materials with a chiral auxiliary have generally been
employed.
In Chapter T w o , the synthesis of cyclic N P A A s , through the thermally
induced

Diels-Alder reactions of (2R )-3-benzoyl-4-methylene-2-

phenyloxazolidin-5-one (8) and substituted 1,3-butadienes and substituted
1,3-cyclohexadienes was explored. In general, the reactions were found to
be highly regio selective and exo-diastereoselective. The exo selectivity of
these reactions was explained by a secondary orbital interaction between
the Af-donor group of the oxazolidinone ring of (8) (a captodative alkene)
and the diene.

T h e N P A A , (2S,4S)-2-aminobicyclo[2.2.2]octane-2-

carboxylic acid, was prepared in optically active form starting with (8) and
cyclohexadiene.
In Chapter Three, the 1,3-dipolar cycloaddition reactions of (2R)-3benzoyl-4-methylene-2-phenyloxazolidin-5-one (14) with nitrones and
nitrile oxides are reported. In general the nitrone reactions occur under
equilibrating conditions to give the more stable adducts that result from
addition to the exo -cyclic methylene of (14) from the sterically more
hindered 7t-face. The major adducts from the reaction of (14) and nitrile
oxides (2) and (37) had the expected stereochemistry, addition of the 1,3dipole occurred from the least hindered 7C-face of the exo-cychc methylene

viii

of (14). Hydrogenation / hydrolysis of the cycloadduct of (14) and C,Ndiphenylnitrone gave the novel compound, cw-(2/?,45)-l,4-diphenyl-2benzoylazethane (58).
In Chapter Four, a new method for the synthesis of polyfunctional prolines
w a s established through ejco-diastereoselective 1,3-dipolar cycloaddition
reaction of (2/?)-3-benzoyl-4-methylene-2-phenyloxazolidin-5-one (22)
and Af-benzylidene a-amino acid esters. T h e proline derivatives (49) and
(50) were synthesised in high enantiomeric purity ( 9 2 % e.e.) by
methanolysis of the oxazolidinone moiety of their respective cycloadducts.
In the case of ethyl N-benzylidene glycinate, a Michael addition product
(35) and two novel tricyclic compounds (30a) and (30b) were also isolated
and characterized.
In each Chapter, the stereochemistry of the products was determined by a
combination of single crystal X-ray structural analysis, I D and 2 D N M R
spectroscopy and molecular modelling.
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CHAPTER ONE

INTRODUCTION
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1-1. Non-Proteinogenic a - A m i n o Acids ( N P A A s )

The a-amino acids form one of the five major classes of natural products
and they exhibit an important and diverse range of biological properties.
Historically, the a-amino acids have been subdivided into the 20
proteinogenic and the non-proteinogenic ( N P A A ) representatives. The
number of k n o w n naturally occurring non-proteinogenic examples is
constantly increasing and had reached 1000 w h e n counting was
discontinued in 1989.1 These compounds are mainly produced by various
micro-organisms and m a n y of them are the end products of secondary
metabolism, which have evolved to interfere with the biochemical
pathways of other organisms.la The number of non-natural or totally
synthetic amino acids could in principle be almost infinite. The N P A A s
possess enormous structural diversity and a broad range of biological
activity including medicinal properties,2 and the ability to act as enzyme
inhibitors.^ S o m e N P A A s , are important intermediates in biosynthesis,4
while others have found application in the investigation of enzymatic
mechanisms.5
New peptide pharmaceuticals have been developed by incorporating one
or more conformationally restricted N P A A s into bioactive peptides,
including peptide hormone analogues and enzyme (protease) inhibitors.63
This incorporation constitutes an important approach to the systematic
study of the structure-activity relationships of peptides and also offers the
potential to discover analogues with improved stability, bioselectivity and
bioavailibility. Af-methyl amino acids, a,a-disubstituted amino acids,
proline analogues and dipeptide lactam derivatives are c o m m o n examples
of moieties that m a y be incorporated to influence the local conformation
of peptides.61*

Chapter 1

3

Like proteinogenic amino acids, N P A A s can also be used as chiral
starting materials in organic synthesis and for the preparation of chiral
auxiliaries for use in asymmetric synthesis.7
1-1-1. Cyclic Non-Proteinogenic A m i n o Acids
Conformational^ rigid cyclic a-amino acids are useful for probing the
structure and steric requirements of the receptor sites by which amino
acids are transported or stimulate hormonal secretion.8 Since m a n y of
these cyclic a-amino acids are a',a"-disubstituted amino acids,
conventional enzymic optical resolution technology cannot be applied
effectively to their asymmetric synthesis. While various synthetic
methods have been reported for the synthesis of cyclic amino acids, no
general method has been developed for the asymmetric synthesis of these
compounds.
1-1-1-1.

Bicyclic A m i n o Acids

(2iS)-2-Aminonorbornane-2-carboxylic acids (1) and (2) are cyclic amin
acids in which rigidly specified positions are taken by carbon atoms
corresponding to those of the ordinary branched chain amino acids (S)isoleucine (3) and (S)-valine (4), respectively. A m i n o acids (1) and (2)
are transported by the same system operating for amino acids with
branched, hydrophobic side chains (eg. (3) and (4)) in some cells and
tissues.9 Evidently, several of the carbon atoms in (1) and (2) take
critical positions in space which meet the site-fitting requirements that are
met so well by the branched chains of leucine and isoleucine (3), less well
in the case of valine (4). For the species in which the transport system
shows the narrowest specificity to such amino acids, namely that in
Escherichia coli, the restriction to one of the two stereoisomers (1)
appears complete.8a The compounds (1) and (2) have also been used as
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stimulators for the release of insulin from the rat pancreas.9a These
results bear significantly on the character of the receptor site at which
administered leucine and other amino acids produce their hypoglycaemic
action and their stimulation of insulin release.90
CH3

VI .NH2
*^—'

V

C02H

(2S)-endo (1)

CH3

H C02H

(5)-Isoleucine (3)
CH3

H

H3CJ^C02H
ft

NH2
(2S)-exo (2)

NH2
(5)-Valine (4)

A similar study on 2-aminobicyclo[2.2.2]octane-2-carboxylic acid (5) has
been reported.8b In this study the effect of this compound on the levels
of the neutral and aromatic amino acids of the rat cerebral cortex was
examined. C o m p o u n d (5) caused an elevation in the levels of isoleucine
and leucine. The level of methionine, on the other hand, was depressed
by this compound. The observed effects of this bicyclic amino acid and
other cyclic amino acids as selective perturbators of the cerebral free
amino acid pool, provide n e w avenues of entry for the study of amino
acid-dependent dysfunctions of the brain. Foremost a m o n g these is the
capability they afford to experimentally manipulate cerebral amino acid
levels where they are abnormal.8b
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A m i n o acids with the norbornane skeleton have been prepared by two
different routes: Strecker or Bucherer synthesis from the corresponding
carbonyl compounds (Scheme l.l),10 and the Diels-Alder reaction with
cyclopentadiene and a,(3-dehydroamino acids ( D H A A s ) .

T h e latter

synthetic approach has also been used for the asymmetric synthesis of 2aminonorbornane-2-carboxylic acids (Scheme 1.2).11
2-Amino-1,2,3,4-tetrahydro-1,4-methanonaphthalene-2-carboxylic acid
(7), of unknown stereochemistry, was obtained as the sole amino acid
product from l,2,3,4-tetrahydro-l,4-methanonaphthalene-2-one (6) using
the Strecker or Bucherer method of synthesis.10 C o m p o u n d (5) was
prepared by Zand et al. via a similar procedure.813
Scheme 1.1
Strecker route
CONH2

Qfc/"^' Obr>Ob;
NHCH2Ph -—*- —' NHCH2Ph

(6)

Bucherer
iv
route

t

m

I

(7)
i, P h C H 2 N H 2 , K C N ; ii, H 2 S 0 4 ; iii, Pd-C 5%, EtOH; iv, (NH 4 )2C0 3 , K C N ; v,
Ba(OH) 2 , vi, 10% H 2 S 0 4

Cativiela et a/.n(b-e) reported that the Diels-Alder reaction between
cyclopentadiene (CPD) and (-)-menthyl N-acetyl-a,p-dehydroalaninate
(8a) is an excellent method for the asymmetric synthesis of 2-endoaminonorbornane-2-exo-carboxylic acids (2) and (10), whereas the use of
the Af-acetyl-a,p-dehydroalaninate of (-)-c/s-3-hydroxyisobornylneo-
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pentyl ether (8b) as a dienophile is a better method for the asymmetric
synthesis of 2-ejto-aminonorbornane-2-e«<i0-carboxylic acids (9) and (1)
(Scheme 1.2).
Scheme 1.2
.C02RH
H2C=
NHCOCH3
(8)

"

/b

V

NHCOCH3+ / X ^ j T
CO2R*

/Oc°2R*+

*•

JCO2R*
"^ N H c o c H 3

NHcocH3

C0 2 R*

Jb» ,&£

C02H

C02H
(9) (IR, 2R, 4S)

V

NHCOCH3

(1) (IS, 2S, 4R)

&F"'&C
C02H

NH2

(2) (IR, IS, 45)

(10) (IS, 2R, 4R)

CH 3
a : R* = xPr

b:R* =

In the above reactions the (2S) stereoisomers (1) or (2) are produced
predominantly.

In 1993, E. Bunuel et al.12 introduced AT-[bis

(methylthio)methylene]-dehydroalanine methyl ester (11) (a stable
derivative of a,p-dehydroalanine) as a new excellent dienophile for this
type of reaction (Scheme 1.3). In this reaction the ratio of the exo
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carboxylic acid to the endo one can be changed by changing the Lewis
acid catalyst from T i C U to EtAlCb.
Scheme 1.3

^/b

C0 2 CH 3
CPD
= ^
/SCH3
N
(
H
^ -\
Lewis acid
SCH 3
(11)

,C02CH3
I
,SCH3
N=cf
SCH 3

+

//
CO2CH3

The use of the Diels-Alder reactions of 1,3-cyclohexadienes with a chiral
D H A A to prepare some N P A A s with the norbornane skeleton will be
considered in Chapter Two.
1-1-1-2. Cyclic Phenylalanine Analogues
The conformationally restricted cyclic amino acid analogues of
phenylalanine, as shown in the general structure (12), have proven useful
for determining the importance of tyrosine conformation in the
enkephalins on analgesic activity and receptor recognition.13
(CH2)fNC02H
•NH2

(12)
These series of compounds have been prepared13 by the Diels-Alder
reactions of 1,3-butadiene and 2,3-dimethyl-l,3-butadiene with (Z)-2phenyl-4-benzylidene-5(4H)-oxazolone (13), to give the l-amino-2phenylcyclohexanecarboxylic acid derivatives (14) and (15) (Scheme 1.4).
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Scheme 1.4

V

^ ~ \

(C02H

d:^a

NH 2

Ph

^
Ph
(14)

X xt

\

AlCl2Et

The azetidine-based analogues (16a) and (16b) have structural features
that m a y prove useful when incorporated into peptides as phenylalanine
mimics. 14a For example, they should have improved metabolic stability
since tertiary amide bonds are resistant to proteolysis. 14b » c T h e
conformationally restricted analogues (16a) or (16b) m a y also be useful
in the design of novel peptide-based enzyme inhibitors.15

N—L
H'

C0 2 H
(16a)

The efficient method15 for the synthesis of this ring system starts from
the alkylation of benzhydrylamine (17) with tert-butyl bromoacetate (18),
and after 4 steps a mixture of the trans isomer (16a) and the cis isomer
(16b) were obtained. The trans isomer (16a) was the major product
(Scheme 1.5).
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Scheme 1.5

R N H 2 + BrCH2C02Bu't
(17)

H
.N
R

l

(18)

u
C0 2 Bu t

(R = Ph2CH)

v
H

'C02H

iv

H

C0 2 Bu l
C0 2 Bu l

35% overall (16a) (trans)
6% overall (16b) (cis)
i, K2CC>3, KI, D M F ; ii, Hunig's base, PhCOCH 2 Br, acetone; iii, 1. NaBH 4 , CeCl3, 2.
SOCl2, CHCl3;,iv, 1. NaN(Si(CH3)3)2, THF, -78 °C, 2. Pd(OH)2, H 2 , HCl-MeOH; v,
H C 0 2 H (88%), 80 °C.

The synthetic method for the preparation of (16a) and (16b) may also be
applicable to the synthesis of similar conformational^ restricted
analogues of other amino acids, such as tryptophan, tyrosine, methionine,
lysine, leucine, and histidine.
The 2-amino substituted l,2,3,4-tetrahydro-l,4-methanonaphthalenes (19)
and (20) represent rigid, pharmaceutically interesting analogues of more
conformationally flexible phenylamino compounds such as amphetamine,
dopamine, and noradrenaline, which m a y provide useful information
about

the nature

of agonist-receptor

phenylethylamine systems.10

interactions

in these
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Replacement of the 1-tyrosyl moiety in Leu-enkephalin methyl ester with
one of these two amino acids led to a 7 to 8 times higher agonist activity
at the analgesic JI -receptor subtype in guinea pig ileum (GPI), when
compare to Leu-enkephalin.16
1-1-1-3. Cyclic Alanine Analogues

Replacement of the alanyl-proline portion of a peptide with the bicycli
moiety (21) has been used to generate novel metalloprotease inhibitors
for the treatment of hypertension and congestive heart failure17 (eq 1.1).
The alanine methyl group is joined to the C-5 position of proline ring by
a ethylene linker to make the fused bicyclic lactam (21).
Me
\

(eq 1.1)

°

C02H

°

C02H

(21)
1-1-1-4.

Prolines

Proline is an amino acid that plays a significant role in the biochemi
of proteins, including preference for secondary structural motifs.
Several proline analogues are rare naturally occurring amino acids, they
are constituent amino acids in antibiotics, and recently they have gained
interest in the development of novel Angiotension Converting E n z y m e
( A C E ) inhibitors as a target of therapeutic agents designed to lower blood
pressure in man. 1 8 The antibiotic P 168 (22) was isolated from a culture
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filtrate of paecilomyces lilacinus and has 4-methyl proline as one of its
amino acids.19a This antibiotic was found to possess a wide antimicrobial
spectrum against fungi, yeasts, and gram-positive bacteria.19b
CH3

I
C 2 H 5 CHCH= C H C O — N — r — C — N H C H C O — N H C H C O — N H C C O — N H

I

/

\ °

\

\

I

CH'
CHCO
NH
H3C—C—CH3
CO
NH
H3C—C—CH3
CO

I
H3C

NH2CHCHN
CH3 CH3
(22)

OCH2CH2CHN

NH
OCCH2CH2

Substituted prolines provide a n e w type of simple conformational
constraint. 4-Substituted prolines have been synthesised by chirospecific
transformations of glutamic acid (23), in four steps as shown in Scheme
1.6.18

A suitably protected glutamic acid derivative (25) (9-[9-

phenylfluorenyl] is the nitrogen protecting group) was alkylated and
selective reduction of the distal esters of (26) and (27) was achieved by
the proper choice of ester protecting groups. Finally ring closure to
prolines (28) and (29) completed the synthesis (Scheme 1.6). The optical
integrity of the final proline derivatives was shown to be > 9 9 % .

3 0009 03143377 9
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Scheme 1.6
H2N,, X 0 2 H

PhFlHH C02R PhFlH^ COzBu1 PhFlHN, C02Bu'
l.KMHDS
2.RX •

vR +

C0 2 CH 3
(23)

C02CH3

C0 2 CH 3

(24) R = H
(25) R = Bul

(26 a-d)

PhFlHN,, X02Bu

l

J

PhFlHN, X02Bul
..*R

CH2OH

R

R
^ NN^ C OC0
z B2Bu
u 1l
I
PhFl
(28 a-d)

26 - 31 a) ; R = CH 3
b); R = CH 2 CH 2 CH 3
c) ; R = CH 2 CN
d);R = C 6 H 5

N+
H2

C0
C 022"

(30 a-d)

^ N ^C02Bul
PhFl
(29 a-d)

N+
N+
H2

C02-

(31 a-d)

Other examples of non-proteinogenic proline derivatives are compounds

(32) and (33). They have recently been detected in a novel cyclic pept

scytonemin A, a metabolite of cultured cyanophyte Scytonema sp., which
possesses potent calcium antagonistic properties.20

Chapter l

13

Q^

C0 2 H

•-A.

H

N
H

(32)

(33)

"C0 2 H

Several other structurally novel proline derivatives are potent ACE
inhibitors (34 a-e) and contain L-proline as the C-terminal portion.2la
Captopril (34 a) is the first A C E inhibitor to have been approved as a
drug. It is used in the treatment of essential hypertension and congestive
heart failure.2lb Captopril and its analogues have several advantages
over conventional antihypertensive therapeutics including the lack of
interaction with the central and automatic nervous systems.

^j/^C02H

(34 a) ; R
(b) ; R
(c) ; R
(d) ; R
(e) ; R

I
R
= HSCH 2 CH(CH 3 )CO
= HSCH2CH2CO
= PhCH 2 CH 2 CH(C0 2 Et)NHCH(CH 3 )CO
= PhCH 2 CH 2 CH(C0 2 H)NHCH(CH 3 )CO
= PhCH 2 CH(NHCOPh)COCH 2 CH 2 CO

The introduction of conformationally constrained analogues of proline
into peptides by incorporating 3-substituted derivatives is an important
tool in developing peptide-derived pharmaceutical agents.22 The
replacement of appropriate residues in biologically active peptides with
these analogues could lead to important conformational information and
offer the potential to discover peptide analogues with improved
selectivity, stability, or bioavailability. D u e to motional restrictions
inherent to the pyrrolidine ring, the presence of a proline residue greatly
reduces the available conformational space of a peptide and gives rise to
conformers separated by relatively high interconversion barriers. Thus,
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information can be obtained about the bioactive conformation of a
peptide, and the biological potency m a y be increased by incorporation of
a proline residue.23
Replacement of proline by its higher homologue is reported to
dramatically improve pharmaceutical potency in peptide-based H T V
proteinase inhibitors.24 Since the amide bonds of proline residues (35)
and (36) are not susceptible to cleavage by mammalian endopeptidases,
these compounds can provide a basis for the rational design of H T V
proteinase inhibitors selective for the viral enzyme.

CO-

OH

9
CO-

Reduced amide

Hydroxyethylamine

(35)

(36)

The reduced amide (35) and the hydroxyethylamine (36) structures most
readily accommodate the amino acid moiety characteristic of Phe-Pro and
Tyr-Pro in retroviral substrates. Although the compounds containing the
reduced amide function are relatively poor inhibitors, the compounds
incorporating the hydroxyethylamine moiety are very potent and highly
selective inhibitors of H I V proteinase.24
The 1,3-dipolar cycloaddition reactions of azomethine ylides from Nalkylidene a-amino acid esters to electron deficient alkenes is an
extremely powerful method for the asymmetric

synthesis of

polyfunctional prolines.lb In this synthetic method, that will be outlined
in Chapter 4, a chiral D H A A will be employed as a dipolarophile for the
asymmetric synthesis of proline derivatives.
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Cyclic Glutamate Analogues

L-Glutamate is the major excitatory neurotransmitter in the mammalian
central nervous system.25 In this role glutamate binds to a number of
different proteins, including several distinct receptors, transport systems,
and enzymes. In addition, abnormal levels of glutamate have been linked
to a wide spectrum of neurological disorders, including ischaemia,
anoxia, hypoglycaemia, epilepsy, and Huntington's, Parkinson's, and
Alzheimer's diseases.26 In particular, structure-activity studies with
conformationally restricted glutamate analogues have provided valuable
n e w information about the structural requirements for binding to the
various glutamate receptors, and to the high-affinity glutamate uptake
system responsible for removing glutamate from the synaptic cleft.
Kainic acid (37) occurs naturally in red algae and exerts a powerful
neuroexitatory effect on glutamate receptors.27 This compound exhibits
neurotoxic activity and has a role in the treatment of Huntington's disease
(a rare hereditary disease of the nervous system).
H3c^-\ ^—C02H
\N/^CO2H

I
H
(37)
In Scheme 1.7 the enantioselective synthesis of the four diastereomeric
pyrrolidine-2,4-dicarboxylates (39, 40, 42, 43) from commercially
available frans-4-hydroxy-L-proline (38) and cw-4-hydroxy-D-proline
(40) is outlined.28 These rigid analogues contain an embedded glutamate
moiety. While none of the four analogues binds effectively to the

Chapter 1

16

excitatory receptors, the L-trans-isomer (40) is a potent and selective
competitive inhibitor of L-glutamate transport.28
Scheme 1.7
H0 2 G

TsQ
a.b,^
N/^C02Et

HO

C0 2 H

CBZ

CBZ
(39)

NT*C02H
H
(38)

H02C%

H 3 C0 2 C^

TsQ

_a_,h,i

d,e^ / \ f,

b

N/^C02H
I
H

/
C02Et N ^C02CH3

^

CBZ

CBZ

(40)

a,b,c^

I

V

d,e»
C02Et

o.
N

C0 2 H

f,

ex
N
I
CBZ

CBZ

HQ

H02C

H 3 C0 2 C.

TsQ

••vC0 2 H

C0 2 CH 3

I
H
(42)

j,k,c

I

H
(41)

HOzQ,

H 3 C0 2 C 4
d, e^
C02Et
CBZ

o,

1^ "
••*

C0 2 CH 3

C0 2 H

H

(43)
CBZ
(a) ClC0 2 CH 2 Ph, N a H C 0 3 , H 2 0 , PhCH 3 ; (b) EtOH, p-TsOU; (c) TsCl, py; (d) NaCN,

DMSO; (e) HCI, wet CH3OH; (f) NaOH, THF-H20 1:1; (g) H2 (48 psi) / 10%

CH3OH; (h) Jones oxidation; (i) NaBILj, CH3OH; (j) n-Bu4NOAc, acetone;
EtOH
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Aminocyclobutanecarboxylic

Acids

Amino acids of the cyclobutane series (AACB) are compounds which
have been relatively little investigated. These compounds were almost the
only type of amino acids which have not been detected in natural sources
until 1980 when Bell et al29 isolated them from Atelia Herbert Smithii
(Sophoreae, Leguminosae).

Since biologically active substances with

antiviral, neurotropic, analgesic, depressant, antimicrobial, and other
activities have been found among A A C B derivatives, these compounds
have attracted the attention of chemists during the recent decades.30 1Aminocyclobutanecarboxylic acid (44) is an inhibitor of the growth of
tumours and a selective antagonist of N-methyl-D-aspartic acid in relation
to the [2H]-receptors of histamine and [3H]-receptor of glycine. The 2-(3methoxyphenyl) derivative of (44) inhibits aminooxidases in rat liver
mitochondria.30
C02H

<X
v

NH 2
(44)

A successful preparative method for the synthesis of compound (44) is the
classical hydantoin synthesis of amino acids (Scheme 1.8).31
Scheme 1.8

A / ™ 2
\Ax>NH2

1-NaOCl
2.NaOCH3

^VC°fH

QH

"

»

(44)

\/\HCO

In 1986, M. Jouda et al.32 reported the use of ethyl isocyanoacetate (
and 1,3-dibromopropane (46) for the preparative synthesis of compound
(44) in 9 8 % yield (Scheme 1.9).
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Scheme 1.9
C 2 H 5 0 2 CCH 2 N=C: + Br(CH2)3Br
(45)

^
• /\S
*2
D M S O / (C2H5)20
V ^ ^ C:

5

(46)
1. HC1/C2H50H 2. NaOH

(44)

1-1-1-7. Cyclopropane Amino Acids
Among conformationally restricted amino acids, 1-aminocyclopropane
carboxylic acid ( A C C ) derivatives constitute a wide family of naturally
occurring or synthetic compounds which have attracted special attention
due to their biological activities as phytochemical agents, enzyme
inhibitors and probes in metabolism studies.33 These sterically rigid
cyclopropane amino acids were found to be a key constituent not only as
conformational constraint but also as a structural element to avoid
enzymatic degradation.34

For instance, the parent compound (47),

isolated from several fruits (cider apples and perry pears), has been
found to be the biosynthetic precursor to the plant hormone ethylene.35
It has also been shown that allonorcoronamic acid (47) is a substrate and
the strongest k n o w n competitive inhibitor of the ethylene-forming
enzyme in m u n g bean hypocotyls.40

* ^ XT

"02C

H

02C
(47)

(48)

Incorporation of cyclopropane amino acids into several peptides has
achieved for some neuropeptides, hormones, and enzyme inhibitors.34
T w o interesting examples that involve the use of methanophenylalanine
(49) include novel enkephalin and aspartam analogues. Enkephalin
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analogues showed reduced activity in the mouse vas defens and GPI
muscle assays, the peptides showing a strong preference for the 5receptor of the G P L 3 7

(49)

These studies illustrate the potential medicinal utility of peptides
incorporating A C C derivatives.
Mono- and disubstituted ACCs have been synthesised through the
following routes:
1) Tandem dialkylation of a glycine equivalent with a 1,2-dibromoalkane
(Scheme 1.10) 38a or a similar 1,2-disubstituted electrophile.38b
Scheme 1.10

BrCH 2 CH 2 Br

+

H2<

N

,C6H5
N=CX
C6H5

C 6 H 5 CH 2 N + (C 2 H 5 )3Cr/
50
% aq. NaOH / toluene ^

£SCN
^
N=K
C6H5

1. 1 normal HCI
2. cone. HCI, reflux
C02H
NH2
87% (overall)

2) Diazoalkane or dimethylsulfoxonium methylide addition to
dehydroamino acid derivatives, followed by extrusion of N 2 gas 3 9 a
(Scheme 1.11) or elimination of D M S 0 3 9 b , respectively.
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Scheme 1.11
Ph

Ph
CH 2 N 2

N2

x

HN^O

ROH

N ^ ~0

DMAP

C02R
H
1. Et30+BF4"
2. H + /H 2 0

P h . N H

2

H2/Pd

C0 H
lAAx>*
2

V/

+
3 C1"

1NH

C02R

In the above synthetic methods there is no single, general stereocontrolled
approach to differentially substituted A C C derivatives in optically pure
form.
Williams et al^1 prepared (E)-2-alkyl ACCs (54) in high enantiomeric
purity. This approach employs the phosphonate ester (51) which is
produced by bromination of the lactone (50) and then treatment with
trimethyl phosphite under reflux (Scheme 1.12). Subsequent treatment of
(51) with base and aldehyde through the Wittig reaction provided the
cyclic (iTJ-ajp-dehydroamino acid derivative (52). The cyclopropanation
reaction product was obtained upon treatment of the D H A A (52) with the
NaH-derived dimethyloxosulfonium methylide (53).
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Scheme 1.12
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Ph

H |

Ph
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0
3

Ph

NaH/THF^ ^ j " fc-n
RCHO t.B0C' " I

X°

MeO^f^O
OMe

(50)

H

R

(52)

(51)

DMSO
^

+

' Et2N
(53)

+
H

3N. y. H
\yX/
-02C
R

t-BOCH V / \ /

1
. HCI / MeOH
2. propylene oxide
EtOH, reflux

H0

2c

R

Li°/NH3/THF
EtOH
t-BOCN

(54)
H

R

1-1-1-8. Other Cyclic A m i n o Acids
The clinical studies of Zabicipril (55) (alanine analogue) suggest that this
compound is a well tolerated, powerful and long acting inhibitor of A C E ,
with maximal inhibitory effect at 2.5 m g per day when given via the oral
route.40a Compound (55) is an acid-ester, devoid of activity per se,
which is transformed by liver esterases into its active diacid form
Zabiciprilate (56) (eq 1.2). In vitro, (56) is a very active compound
(IC50=1.8 nmol, substrate: hippuryl-histidyl-leucine).40b It is believed
that the two carboxylic groups of (56) bind to the positive sites of A C E ,
which suggests the spatial disposition of these charged groups in the
enzyme.
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C02H

A^y

C02H

Liver esterases

N
^

(eq 1.2)

*f H
H

J>\ ^COzH

\^C0 2 C 2 H 5

H.HcV^CeHs

H.HC1^

(55) Zabicipril

X

c6H5

(56) Zabiciprilate

The synthesis of (55) and (56) was performed via coupling of the two
intermediates (57) and (58) following the route outlined in Scheme
1.13.40
Scheme 1.13

J2>

C02H

A"

u

N
H
+ H 2 cr

C6H5

£ C02H
,C02CH2C6H5
m

N Jj
H

C02C2H5
(58)

AK, ^J^T*
C02CH2C6H5

vi

^N H

H3

0
,\ \^C0 2 C 2 H 5
H

C6H5

\ X

H* N
H

(56)

\>C02C2H5
C6H5

(55 a), neutral form
(55), hydrochloride

i, N a O H ; ii, resolution by (-)-tartaric acid; iii, C 6 H 5 C H 2 O H , P T S H ; iv, coupling; v, H 2
cat Pd/C;vi, N a O H
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Cyclopentylglycine is an excellent inhibitory analogue of isoleucine in
that the toxicity of the analogue for E. coli is prevented in a competitive
manner over a broad range of concentrations at a relatively low
inhibition index. A study of the effects of the metabolites on the toxicity
of cyclopentylglycine has revealed that certain metabolites, particularly
threonine, allow E. coli to synthesise increased concentrations of
isoleucine. The keto analogue of isoleucine, a-keto-P-methylvaleric acid,
is very effective in preventing the toxicity of cyclopentylglycine, and this
activity can be accounted for only in part by its conversion to
isoleucine.41
Introduction of a cycloalkyl group to the p-position of an a-amino acid
and incorporation of the so-obtained cycloalkylglycine into peptides
provides novel renin-inhibitors.42a The renin-angiotension system plays
a central role in the pathogenesis of hypertension, mostly via the
circulating vasoconstrictor angiotensin II. The most important reaction
of renin is the proteolysis of the Af-terminus of the globular protein
angiotensinogen to the decapeptide angiotensin I. Replacement of the
Leu-Val peptide bond that is cleaved in this reaction, with a cyclic
substituted (S)-hydroxyethylene amide bond surrogate, renin-inhibitors of
the type (59) are obtained.4215

Since these molecules resemble the

transition state for cleavage by aspartyl proteases they possess a high
affinity for renin but are not cleaved by the enzyme. 4 2 a
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The enzyme inhibitory activity against endogenous renin from human
plasma of the renin-inhibitor (60) that incorporates a cyclopentylglycine
had an ICso=1.3 nmol L"l. 42a

H
Q
^

N-CO-NH CO-NH

CO-NH
OH
(60)

The 1,3-dipolar cycloaddition of allylamines (61) with N-benzylnitrones
(62) provides an easy access to this type of structure.

The

stereochemistry of the product can be influenced either by employing
chiral nitrones or chiral allylamines. The synthesis of the renin inhibitor
(60) via the chiral and enantiomerically pure isoxazolidine (63a) is shown
in Scheme 1.14.42a
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Scheme 1.14
CH3
N;

1,11

k.Ph
(61)

H2N-^^/CH3
0— N^^Ph

(62)

(63a) (12?, 35, 45)

H2N
OH

BocHN

CH3

0

C0 2 H

CO-NH
OH

CH3

0

vin

6

N- C O - N H

C0 2 H
(60)

i, Mesitylene; ii, Si02, chromatography, n-hexane/ether 7:3; iii, NH4+HC02", 1 0 %
Pd/C, C H 3 O H , reflux; iv, ( n - C ^ C O h O , NEt3, C H 3 O H ; v, 4 N HCI, dioxane; vi,
dicyclohexylcarbodiimide (DCC), hydroxybenzotriazole (HOBT), diisopropylethyl amine
(DIPEA); vii, 4 N HCI, dioxane; viii, D C C , H O B T , DIPEA
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1-1-2. Asymmetric Synthesis of Chiral A m i n o Acids
While a number of methods have been reported for the synthesis of
biological active cyclic amino acids, these approaches have their
individual strengths and weaknesses.

S o m e of them were not

stereoselective and gave the target molecules with no defined
stereochemistry.

Others were racemic in design, and incorporated

enzymatic or chemical resolutions as the final step. While in others,
although the target compounds have been prepared in enantiomerically
pure form, they involved lengthy synthetic procedures using many
reagents.
In this thesis the asymmetric synthesis of some NPAAs through
cycloaddition reactions, starting with the chiral D H A A , (2fl)-3-benzoyl4-methylene-2-phenyloxazolidin-5-one (64) will be developed (Scheme
1.15). In principle theses approaches would allow access to the target
molecules with high enantiomeric purity and achieve the rapid assembly
of the N P A A s in a minimal number of synthetic steps.
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Scheme 1.15

R-r-

C0 2 Me
*"' N H 2
C0 2 H

R'H

H0 2 C

NH2

In Chapter T w o , the development of asymmetric synthesis of N P A A s
through the Diels-Alder reactions of substituted 1,3-cyclohexadienes and
substituted 1,3-butadienes with compound (64) will be considered. The
1,3-dipolar cycloaddition reactions of chiral oxazolidinone (64) with
nitrones and nitrile oxides will be explored in Chapter Three. The
asymmetric synthesis of polyfunctional prolines through the 1,3-dipolar
cycloaddition reaction of azomethine ylides derived from Af-alkylidene aamino acid esters with compound (64) will be described in Chapter Four.
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1-2. oc,P-Dehydroamino Acids (DHAAs)
D H A A s are recognised to be intermediates of extensive value in both
organic synthesis and biological transformations.43 These compounds
are extremely useful substrates for preparing both natural and nonproteinogenic amino acids (NPAAs). These substrates have the following
structural unit (65):44

Y--.

(65)
Y = 0,N
X = HCO, CH3CO, ArCO, alkylC^C, aralkyl02C, a-aminoacyl
R, R' = H, alkyl, aryl, heterocycle

DHAAs have been prepared by various synthetic methods. These
methods involve syntheses via elimination reactions or via C-C double
bond

forming

reactions.44

The Af-chlorination

and

then

dehydrochlorination of a-amino acid esters (Scheme 1.16) and a-N-acyl
amino esters (Scheme 1.17) are examples of the former synthetic method.
Scheme 1.16
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NH

NH 2
HCI

J

Chapter 1

29

Scheme 1.17
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R 1-X
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The condensation of aldehydes and ketones with isocyanoacetates is an
example of the synthesis of D H A A s through the later synthetic method
(Scheme 1.18).
Scheme 1.18
for R 3 = Bul
NaNC
R'
Rl

C02R~

•u
R

Bu 4 OK
1 2 R~
C0

NC

for R 3 = C 2 H 5
BuLi or NaH
orB u t Q K

»

R'
R 1

/^/C02RJ

HN^
CHO
The vast majority of the literature dealing with the chemistry of D H A A s
involves nucleophilic and electrophilic addition reactions to give P and a
substituted amino acids, respectively. Relatively few applications of
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cycloaddition reactions of D H A A s to the synthesis of geminally
functionalized cyclic amino acids have been described to date.43 Racemic
a-amino acids have been prepared from the conjugate addition of
nucleophilic reagents to D H A A s . 4 4 These substrates ( D H A A s ) have been
employed as dienophiles in Diels-Alder reactions 11-13 and as
dipolarophiles in 1,3-dipolar cycloaddition reactions (Scheme 1.19)43for
the synthesis of cyclic amino acids.
Scheme 1.19
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To prepare the cyclic a-amino acids in high enantiomeric purity chiral
D H A A have to be employed. The chiral D H A A that w e have chosen is
the chiral 1,3-oxazolidinone derivative (64).
1-2-1. 1,3-Oxazolidinones as the Chiral Auxiliary.
In 1987, Seebach et alA5 reported the synthesis of the DHAA, (25)-3benzoyl-2-te7t-butyl-4-methyleneoxazolidin-5-one (67) from the
bromination and then dehydrobromination of the oxazolidinone (66),46
derived from (S)-alanine (Scheme 1.20). In 1990, a modified synthesis of
(67) was reported by Beckwith et alA1 The latter author has employed
this compound as a useful Michael acceptor for alkyl radicals to produce
a-amino acids in high enantiomeric purity.
Scheme 1.20
H Me

CH2

X ^ ° ...
PhCON T
H Bu1
(66)

A^°

''" » PhCON J
H Bu1

+

PhU N
%
H

i
W

(67)

i, N-bromosuccinimide (2 eqiv.), hv, (PhC02)0; ii, Nal, acetone, heat

More recently, Pyne et a/.48a'b reported a new method for the synthesi
of (67) and its (2R) analogues (64), (68a) and (68c) from (S)-Smethylcysteine (Scheme 1.21). These compounds have been employed as
dienophiles in Diels-Alder reactions with cyclopentadiene and 1,3cyclohexadiene48 and the resulting adducts were used to prepare cyclic
N P A A s (2) and (9) in high enanatiomeric purity.
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£E>O 2 H

£Lj(

A
NH2

NH2

(2)

(9)

1-2-2. Synthesis of (25) and (2fl)-4-Methylene oxazolidin-5-ones
The reaction of (25)-5-methylcysteine (69) with benzaldehyde or
pivaldehyde and then treatment with benzoyl chloride or acetyl chloride
gave a mixture of cis and trans oxazolidin-5-ones (70) and (71). This
mixture was converted into a mixture of sulfones (72) and (73) by
oxidation with Oxone in acetonitrile in good yield. Treatment of
diastereomerically

pure

(72a)

or

(73a-c)

with

1,8-

diazabicyclo[5.4.0]undec-7-ene ( D B U ) smoothly yielded (67), (68a), (64)
and (68c) respectively, in high enantiomeric purity (Scheme 1.21).
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Scheme 1.21
SMe

SMe
SMe

vy"
H 2 N*"y

x

S

OH

\

»RCHO
h) R
_____
!SS

+ R 2 CON

COC1

T,

H R
(69)

(71)
Oxone

S02Me

R2CON T

+ R C0N

S02Me

v •

H R1 H Rl
(73)
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S02Me
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(67)
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- • R2CON

R2

(a) Bul Ph
(b) Ph Ph
(c) Ph Me

f^

H R1
(73)

(68a) ; R1 = Bu1, R 2 = Ph
(64) ; R1 = Ph , R2 = Ph
(68c) ; R1 = Ph , R2 = Me

In the first reaction, the ratio of cis and trans isomers (70) and (71), was

dependent upon the nature of the substituents R1 and R2 as shown i
Table 1.1.

Chapter 1

Table 1.1. Diastereomeric ratio of the cis/trans oxazoIidin-5-ones (70) :
(71).48
Product(s) from (69) Diastereoselection
(70): (71)

Yields(%)

(70a)/(71a)

81:19

49

(70b)/(71b)

6:94

28

(70c)/(71c)

8:92

23

While the purified yields of (71b) and (71c) were poor, these latter
reactions were m u c h more diastereoselective than that leading to (70a)
and (71a). Furthermore, these syntheses avoid the use of expensive
pivaldehyde. Since (71b) can be more easily obtained diastereomerically
pure than (70a) or (71c), it was decided to study the cycloaddition
chemistry of the (2#)-oxazolidinone (64).
1-2-3. T h e Structural a n d Electronic Properties of the
Oxazolidinone (64).
The delocalisation of the electrons around the methylene, amide and
lactone groups of (64) are responsible for the electron deficient character
of the 4-methylene moiety of this compound. The lactone carbonyl group
in (64) withdraws electron density from the exo-cyclic methylene group
by resonance (Figure 1.1a), while the nitrogen of the amide group
reduces the electron density by induction as outlined in Figure 1.1b. The
nitrogen of the amide group would also be expected to donate electron
density into the exo-cyc\ic group by resonance. X-ray studies48 have
shown that the nitrogen of the amide group is intermediate in character
between sp 2 and sp 3 hybridisation. Alkenes like (64) which are geminally
substituted by both an electron-withdrawing (captor) and an electronreleasing (donor) groups are classified as "captodative" alkenes.49
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However, overall the exo-cyclic methylene group in (64) would be
expected to be an electron deficient double bond.
+
CH2

CH2

a)
H Ph

H Ph

1I

-A

b)

Vv-o
-0

PI/

Pff

\-0

u Ph

H Ph

PIT

CH2

V^O
H Ph

Figure 1.1. The resonance structures for the carbonyl and benzamido groups in
oxazolidinone (64).

The phenyl group at the C-2 position in (64) is a bulky group which
effectively shields the (3-face of the exo-cyclic methylene group to attack
by reagents.
cc-face

P h ^

{r

p-face

The steric and electronic features of the molecule are summarised in
Figure 1.2.

The lactone and amide groups control the electronic

properties of (64) while the C-2 phenyl group is responsible for the steric
properties of this compound. These electronic and steric features will
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determine the direction of approach and the selectivity of reactions
involving compound (64).
Electronic Control Side
CH2

PhOCN T

F

5

H Ph
Steric Control Side
Figure 1.2. The overall electronic and structural factors of the oxazolidinone (64).
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CHAPTER TWO

Asymmetric Synthesis of Cyclic A m i n o Acids via ExoDiastereoselective Diels-Alder Reactions
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2-1. A s y m m e t r i c Diels-Alder Reaction
Diels-Alder cycloadditions, which have been discovered over seven
decades ago, play an ever increasing role in contemporary organic
synthesis.50 in particular, asymmetric Diels-Alder reactions have become
of prime interest during the present decade, this being in great part due to
the fact that modern pharmacopoeia requires enantiomerically pure drugs,
with the potential advantage of a lower dose and a greater safety, as
compared to the corresponding racemates.
The usefulness of the Diels-Alder reaction in synthesis arises from its
versatility and its high regio- and stereoselectivity. In addition, this type of
reaction can be used in asymmetric synthesis, with a non-statistical mixture
of optically active diastereomeric products resulting when either the diene
or dienophile is chiral, enantiomerically enriched and facially selective.
O n e type of asymmetric Diels-Alder reactions has been realized by
temporarily attaching to the diene or dienophile an optically active
auxiliary group.

This auxiliary can then be removed from the

diastereomerically pure adduct to give an enantiomerically pure product
(Scheme 2.1)51
Scheme 2.1

C- r

R*

R * = Optically active
auxiliary group

-d

R*

Auxiliary R * removed
from purified diastereomer

H

Or

Chapter 2

39

A number of optically active alcohols have been employed as auxiliary
groups in this sequence, including menthol and, better, (-)-8phenylmenthol or neopentyl alcohols (1) and (2).52

(D (2)
In Lewis acid catalysed Diels-Alder reactions of the acrylate ester of
alcohol (1) with cyclopentadiene, the adduct (3) was obtained with almost
complete diastereomeric selectivity. Reduction of the purified product
with Uthium aluminium hydride regenerated the auxiliary alcohol and gave
the optically pure endo alcohol (4) (Scheme 2.2). 51a
Scheme 2.2
^C02R*

+

fl TiCl2(Ol¥)2

x

X X

CH2C12,-20°C

Jh.H

C02R*

(3)
LiAlH4

CH2OH
(4)

This reaction is believed to take place by addition of the diene to the ester
in the conformation (5) in which access to the front face of the double bond
is hindered by the neopentyl group. Other chiral auxiliaries and chiral
Lewis acid catalysts have also been employed in asymmetric Diels-Alder
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reactions, however these have been recently reviewed 5 lb and will not be
discussed in this thesis.

The chiral D H A A s (6) and (7) have been employed as a dienophile in
Diels-Alder reactions by C. Cativiela et a/.llb_e to prepare exo or endo
diastereofacial selective adducts in high enantiomeric purity (Scheme 2.1,
Chapter 1).
,co2R*
H2C

(exo diastereofacial selective)

(endo diestereofacial selective)

In this Chapter, the asymmetric Diels-Alder reactions of oxazolidinone (8)
as a chiral D H A A , with substituted 1,3-butadienes and substituted 1,3cyclohexadienes is reported as a method for the asymmetric synthesis of
novel cyclic amino acids. The regioselectivity and stereoselectivity of
these reactions is also addressed.
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2-2. Synthesis of Cyclic N P A A s by Asymmetric Diels-Alder
Reactions of (2S)- a n d (2fl)-2-Substituted

3-Benzoyl-4-

methyleneoxazolidin-5-ones
In 1993, Pyne et alA%A9 reported a new method for the synthesis of
OR) or (S) cyclic N P A A s . In this synthetic method, (2S)-3-benzoyl-2-fmbutyl-4-methylene-oxazolidin-5-one (9) and (2/?)-3-benzoyl-4-methylene2-phenyl-oxazolidin-5-one (8) were used as chiral dienophiles in DielsAlder reactions with cyclopentadiene (i) at room temperature and with 1,3cyclohexadiene (ii) at 130 °C (Scheme 2.3).
Scheme 2.3
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Scheme 2.3 (cont'd)

(ii)

(9)

PhCO

./>„
Bul H

(13)
While (8) appeared to be more reactive than (9) as a dienophile towards
cyclopentadiene, the diastereoselectivity in both cases was the same.
H o w e v e r the diastereoselectivity in the case of (8) toward 1,3cyclohexadiene was less favourable (Table 2.1).
Table 2.1. Diels-Alder reactions of (8) and (9) with cyclopentadiene (i) and
1,3-cyclohexadiene (ii).48
Dienophile

Diene

Temp.

Yield

CO

Time
(days)

(%)

Diastereoselection
(products)

(8)

(i)

25

5

100

>97 (10): <3 (others)

(8)

(ii)

130

16

63

67 (11): 33 (isomer)

(9)

(i)

25

5

70

>97 (12): <3 (others)

(9)

(ii)

130

16

62

>97 (13): <3 (others)

The exo stereochemistry of (10), (12) and (13) was established by a single
crystal X-ray structure analyses. In these reactions the diene had added to
the face of the 4-methylene group of (8) and (9) that was anti to the bulky
C-2 substituent as shown in Figure 2.1.
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PhCC^

a)

b)

Figure 2.1. Exo transition states for the addition of cyclopentadiene to a) (8) and b)
(9), addition of the diene occurs anti to the C-2 substituent.
The high e*o-diastereoselectivity in these reactions is in accord with the
work of Mattay 5 3 and Roush 5 4 w h o reported high ejco-diastereoselectivity
for the thermally induced reactions of 2-terf-butyl-5-methylene-l,3dioxolan-4-one (14a) and the related oxazolidinone (14b), respectively,
with cyclopentadiene.
£H2

if

Bul

H

(14a) ; X = O
(14b) ; X = NAc

The Diels-Alder adducts (10) and (12) were converted into related amino
acids, by first hydrogenation over palladium on carbon and then acidcatalysed hydrolysis of the oxazolidinone moiety. (\R,2S,4S)-2-endoaminobicyclo[2.2.1]heptane-2-ejc0-carboxylic acid (15) was obtained in
high enantiomeric purity (e.e. 9 2 % ) via the above procedure (Scheme
2.4).48
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Scheme 2.4
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The oxazolidinone (8) is extremely valuable since it gives cyclic amino
acids with the natural (25)-configuration, which have been used to study
the transport of amino acids with hydrophobic side chains such as leucine,
isoleucine and valine.9
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2-3. Diels-Alder Reactions of (8) a n d Substituted 1,3Butadienes
2-3-1. Diels-Alder Reactions of (8) and 2,3-Dimethyl-l,3-Butadiene
(16)

The thermally induced reaction of (8) and 2,3-dimethyl-l,3-butadiene in
C H 2 C I 2 gave two diastereomeric products. The diastereomeric ratio of
these products was dependent upon the reaction temperature (Table 2.2,
page 47). The reaction at 130 °Cfor 24 hr, resulted in a 50 : 50 mixture of
diastereoisomeric cycloaddition products, while at 60 °C over a period of 9
days the diastereomeric ratio was 97 : 3. The ratio of the diastereoisomeric
cycloadducts was determined by * H N M R spectroscopy on the crude
reaction mixtures. The major diastereomeric adduct (17) from the above
reaction at 6 0 °C could be obtained diastereomerically pure by
recrystallization. The structure and stereochemistry of this compound was
secured by a single crystal X-ray structural determination (Figure 2.2).
This analysis showed that the 2,3-dimethyl-l,3-butadiene had, as
expected, added to the least hindered diastereotopic face of the 4methylene group of (8). This solid state structure revealed the AT-benzoyl
group of the oxazolidinone ring was pseudo-equatorial with respect to the
cyclohexene ring moiety of (17). This structure is concordant with the
solution structure of (17) from *H N M R analysis that showed both H 3 p
and H 5 p are strongly deshielded (8 3.36 and 5 3.15), compared to H3oc (8
2.24) and H5oc (8 2.12) respectively, which is consistent with the close
disposition of these former two protons and the benzoyl carbonyl group in
the solid state structure (Figure 2.2). This solid state structure proved
extremely useful for assigning the stereochemistry of other Diels-Alder
adducts of (8) and 1 -substituted-1,3-butadienes that are discussed later in
this Chapter. The optimised temperature for these series of reactions was
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60 °C because of the high diastereoselectivity of cycloadducts. Heating a
solution of (17) at 130 °C for 24 hr gave a 50 : 50 mixture of the above two
diastereoisomers (Scheme 2.5).
Scheme 2.5
CH 2

phcoN y

)T0

+

r

MeA

H Ph
(8)

(16)

60 °C
PhCON'4>y-sO

PtT

PhCON^ N--sO

Ph

PhCH

0-

(19)

ent-(lS)

The minor diastereoisomeric adduct formed at 60 °C could be either
compound (18) or ent-(\S) or a mixture of these compounds. Compound
(18) could arise from addition of the diene to the more hindered 7U-face of
the 4-methylene group of (8), while ent-(lS) could arise from the
epimerization of (17) at C2' during the course of the Diels-Alder reaction.
The thermally induced ring opening of the oxazolidinone ring of (17) to
give an intermediate iminium ion (19), which could ring close to give
either (17) or ent-(\S), would be facilitated by the C2' phenyl group which
can stabilize the incipient carbocation ring-opened intermediate (19)
(Scheme 2.5). Unfortunately the minor adduct could not be separated from
the major diastereomeric product and w e were therefore unable to quantify
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the enantiomeric purity or determine the absolute stereochemistry of this
compound.
Table 2.2. Diels-Alder products f r o m the reactions of (8) a n d dienes at 6 0 ° C

Entry

Diastereoselection0
(products)

Time
(days)

Yield

1 (130 °C)

ND

50 : 50 (17,18)

2

1 (100 °C)

52

86 :14 (17,18)

3

2 (80 °C)

59

91:9(17,18)

4

9

81

97 : 3 (17,18)

1-methyl-1,3-butadiene
(23)
1-methoxy-1,3butadiene (24)

15

50

94 : 6 (25a, 25b)

10

51

82:18 (26a, 26b)

7

l-methoxy-3(trimethylsilyloxy)-l ,3butadiene (27)

2

40d

50: 50 (28a, 28b)

8

2-methyl-1,3-butadiene

10

96

66:31:3(29,30,31)

9

1,3-cyclohexadiene

15

60

74:26(11,32)

10

1-methoxy-1,3cyclohexadiene (35)
1 -(trimethylsilyloxy)1,3-cyclohexadiene
(36)
2-(trimethylsilyloxy)1,3-cyclohexadiene
(39)

8

81

89: 11 (37, c)

15

84

97 : 3 (38, c)

25

37 d

50:26:12: 12
(40a, 40c, 40b, c)

8 (80 °C)

45d

19 : 24 : 47 : 10
(40a, 40c, 40b, c)

1

5
6

11

12

13

a

Diene
2,3-dimethyl-l,3butadiene (16)

(%) a

After purification. b Determined on the crude reaction mixture by *H N M R (400 M H z ) .
c
The structure of the minor isomer is uncertain. d Yield after acid hydrolysis.
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Figure 2.2. Molecular projection of (17) normal to the plane of the five-membered
ring. 2 0 % thermal ellipsoids are shown for the non-hydrogen atoms; hydrogen atoms
have an arbitrary radii of 0.1 A.

In order to determine the enantiomeric purity of the reaction product (17),
the condensation reaction of (17) with CR)-(+)-oc-methylbenzyl amine (20)
was attempted (Scheme 2.6). Attempts to do this reaction thermally in
CH2CI2 or D M F at 60 °C were not successful and only starting materials
were isolated. The reaction of (17) with the lithium salt of (20) (prepared
from (20) and n-BuLi at -78 °C) in T H F at -78 °C to 0 °C was also
unsuccessful, with starting material being recovered along with some
impurities.
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Scheme 2.6

Me

PhCOHN

-^—

N
H

H

£ rPht M e

However, reduction of the 97 : 3 mixture of diastereoisomers that was
obtained from the above Diels-Alder reaction at 60 °C, with sodium
borohydride ( N a B H 4 ) 5 5 gave the alcohol (21) (Scheme 2.7). The
enantiomeric purity of (21) was determined to be 9 4 % from *H N M R
analysis of its Mosher ester (22) prepared from the reaction of (21) and
(/?)-(-)-a-methoxy-a-trifluoromethylphenylacetyl chloride.56 Integration
of the resonances for the diastereotopic methylene

protons

(CHAHBOCOC(Ph)(CF3)OMe) for the major and minor diastereoisomers
of (22) allowed the enantiomeric purity of (21) to be calculated (97 : 3
mixture of diastereoisomers, Figure 2.3).
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Scheme 2.7

NaBI

(17) + (18) (ent-lS)
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Figure 2.3. Expanded section of the * H N M R (400 M H z ) spectrum of the Mosher
ester (22) showing the diastereotopic methylene protons for the two diastereomeric
products (ratio 97 : 3). * major diastereoisomer; ** minor diastereoisomer.
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2-3-2. Diels-Alder Reactions of (8) a n d l-Substituted-1,3Butadienes

The high regio- and stereoselectivity of the Diels-Alder reaction has l
its widespread application in the synthesis of complex natural products. In
principle two regioisomeric adducts are produced from the reaction of an
unsymmetrical diene with an unsymmetrical dienophile, but in practice one
product generally predominates.51a,57 Generally in Diels-Alder reaction of
a l-substituted-l,3-butadiene with an electron deficient dienophile the
'ortho' adduct is favoured, while with 2-substituted-l,3-butadienes the
'para' isomer predominates.512
2-3-2-1. Diels-Alder Reactions of (8) with l-Methyl-l^-Butadiene (23)
and 1-Methoxy-1,3-Butadiene (24)
The Diels-Alder reaction of (8) and 1-methyl-1,3-butadiene (23) at 60
for 15 days was highly diastereoselective (d.r. 94 : 6) and gave a mixture of
the exo and endo adducts (25a) and (25b) respectively, in 5 0 % yield. The
major adduct could be isolated pure by semi-preparative H P L C . The major
and minor diastereomeric adducts were assigned to be the exo and endo
diastereoisomers, (25a) and (25b), respectively, from a combination of
C O S Y and N O E S Y lH N M R and molecular modelling (PC M O D E L ,
using the M M X force field) studies (Scheme 2.8).
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Scheme 2.8

(8)

60°C
-•

PhCQ^

H*I ^*0
(23) ; R = M e

(exo transition state)

(24) ; R = O M e

exo (25a) ; R = M e
(26a) ; R = O M e

endo (25b) ; R = M e
(26b) ; R = O M e

The energy minimized structures for (25a) and (25b) are shown in Figure
2.4, along with the calculated proton-proton bond distances and observed
N O E cross peaks in the N O E S Y N M R spectrum for each diastereoisomer.
These energy minimized conformations showed close correlation to the
solid state structure of (17) (Figure 2.2). The lU N M R spectrum of (25a)
showed H 5 p was highly deshielded (8 2.76, compared to H5oc, 8 2.30), as
expected from the close proximity of this proton to the Af-benzoyl carbonyl
group. The stereochemistry of (25a) was evident from the strong N O E
cross peaks between H 5 p and the C 3 M e group and between H2' and H3oc.
In contrast, the minor diastereoisomer (25b) showed a significant N O E
cross peak between H 2 ' and the C 3 M e , consistent with the endo
stereochemistry.
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Figure 2.4. Energy minimized structures for (25a) and (25b) showing interatomic
distances calculated using PC M O D E L and the M M X force field parameters. Double
headed arrows indicate observed N O E cross peaks in the 2D lH N M R N O E S Y spectrum
of these compounds.
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The Diels-Alder reaction of (8) and 1-methoxy-1,3-butadiene (24) at 60 °C
for 10 days gave a 82 : 18 mixture of the exo and endo cycloaddition
products (26a) and (26b), respectively in 5 1 % yield (Scheme 2.8). The two
diastereoisomers could not be separated. The stereochemistry of these
adducts was assigned on the basis of C O S Y and N O E S Y

NMR

experiments on a mixture of the two isomers.
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Figure 2.5. Expanded section of the N O E S Y N M R spectrum (400 M H z , CDCI3) of
the adducts (26a) and (26b). (Note: The referencing of the Fl scale offset by 0.2 ppm).

The major diastereoisomer (26a) showed a NOE cross peak between H2' (
6.61) and H3oc (8 4.15). While in the minor diastereoisomer (26b), a weak
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N O E cross peak was observed between H2' (8 6.52) and H 3 p (8 5.03)
(Figure 2.5) and a N O E cross peak was observed between H2' and the
O M e (8 3.62) group.
2-3-2-2. Diels-Alder Reaction of (8) and l-Methoxy-3(trimethylsilyloxy)-l,3-Butadiene(27)

The Diels-Alder reaction of l-methoxy-3-(trimethylsilyloxy)-l,3-but
(Danishefsky's diene) (27) at 60 °C for two days gave a 1 : 1 mixture of
two diastereoisomers. The crude reaction product was hydrolysed with
dilute hydrochloride acid58 to give a 50 : 50 mixture of the exo and endo
cycloaddition products (28a) and (28b), respectively (Scheme 2.9).
Scheme 2.9
OMe

TMSO
(27)

Ph. ^ O H
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X
NOE

OTMS
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NOE
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The stereochemistry of these adducts was assigned on the basis of a
N O E S Y experiment. The H2' proton (8 6.55) in the exo isomer (28a)
showed a strong N O E cross peak to the H3oc (8 4.14), while in the endo
isomer (28b) a cross peak was observed between H2' (8 6.54) and the
methoxy group at 8 3.53. Attempts to convert (28a) and (28b) to the same
a,p-unsaturated ketone by treating these compound with base (eg. D B U or
L D A ) were unsuccessful.
2-3-2. Diels-Alder Reactions of (8) and 2-Substituted-l,3Butadienes

The Diels-Alder reaction of (8) and 2-methyl-l,3-butadiene at 60 °
days gave a 66:31:3 mixture of three diastereomeric adducts in excellent
yield (96%). The two major diastereomeric adducts could be obtained pure
after separation by semi-preparative H P L C . The predominant and second
most predominant adducts were assigned the 'para' (29) and 'epi-CT-para'
(30) structures respectively, on the basis of the following N M R and
chemical experiments.

ph

Plw^.0 H
" 5 [HP

-^° P
^

sL?P

•Me

NOE

(30)
(29)

(31)
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A C O S Y N M R experiment on (29) showed the alkene proton H 2 (8 5.37)
was strongly coupled with H3oc (8 2.38), consistent with a 'para' structure.
The same cross peak was observed between H 2 (8 5.58) and H 3 a (8 2.24)
in minor isomer (30). In a N O E S Y experiment of the major isomer (29) a
strong cross peak was observed between H2' (8 6.61) and H3oc (2.38) but
in the minor isomer this cross peak could not be observed. Another
experiment which established the stereochemistry of the minor isomer (30)
involved heating the major isomer (29) at 100 °C for 24 hr. This
experiment resulted in a 86 : 14 mixture of the compounds (29) and (30),
respectively. The third isomer could not be isolated in pure form and was
possibly the 'meta' product (31).

Attempts to increase the rate of these reactions of (8) with substituted
butadienes by the addition of a Lewis acid (e.g. BF3(C2Hs)20 and
TiCl2(OPri)2) were unsuccessful. These experiments resulted in either no
enhancement of the rate or in the destruction of the dienophile (8).
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2-4. Diels-Alder Reactions of (8) and Substituted-1,3Cyclohexadienes
2-4-1. Diels-Alder Reactions of (8) and 1,3-Cyclohexadiene

It has been reported that the thermally induced reaction of (8) and 1,3
cyclohexadiene gave two diastereomeric products.48 The ratio of these
products was dependent upon the reaction temperature. W h e n this reaction
was performed at 130 °C, the two diastereomeric adducts were obtained in
a ratio of 67 : 33.48 In this study it was found that the diastereomeric ratio
was more favourable (74 : 26) at 60 °C, although the reaction time for
complete consumption of (8) was dramatically increased (15 days, Table
2.2, page 47). These two diastereomeric adducts could be obtained
diastereomerically pure after purification of the reaction mixture by semipreparative H P L C or by fractional crystallization from ethyl acetate /
hexane. The stereochemistry of these isomers was determined to be (11)
and (32).

PhCON^.0

X
H Ph
(H)

PhCON^.0

A
Ph H
(32)

The major adduct was confirmed to have the exo-stereochemistry by
comparison of its *H N M R with that of the compound (IO) 48 which was
established by a single crystal X-ray structural determination. The
aromatic proton resonances for the two structures (10) and (11) were
almost identical, as were the signals for H2' in (10) (8 6.56) and (11) (8
6.57). C O S Y and N O E S Y N M R experiments also established the
stereochemistry of the major isomer as shown in (11) (Figure 2.6).

Chapter 2

59

NOE A ' H a ^ n , H|T*\NOE

TIL YX
y nHf
T

Ha

i
5

\

/ PhCO^U^O

V H 'Ph
i\ *f
(11)
H8a/H7(3

H3a

FS
(ppm J

1.4-

1.6

1.8-

e.e-

3-e-.

' ' " " l " " ! " " !
3.e

3.8

I
e.8

I"
E.6

i •.. ...... |
e.4

e.e
Fl

[in
e.o

,....,.,..,
1.8

1.6

1.4

|.M
I.?.

(ppra)

Figure 2.6. Expanded section of the C O S Y N M R spectrum (400 M H z , CDCI3) of the
adduct (11). (W-coupling between H3p and H 8 a indicated by
line).
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In the C O S Y spectrum of (11), strong cross peaks were observed between
H 5 (8 6.16) and H I (8 3.12) and between H 3 p (8 2.90) and H8oc (8 1.22)
due to W-coupling (Figure 2.6). The N O E S Y spectrum showed strong
cross peaks between H2' (8 6.57) and H I (8 3.12) and between H 8 p (8
1.72) and H 3 a (8 2.23) and also between H 5 (8 6.16) and H 8 a (8 1.22).

The stereochemistry of the minor isomer was assigned on the basis of t
following experiments that were performed on a 76 : 24 mixture of the
diastereoisomers (11) and (32) (Scheme 2.10). 1. W h e n a solution of these
diastereomers was heated at 100 °C or 130 °C for 24 hr, a 55 : 45 mixture
of two diastereomeric products ((11) and (32), respectively) resulted that
were identical to the major and minor diastereomeric adducts, respectively,
that were obtained from the Diels-Alder reaction of (8) and 1,3cyclohexadiene at 60 °C. 2. Reduction of the above 55 : 45 mixture of
diastereomers, with N a B H 4 gave the alcohol (33) in > 9 7 % diastereomeric
purity from lH N M R analysis (400 M H z ) .
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Scheme 2.10
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The above experiments clearly demonstrate that the two diastereomeric
Diels-Alder adducts had the same configuration at C 2 (C4') and were
epimeric at the amino-acetal carbon C2'.

T h e major and minor

diastereomeric Diels-Alder adducts are therefore structures (11) and (32),
respectively. The poor diastereoselectivity in the Diels-Alder reaction of
(8) and 1,3-cyclohexadiene is hence the consequence of a thermally
induced epimerization, at C2', of the initially formed exo adduct (11) and is
not due to the formation of the diastereomeric endo adduct as previously
reported.48 The diastereoisomer (32) is formed from the epimerization of
(11) at C2' through a thermally induced ring opening of the oxazolidinone
ring during the course of the Diels-Alder reaction similar to that observed
in the case of compounds (17). The enantiomeric purity of the alcohol (33)
was determined to be 9 0 % from lH N M R analysis of its Mosher ester (34)
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(95 : 5 mixture of diastereoisomers, Figure 2.7). The enantiomeric purity
of the alcohol (33) indicates that the extent of epimerization at C 2 in the
starting dienophile (8) is about 3 - 4 % at 60 °C over 15 days since the
enantiomeric purity of (8) prior to the Diels-Alder reaction was > 9 7 % . 4 8

Y

f

NHCOP.

NHCOM

(dUultnoatrlc ratio H : 5 tram 'H NMR
taal/ib)

**
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Figure 2.7. Expanded section of the ! H N M R (400 M H z ) spectrum of the Mosher ester
(34) showing the diastereotopic methylene protons for the two diastereomeric products
(ratio 95 : 5). * major diastereoisomer; ** minor diastereoisomer.

2-4-2. Diels-Alder reactions of (8) a n d l-Substituted-1,3Cyclohexadienes

The Diels-Alder reactions of (8) and 1-methoxy- or l-(trimethylsilyloxy
1,3-cyclohexadiene (35) and (36) at 60 °C were highly regioselective and
diastereoselective and gave (37) and (38), respectively, as the major
diastereomeric adducts (Scheme 2.11). The diastereoselectivity of the
latter reaction (d.r. 97 : 3) was greater than that of the former reaction (d.r.
89: 11) (Table 2.2, page 47).
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Scheme 2.11

60 °C

PhCG^

(8)

(35);R = OMe
(36);R = OTMS
(exo transition state)

kl
<2J
4
/

R

:ON^2/

(

?h

]

A
H Ph

(37) ;R = O M e (d.r. = 89:11)
(38); R = O T M S (d.r. = 97 :3)

The structure and stereochemistry of the major diastereomeric adduct (37),
from 1-methoxy-1,3-cyclohexadiene and (8), was established by a single
crystal X-ray structural determination (Figure 2.8). The structural analysis
showed that the diene had added to the face of the 4-methylene group
which was anti to the C2' phenyl group and that the 'ortho' regioisomer had
been obtained.

T h e structure determination also showed that the

oxazolidinone carbonyl group in (37) was exo to the ethano bridge of the
bicyclo[2.2.2]octenyl ring system (Figure 2.8). T h e stereochemistry
assigned to (38) was based on the similarity between its *H N M R spectra
and that of (37) (Experimental Section, Chapter Two).
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Figure 2.8. Molecular projection of (37), normal to the plane of the five-membered
ring. 2 0 % thermal ellipsoids are shown for the non-hydrogen atoms; hydrogen atoms
have an arbitrary radii of 0.1 A.

In contrast to (11), heating a solution of (37) at 100 °C for 24 hr resulted in
the recovery of only diastereomerically pure starting material and no
products that would result from epimerization at C2' could be detected. It
seems likely the bridgehead M e O or T M S O in (37) and (38) respectively is
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responsible for an increase in the energy barrier for ring opening of the
oxazolidinone ring in these compounds. This could be possibly due to an
increase in steric interactions between the bridgehead substituent and the
Ph and P h C O substituents about the developing iminium ion that would be
required for ring opening (cf (19), Scheme 2.5). The minor cycloadducts
from the above two reactions could not be isolated diastereomerically pure
and therefore their structures could not be unequivocally determined.
2-4-3. Diels-Alder Reaction of (8) a n d 2-Substituted-l,3Cyclohexadiene

The Diels-Alder reaction of 2-(trimethylsilyloxy)-1,3-cyclohexadiene (39
and (8) at 60 °C, followed by hydrolysis of the crude reaction products
with dilute acid, gave a mixture of four diastereomeric adducts (d.r. 50 : 26
: 12 : 12; Table 2.2, page 47). Three of the adducts have been identified as
(40a), (40b) and (40c). The fourth diastereomeric adduct could not be
isolated pure and its structure could not be determined. From C O S Y and
N O E S Y N M R experiments the structure of the major diastereoisomer was
determined to be the 'para' exo adduct (40a).
OTMS

(39)

O

o

PhCON-^/
H
(40a)

Ph

Ph

H

(40b)

T w o strong cross peaks were observed in the C O S Y spectrum of (40a) due
to W-coupling (Figure 2.9) between H 3 P (8 2.85) and H 8 a (8 2.50) and
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between H 7 p (8 1.88) and H6p (8 3.63). The N O E S Y spectrum showed
strong cross peaks between H2' (8 6.54) and HI (8 2.72) and between H 3 a
(8 2.29) and H8p (8 1.64) and between H6oc (8 2.57) and H 7 a (8 2.14).

NOE,

tH(

y PhCO^r^O

K*Ph
v

H

N O E (40a)
V—Y

F2
(pp.]

nm Q m mr~
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Figure 2.9. Expanded section of the C O S Y N M R spectrum (400 M H z , CDC1 3 ) of
adduct (40a). (W-couplings indicated by ~—line).
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The structure of compound (40a) was unequivocally established by a single
crystal X-ray structure determination (Figure 2.10).

k

fl

PhCON^V
H Ph
(40a)

Figure 2.10. Molecular projection of (40a) normal to the plane of the five-membered
ring. 2 0 % thermal ellipsoids are shown for the non-hydrogen atoms; hydrogen atoms
have an arbitrary radii of 0.1 A.

The stereochemistry of one of the minor isomers (40b) was determined to
be the exo diastereoisomer (40b) in which epimerization had occurred at
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C2', by the conversion of both isomers (40a) and (40b) with M e O H /
K 2 C O 3 to the same methyl ester (41) (Scheme 2.12).
Scheme 2.12
(40a)

MeOH/K2CQ3
C02Me
NHCOPh

(40b)
MeOH/K2C03

(40c)

MeOH/K2C03

(41)

C02Me

T h e methyl ester (42) w a s prepared using the above reaction conditions
from minor isomer (40c) (Scheme 2.12). This c o m p o u n d (40c) w a s
determined to be the 'meta' regioisomer from C O S Y N M R analysis of its
ester derivative (42). T w o strong cross peaks were observed between H 5 P
(8 3.20) and H 8 P (8 2.00) and between H 3 p (8 2.38) and H 8 a (8 2.20) ( W couplings) in the C O S Y spectrum of C o m p o u n d (42).
2-4-4. Preparation of the Dienes (36) a n d (39)
The diene (36) was prepared from 3-cyclohexene-l-one (44), which was
available from the hydrolysis of 1-methoxycyclohexa-l,4-diene (43) with
perchloric acid in carbon tetrachloride and water (Scheme 2.13). 59 T h e
enolates (45) and (47) were prepared from treatment of ketones (44) and
(46), respectively, with lithium diisopropylamide in T H F - E t 2 0 at -78 °C.
T h e resulting enolates (45) and (47) were treated with trimethylsilyl
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chloride to give exclusively the dienes (36) 6 0 and (39) 61 , respectively
(Scheme 2.13).
Scheme 2.13
OCH3
HC10 4
H 2 0/CC1 4
(43)

(44)
0"Li+

(44)

LDA, THF/Et2Q

TMSC1
0°C

•

-78 °C

0

(45)

(36)

0"Li+

OTMS

LDA, THF/Et2Q^
-78 °C
(46)

OTMS

TMSC1
0°C

*
(47)

(39)
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2.5. £xo-Diastereoselectivity of the Diels-Alder Reactions
Diels-Alder reactions often display a preference for endo
cycloadducts.50,57,62 Numerous attempts have been undertaken to explain
this phenomenon.

In 1937, Alder et al. suggested the m a x i m u m

accumulation of unsaturation in the transition state as a heuristic
principle.63 The Alder rule stimulated a number of rationalizations
including stabilization of the endo transition state by: (1) inductive (van der
Waals or dipolar) forces,64 (2) charge transfer,65 (3) favourable geometry
for overlap,66 (4) secondary bonding forces,67 (5) secondary orbital
interactions.68 It should be noted that the endo rule applies only to the
kinetic products of Diels-Alder reactions, and that its application to
intramolecular cycloadditions is more uncertain.51 In some cases a
destabilizing steric interaction was considered for the endo transition state,
in the reactions of cyclic dienes.69-7! Exo selective Diels-Alder reactions
of cyclic dienes and D H A A s 1 1 ' 6 9 and related dienophiles70,54,71 are w e u
documented.

Diels-Alder reaction of the y-iY,AT-dibenzylamino

dehydroamino acid ester (48) and cyclopentadiene produced the exo
cycloadduct (49), in high diastereomeric excess (d.e. 9 6 % ) (Scheme
2.14).69*
Scheme 2.14

2Et

aAia

r //j
A^r^ c1o E t
w

2

OHCHN

^

(49)
The cycloaddition reaction of the D H A A (50) with l-(trimethylsilyloxy)1,3-cyclohexadiene (36) gave the exo and en do cycloadducts in a ratio of
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62 : 38 (Scheme 2.15). 69b It was not clear, however, if these adducts were
formed under kinetically or thermodynamically controlled conditions.
Scheme 2.15
CH 2
H3C02C

n

OTMS

*J(
+
<H~\
(50)

(36)
150 °C
48 hrs

TMSO

i
\
C02CH3 0

(endo)

Other a-substituted acrylate esters such as methyl methacrylate (51) also
give exo cycloadducts with cyclopentadiene.72
CH 2

X
H3C^X02CH3
(51)

The related cyclic dienophile (52) reacted with 1.2 equivalents of
cyclopentadiene in methylene chloride to give the exo adduct (53) as a
single stereoisomer in 9 0 % yield (Scheme 2.16). 70a
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Scheme 2.16

.0.

25 °C
16 hrs

(52)

(53)

For the Diels-Alder reactions of dienes with our dienophile (8), and related
a-substituted acrylates, the endo transition state (54b) would be expected
to be destabilized due to an unfavourable steric interaction between the asubstituent (the stericaly demanding P h C O N group in our reactions) and
the methylene proton(s) on the cyclic diene and thus the exo transition state
(54a) would be expected to be favoured.

o i-w

®

(54a)

^

0

c

o

©

(54b)

Using this stereochemical argument however, one would expect that the
reaction of (8) with 1 -substituted-1,3-butadienes to give endo cycloaddition
products rather than the observed exo cycloadducts, since there is now no
significant destabilizing steric interaction between the a-substituent and
the diene in the endo transition state. It appears that electronic factors
rather than steric factors are responsible for the high exo selectivity in the
Diels-Alder reactions of (8) and related dienophiles. It has been recently

Chapter 2

73

suggested by Roush et #/.71a that dipole-dipole interactions between the
diene and dienophile are responsible for the exo selectivity in the DielsAlder reactions of exo cyclic-methylene dienophiles like (8). R o u s h
suggests that the exo transition state for the reaction between dioxolan-one
(14a) and cyclopentadiene is favoured because this transition state structure
has the smallest permanent dipole m o m e n t (Scheme 2.17). T h e dipole of
the diene must have its negative end bisecting C 2 and C 3 of the
cyclopentadiene ring and its positive end toward the saturated methylene
group because the electronegativity of a sp 2 carbon is greater than that of a
sp 3 carbon.72 T h e negative end of the dipole due to the dienophile must lie
toward the carboxy function. Although some change in the magnitudes of
the two dipole moments might be expected in passing from the reactants to
the transition state, the directions are expected to remain qualitatively the
same (Scheme 2.17).
Scheme 2.17

h^r^
JS>°
0

J
(endo)

(dipoles aligned)

.0

(dipoles anri-parallel)

(exo)

Y..»Bu'
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In the endo transition state, the component dipoles point in roughly the
same direction and, consequently, the net dipole m o m e n t is expected to be
greater than that of the exo transition state, where the component dipoles
point in roughly opposite directions (Scheme 2.17).
Berson and co-workers have suggested that "the permanent dipole moment
of the endo transition state is greater than that of the exo" J2

This

suggestion resulted from the analysis of the stereoselectivity and solvent
dependence of the Diels-Alder reactions of cyclopentadiene and methyl
acrylate, methyl methacrylate, and methyl crotonate. They established a
n e w solvent polarity constant based on the solvent dependence of the
exo/endo ratio (increased exo selectivity in low polarity media). In the
cycloaddition reaction of cyclopentadiene and methyl methacrylate (51) in
1,2-dichloroethane at 30 °C they found a ratio 70 : 30 for the exo and endo
adducts, while in the more polar solvent such as ethanol the exo/endo ratio
was 6 4 : 36.
The explanation of Roush can be used to explain w h y the transition state
(55a) is favoured over (55b) in our study based on dipolar considerations.

\

PhCQ

^ ^

*r\ *

HJ > O ^

"S^rf*0

N-\

(55a)

(55b)

Our reactions however, showed no rate enhancement, or change in
exo/endo selectivity, w h e n the reaction solvent was changed from CH2CI2
to benzene or acetonitrile. This lack of a solvent effect suggests the dipoledipole interactions in the transition state are not responsible for the exodiastereoselectivity in our reactions. It seems likely that electronic factors
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are responsible for the exo-diastereoselectivity and that more sophisticated
theoretical calculations are required to understand the diastereoselectivity
in these reaction.
Bueno et al. in 198773 introduced a system in which secondary orbital
interactions from the donor group of captodative dienophiles might
stabilize the exo transition state.

In this study N - a c y l - a , P -

dehydroalaninates (56) were treated with cyclopentadiene under several
conditions (Scheme 2.18). Complete consumption of (56) was achieved by
using a moderate excess of cyclopentadiene, T i C U as a catalyst, or high
reaction temperatures in various solvents (Table 2.3). In all cases the exo
stereoisomer was favoured over the endo one.
Scheme 2.18
C02CH3
H2C=
NHCOR
(56)
a; R = CH 3
b;R = C6H5

-• /C^C°2CH3 + £X3> N H C O R
C02CH3

NHCOR
(exo)

(endo)

Table 2.3. Diels-alder reactions of A/-acyl-a,P-dehydroaIaninates (56) with
cyclopentadiene.73
Substrate Temperature Time
(hr)
(56a)
5
90-100
5
(56a)
90-100
(56a)
130-140
5
80-90
5
(56a)
25-30
5
(56a)
5
-10
(56a)
130-140
5
(56b)
^kiienophile/diene. b N o reaction.

Solvent Lewis Reagents
ratic^
acid
1 .6
Toluene
1 9
Toluene
1 3
Xylene
1 3
EtOH
1 3
C H 2 C 1 2 TiCU
1 6
C H 2 C 1 2 TiCU
Xylene
1- 9

Yield

Adducts

(%)

exo/endo
6.9:3.1

100
100
100
78
100
NRb
25

7.1 : 2.9
7.2:2.8
6.4 : 3.6
5.7 :4.3
-
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Perturbation M O calculations, using wave functions generated by the
M N D O method, were used to rationalize the relative reactivity of these
captodative dienophiles74 and stereoselectivity observed. Bueno explained
the exo/endo selectivity of Diels-Alder reaction of the captodative alkene
(56) with cyclopentadiene, by secondary orbital interactions. H e focused
his attention on the nitrogen atom in the acylamino group and on the
carbonyl carbon in the ester moiety. Bueno explained if the HOMOdiene LUMOdienophile pair

was

considered, the only relevant secondary

interaction occurred between C 3 of both diene and dienophile, leading to
preference for the endo stereoisomer. However, if one considered the
LUMOdiene-HOMOdienophile pair, the only relevant secondary interaction
occurred between C3-diene and N4-dienophile and this orbital pair
favoured the formation of the exo adduct (Figure 2.11).

Figure 2.11. Endo and exo orbital interactions between (56a) and cyclopentadiene.

H e obtained a AEendo

= -0.082 p c 2 and a A E e x o = -0.089 p c 2 b y

introducing the atomic coefficients and M O energies for cyclopentadiene
and dienophile (56a), and taking the resonance integrals. From these
values he inferred that the exo isomer was slightly favoured over the endo,
being in qualitative agreement with the experimentally observed preference
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for the exo over the endo isomer. F r o m a consideration of the H O M O L U M O energy gaps from cyclopentadiene and dienophile (56b) he found
E

H O M O d i e n e . E L U M O d i e n o p h i l e = _8.605 e V and E H O M O d i e n o p h i l e _

E

L U M O d i e n e = _9.634 e V and also A E e n j 0 = -0.040 p c 2 and ABexo =

-0.054 p c 2 . H e calculated the only important secondary interactions were
those coming from the nitrogen atom of the benzamido group, since the
carbonyl carbon of the ester moiety had no significant coefficients at all.
Consequently the exo stereoisomer was favoured.
A similar explanation can be used to understand the exo selectivity in the
Diels-Alder reactions of dienophile (8). The lactone carbonyl group in
dienophile (8) is a withdrawing group and the benzamido group is a
electron releasing group giving the alkene its captodative properties.49 If
w e consider the frontier orbitals of the alkene (8) and 1,3-diene w e would
expect a secondary interaction between C3-diene and N3-dienophile in the
HOMOdienophile-LUMOdiene pair (Figure 2.12), thus stabilizing the exo
transition state.

LUMO
secondary orbital
interaction

;
PhCQ

HOMO

Figure 2.12. Orbital interactions between dienophile (8) and 1,3-dienes in the exo
transition state.
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2-6. Synthesis of 2-Aminobicyclo[2.2.2]octane-2-carboxylic Acids
The amino acid (59) with the bicyclo[2.2.2]octane skeleton was prepared
by first catalytic hydrogenation of the double bond over palladium on
carbon and then acid-catalysed hydrolysis of the oxazolidinone moiety of
the Diels-Alder adduct (11) (Scheme 2.19). Catalytic hydrogenation of
(11) gave a mixture of (57) and (58). The ratio of (57) to (58) depended
upon the amount of catalyst and the reaction time. C o m p o u n d (57) was
favoured when the catalyst loading was small (5-10%) and shorter reaction
times were used. Acid hydrolysis of the mixture of (57) and (58) in
refluxing 6 M hydrochloric acid11'48,74 followed by purification by ion
exchange column chromatography over D o w e x 50-X8 gave thefreeamino
acid (59), [a]o 2 8 +5.40 (c 1.0 in CHCI3). The structure of (59) was
evident from its spectral analysis. This compound was previously prepared
in racemic form with undefined stereochemistry at C 2 by Zand et a/.8b via
the Strecker synthetic method (Chapter One, page 5). Attempts to prepare
the 1-methoxy analogue of (59) from the hydrolysis of (60) gave a mixture
of two diastereomeric amino acids. Unfortunately there was not sufficient
time to determine the structure of these compounds.
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Scheme 2.19

PhCON^.0

7\
H Ph

Pd/C|
H2

1.6NHC1.A

C0 2 H

*

2. ion exchange

(82%)

NH2
(59)

C02CH2Ph
[oc]D28 +12.40

PhCOHN
(58)

Pd/C|
H2

MeO

(87%)
H Ph
(37a)

MeO

(c 0.5 in H 2 0 )

CON
Ph

Y

H Ph
(60)

2-7. Conclusions
In this Chapter, a new method for the synthesis of cyclic N P A A s , through
the thermally induced Diels-Alder reactions of chiral oxazolidinone (8) and
substituted 1,3-butadienes and substituted 1,3-cyclohexadienes has been
presented. It was found that the exo cycloadduct was favoured in all of
these reactions. A secondary orbital interaction of the donor group of the
oxazolidinone ring seems to be responsible for the exo selectivity of the
Diels-Alder reactions of the captodative alkene (8). In some cases the
initially formed adducts undergo epimerization at the amino-acetal carbon
(C2'), however the stereochemical integrity of the quaternary a-amino acid
stereogenic centre is maintained and Diels-Alder adducts can be obtained
in high enantiomeric purity ( > 9 0 % e.e.). T h e stereochemistry of these
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adducts has been elucidated by single crystal X-ray structure
determinations and 2 D *H N M R analysis. The optically active bicyclic
amino acid (59) was synthesised for the first time by first hydrogenation
and then hydrolysis of the oxazolidinone moiety.
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GENERAL PROCEDURES
(a) Melting Point (m.p.)
Melting points were determined on a Gallenkamp hot-stage apparatus and
are uncorrected.
(b) Infrared (IR) Spectra
Infrared spectra were recorded on a Bio Rad Fourier Transform Infrared
Spectrometer model FTS-7 or Perkin-Elmer 783 Infrared Spectrometer as
mulls in nujol unless otherwise stated.
(c) Optical Rotation [a]o
All optical rotations were recorded with a JASCO, DIP-370, Digital
Polarimeter in analytical reagent (AR) grade chloroform unless otherwise
stated.
(d) lH Nuclear Magnetic Resonance (NMR) Spectra
l

H N M R spectra were recorded on the following instruments: J E O L F X

90Q F. T. N M R Spectrometer operating at 90 M H z , Varian Unity 400 F. T.
N M R Spectrometer operating at 400 M H z , and Varian Unity 300 F. T.
N M R Spectrometer operating at 300 M H z . Chemical shifts are reported as
8 values in parts per million (ppm). Tetramethylsilane ( T M S ) was used as
nominal standard for all recorded spectra (0.00 ppm). Data are recorded as
follows: chemical shift (5), multiplicity (s: singlet, d: doublet, t: triplet, q:
quartet, m : multiplet, dd: doublet of doublets, b: indicates some degrees of
broadening in the signal, coupling constant (Hz), integrated intensity and
assignment (first order analyses of spectra were attempted where possible
and, consequently, chemical shifts and coupling constants for multiplets
m a y only be approximate). T w o dimensional N M R experiments were
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carried out using the following instruments: Varian Unity 400 F.T. and
Varian Unity 300 F.T. The pulse sequences used were homonuclear
(iH/iH) correlation spectroscopy ( C O S Y ) , Nuclear Overhauser and
exchange spectroscopy ( N O E S Y ) and heteronuclear (iH/^C) correlation
spectroscopy ( H E T C O R ) .
(e) 13C Nuclear Magnetic Resonance (NMR) spectra
13

C NMR were recorded on a Varian Unity 400 F.T. NMR Spectrometer

(100 M H z ) or Varian Unity 300 F.T. N M R Spectrometer (75 M H z ) . The
internal reference was the central peak of CDCI3 (5 77.0 p p m ) .
Distortionless enhancement by polarisation transfer (DEPT) was used in
the assignment of carbon spectra.
(f) Mass spectra (MS)

Low resolution mass spectra were recorded on a vacuum Generator VG 1212 mass Spectrometer. The protonated molecular ion ( M H + ) , if present,
significantly high mass ions and the more intense low mass ions are
reported. Data are presented in the following order: m/z value; relative
intensity as a percentage of the base peak.
g) Microanalyses were performed by the Microanalytical Service Unit,
Australian National University, Canberra or the Microanalytical Service
Unit, the Queensland University, Queensland.
(h) Chromatography
Analytical thin layer chromatography (TLC) was conducted on plastic
sheet coated with Merck Kieselgel KG60F-254. The developed plates
were visualised under shortwave ultraviolet light.

Column

chromatography was conducted on silica gel absorbent using Fluka
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Kieselgel 60 (0.063-0.2 m m ) as the absorbent and analytical reagent (AR)
grade solvents as indicated.
The High Performance Liquid Chromatography (HPLC) was carried out
using a Waters p u m p model 510 and a Waters (I porasil column, (particle
size 10 um, pore size 125 A, dimensions 7.8 m m / 300 m m ) . The U.V.
detector was a Waters series R-400 detector at 254 nm.

(i) Solvents and reagents used in these reactions were purified accordin
to well established procedures.75 Tetrahydrofuran (THF) and diethyl ether
were dried over sodium metal and purified by distillation from a purple
suspension of sodium / benzophenone

ketyl under nitrogen.

Dichloromethane (CH2CI2), chloroform, N,N-dimethylformamide ( D M F )
and acetonitrile were distilled from calcium hydride and stored over
molecular sieves (4A) under nitrogen.

Methanol was purified by

distillation from magnesium methoxide.

(j) Unless otherwise stated, all reactions, particularly reactions invol
n-BuLi, L D A or sodium borohydride, were performed in glassware that
had been oven-dried and cooled in a desiccator prior to use and under a dry
nitrogen atmosphere. All organic extracts were dried with anhydrous
M g S 0 4 and after filtration of these solutions, the bulk of the solvent was
removed on a Buchi rotary evaporator. The last traces of solvent were
removed under high vacuum.
k) Molecular modelling was performed using PC MODEL (Serena
Software, Box 3076, Bloomington, Indiana) using the M M X force field
parameters or Insight II, Version 2.3.0., Biosym Tecnologies, San Diego,

CA.
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The dienes, l-(trimethylsilyloxy)-1,3-cyclohexadiene (36) and 2(trimethylsilyloxy)-1,3-cyclohexadiene (39) were prepared according to the
literature.60,61 For compounds (17), (18), (21), (22), (25), (26), (28), (29)(31) the carbons have been numbered as shown for (25a) in Figure 2.4.
For compounds (11), (32)-(34), (37), (38), (40)-(42) and (57)-(60) the
carbons have been numbered as shown for (11) in Figure 2.6. In the iH
N M R analysis of these compounds the protons have been assigned a or P
as indicated in the structure (24a) and (11). In the lU N M R spectrum
protons like H 3 p are observed as a ddd due to W-coupling (to H 8 a ) . All
crystalline compounds were recrystallized from ethyl acetate/hexane.
X-ray Structure Determinations.
The single crystal X-ray structural determinations were performed by Brian
W . Skelton and Allan H. White at the University of Western Australia.
The room temperature (-295K) single crystal X-ray structure
determinations are derivative of unique diffractometer data sets (2r/r scan
mode; monochromatic M o K a radiation, X = 0.71093 A ) yielding N
independent reflections, iV0 of these with / > 3a(/) being considered
'observed' and used in the full matrix least squares refinement without
absorption correction after solution by direct methods.

Anisotropic

thermal parameters were refined for C, N, O; (x, y, z, £/iSo)H were also
refined. Conventional residuals R, Rw on IFI are quoted at convergence,
statistical weights derivative of o2(7) = a2(/diff) + 0.0004 o4(/diff) being
used; chiralities were adopted from the chemistry. Neutral atom complex
scattering factors were employed, computation using the X T A L 3.0
program system implemented by S. R. Hall. Derivative connectivities,
conformation and stereochemistries are shown pictorially in the Figures,
geometries being essentially as expected.

Full tabulations of atom
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coordinates and thermal parameters, molecular geometries and structure
factor amplitudes have been deposited with the Cambridge
Crystallographic Data Centre. Details of the specimens and refinement are
as follows:
(17). C23H23NO3, M

= 361.4. Orthorhombic, space group P2\2\2\, a =

22.225(9), b = 9.635(4), c = 9.181(6) A, V= 1966(3) A3. D C (Z = 4) = 1.22
g. cm.-3; F(000) = 864. U M O = 0.8 cm.-1; specimen: 0.90 x 0.60 x 0.38
m m . 2r m a x = 50°; _V= 1853, N0 =1510, R = 0.037, /? w = 0.044.
(37). C24H23NO4, M = 389.5. Orthorhombic, space group P2_2i2i (D24,
No. 19), a = 22.094(5), b = 12.588(5), c = 7.211(2) A, V = 2005(1) A3.
D C (Z = 4) = 1.29 g. cm.-3; F(000) = 824. U M O = 0.9 cm."1; specimen: 0.17
x 0.24 x 0.28 m m . 2r m a x = 50°; N = 2045, N0 =1024; R = 0.051, flw =
0.049.
(40a). C23H2jN04,M =375.4. Monoclinic, space group P2\ (C22, No.
4), a = 8.125(1), b = 10.703(2), c = 11.337(2) A, p = 103.40(1)°, V =
959.0(3) A3. D C (Z = 2) = 1.30 g. cm.-3; F(000) = 396. UMo = 0.9 cm.-1;
specimen: 0.58 x 0.48 x 0.40 m m . 2r ma x = 55°; N = 2316, N0 =1922; R =
0.037, /? w = 0.036.
3-Cyclohexene-l-One (44).59
Four drops of 7 0 % perchloric acid were added to a mixture of 1methoxycyclohexa-l,4-diene (43) (8 g, 73 mmol) in carbon tetrachloride
(20 m L ) and water (50 m L ) .

The two-phase system was shaken

vigorously. The reaction was monitored by N M R sampling aliquots from
the carbon tetrachloride layer (the disappearance of the ether methyl
absorbance was particularly apparent). After 12 hr the organic layer was
separated, dried (MgS04) and filtered. Partial removal of the solvent on a
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rotary evaporator gave 5 g (74%) of (44) as an oil. iH N M R 8 5.58 (m,
2H), 2.89 (m, 2H), 2.5 (m, 4H).
Preparation of 1-Trimethylsilyloxy- and 2-Trimethylsilyloxy-l,3cyclohexadienes (36) and (39).

A solution of diisopropylamine (3 mL, 22 mmol) in THF (5 mL) and et
(5 m L ) at 0 °C was treated with n-butyl lithium (12.5 m L , 20 mmol,
solution in hexane). The resulting solution was cooled to -78 °C and
treated with cyclohexenone (44) or (46) (1.44 g, 15 mmol) dropwise under
nitrogen. The solution was stirred for 1 hr. Meanwhile a quenching
solution was prepared from triethylamine (1.4 m L , 10 m m o l ) and
chlorotrimethylsilane (4 m L , 32 mmol) which was centrifuged to remove
any

of

the

insoluble

triethylamine

hydrochloride.

The

chlorotrimethylsilylane solution was added rapidly and with stirring, to a
cooled (0 °C) solution of the above lithium enolate. After the addition was
complete, a white solid (LiCl) began to separate after 5 min. The resulting
mixture was stirred at room temperature for 10 min. and then partitioned
between hexane and a cold solution of 5 % aqueous N a H C 0 3 (20 m L ) .
The organic layer was dried and concentrated to leave a residual liquid
containing the crude silyl ether. Fractional distillation through a short
Vigreux column produced exclusively the silyl ether.
(36) 800 m g (36%). B.p. 40-44 °C / 1 m m . iH N M R 8 5.80 (m, IH), 5.40
(m, IH), 5.09 (d, J = 4.2 Hz, IH), 2.22 (m, 4H), 0.21 (s, 9H, SiMe 3 ).

(39) 1500 mg (60%). B.p. 55-59 °C / 1 mm (Lit.61a 33-37 °C / 10"2 m
iH N M R 8 5.60 (m, IH), 5.50 (m, IH), 4.71 (m, IH), 0.32 (s, 9H, SiMe 3 ).
Diels-Alder Reactions of (8) and Dienes, A General Procedure:

A solution of (8) (225 mg, 0.8 mmol) and the diene (10 molar equiv.
CH2CI2 (3 m L ) under nitrogen was heated at 60 °C in a sealed tube for

Chapter 2

88

several days, as reported in the Table 2.2. The solution was then cooled
and evaporated to dryness. The crude products were purified by column
chromatography on silica gel using ethyl acetate/hexane as the eluent. The
diastereoselection of these reactions were determined from iH N M R (400
M H z ) analysis of the crude reaction product. The adducts (28a), (28b) and
(40 a-c) were obtained by hydrolysis of the crude reaction product in a two
phase system using hydrochloric acid solution (5%) and ether for 30 min,58
followed by purification of the crude reaction mixture by column
chromatography on silica gel.
(2,/^,45)-3,-Benzoyl-l,2-dimethyI-2,-phenyIspiro[cyclohex-l-ene-4,4,oxazolidin]-5'-one (17).
M.p. 166-8 °C; [ a ] D 2 5 (on 97 : 3 mixture) +188.6 (c 0.5 in CHCI3). iH
N M R (of mixture, in part) 8 7.38-6.97 (m, 10H), 6.60 (s, IH, H2') [minor
isomer, 6.55 (s, IH, H2')]; 3.36 (d, J = 17.2 Hz, IH, H3p), 3.15 (m, IH,
H5P), 2.60 (m, IH, H6a), 2.24 (d, J = 17.2 Hz, IH, H3a), 2.16 (m, IH,
H6P), 2.12 (m, IH, H5a), 1.72 (s, 3H), 1.68 (s, 3H). 13c N M R 8 172.5
(CO); 169.3 (CO), 136.6, 136.3, 130.0, 129.7, 128.5, 128.4, 126.6, 126.2,
125.6 (C), 120.8 (C), 89.2 (CH), 61.1 (C), 35.8 (CH 2 ), 29.0 (CH 2 ), 28.6
(CH 2 ), 18.9 (CH3), 18.7 (CH3). IR (nujol) 1770, 1638, 1158, 1032, 731,
639 cm-1. M S (CI) m/z 362 (100%, M H + ) . Anal. Calcd for C23H23NO3:
C, 76.43; H, 6.41; N, 3.88%. Found: C, 76.87; H, 6.81; N, 3.72%.
(2?/?,3/?,4/?)-3'-Benzoyl-3-methyl-2l-phenylspiro[cyclohex-l-ene-4,4'oxazolidin]-5'-one (25a).
M.p. 155-6 °C; [ a ] D 2 7 +79.1 (c 0.30 in CHCI3). IH N M R 8 7.32-6.98 (m,
10H), 6.60 (s, IH, H2'), 5.92 (m, IH, HI), 5.67 (m, IH, H2), 3.01 (m, IH,
H3a), 2.76 (m, J = 6.4, 14 Hz, IH, H5a), 2.50 (m, IH, H6a), 2.41 (m, IH,
H6P), 2.30 (m, J = 6.4, 14 Hz, IH, H5a), 1.30 (d, J = 7.2 Hz, 3H). [minor
isomer (from N M R on the mixture) 6.75 (s, IH, H2'), 5.82 (m, IH, =CH 2 ),
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5.48 (m, IH, =CH 2 ), 1.25 (d, J = 7.6 Hz, 3H)]. 13c N M R 8 174.4 (CO),
169.93 (CO), 137.0, 136.8, 130.0, 129.6, 129.4, 128.6, 128.4, 126.5, 126.2
(=CH), 126.1 (=CH), 89.8 (CH), 65.4 (C), 38.0 (CH), 30.2 (CH 2 ), 23.0
(CH 2 ), 16.4 (CH 3 ). IR (nujol) 1798, 1647, 1223, 1165, 1051, 729, 700
cm-1. M S (CI) m/z 348 (14%, M H + ) , 302 (33), 242 (33), 210 (38), 197
(100), 182 (82). Anal. Calcd for C22H21NO3: C, 76.06; H, 6.09; N, 4.03%.
Found: C, 76.37; H, 6.06; N, 3.94%.
(2'/?,3J?,4/2)-3'-Benzoyl-3-methoxy-2,-phenylspiro[cyclohex-l-ene-4,4foxazolidin]-5'-one (26a).
M.p. 118-20 °C; [ a ] D 2 5 (on 82 : 18 mixture) +56.6 (c 0.45 in CHCI3). IH
N M R (on mixture) 8 7.32-6.89 (m, 10H), 6.61 (s, IH, H2') [minor isomer,
6.52 ( s, IH, H2')], 5.97 (m, IH, HI), 5.90 (m, IH, H2), 4.15 (bs, IH,
H3a), [minor isomer, 5.03 (bs, IH, H3P)], 3.55 (s, 3H, O C H 3 ) [minor
isomer, 3.62 (s, 3H, OCH3)], 2.50 (m, 2H, H5p/6a), 2.34 (m, 2H,
H5a/H6p). 13C N M R (of mixture, in part) 8 172.4 (CO), 170.4 (CO),
137.5, 136.6, 130.1, 129.7, 128.5, 128.0, 127.2, 126.8, 123.2 (=CH), 122.5
(=CH), 90.4 (CH), 75.2 (CH), 65.5 (C), 57.7 (CH 3 ), 28.8 (CH 2 ), 23.1
(CH2). IR (nujol) 1775, 1636, 1395,1335,1168, 1083, 680 cm-1. M S (CI)
m/z 364 (100%, M H + ) , 332 (37). Anal. Calcd for C22H21NO4: C, 72.71;
H, 5.82; N, 3.85%. Found: C, 72.54; H, 6.12; N, 3.95%.
(2'R,3R,4R) and (2,^^5,4/?)-3,-Benzoyl-3-methoxy-2,-phenylspiro
[cyclohexan-l-one-4,4'-oxazolidin]-5,-one (28a) and (28b).

The two diastereoisomers were separated by fractional recrystall
from ethyl acetate / hexane.
(28a): M.p. 205-8 °C; [ a ] D 2 0 +127.7 (c 0.23 in CHCI3). lH N M R 8 7.326.89 (m, 10H), 6.54 (s, IH, H2'), 4.79 (dd, J = 5.2, 11.6 Hz, IH, H3P), 3.53
(s, 3H, OCH3), 3.36, (dd, J = 5.2, 11.6 Hz, IH, H2a), 3.18 (m, IH, H2P),
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3.14 (dd, J = 5.2, 11.6 Hz, IH, H6a), 2.97 (m, IH, H6p), 2.59 (m, IH,
H5p), 2.44 (m, IH, H5a). [NOE cross peak was observed between H2' and
O C H 3 ] . 13C N M R 8 206.5 (CO), 170.7 (CO), 169.8 (CO), 136.1, 136.1,
129.99,129.96,128.7, 128.6,126.9,125.7, 90.8 (CH), 75.2 (CH), 65.5 (C),
57.3 (CH3), 41.7 (CH 2 ), 36.7 (CH 2 ), 27.9 (CH 2 ). M S (FAB) m/z 380
(34%, MH+), 348 (54), 316 (39), 288 (100).

(28b): M.p. 135-8 °C; [a]D20 +80.0 (c 0.3 in CHCI3). lH NMR 8 7.3-6.
(m, 10H), 6.55 (s, IH, H2'), 4.14 (dd, J = 5.6, 12 Hz, IH, H3a), 3.52 (s,
3H, OCH3), 3.00 (m, 4H), 2.65 (m, 2H). [NOE cross peak was observed
between H2' and H3a]. 13C N M R 8 207.3 (CO), 174.5 (CO), 171.3 (CO),
136.6, 136.1, 130.2, 129.9, 128.7, 128.4, 127.0, 126.1, 91.4 (CH), 80.8
(CH), 64.9 (C), 57.8 (CH3), 42.3 (OH 2 ), 36.51 (CH 2 ), 28.84 (CH 2 ). IR
(nujol) 1790, 1705, 1648, 1300, 1222, 1162, 1100, 1025, 695 cm-1. M S
(CI) m/z 380 (10%, MH+), 348 (14), 229 (33), 198 (75), 122 (100). Anal.
Calcd for C22H21NO5: C, 69.65; H, 5.58, N, 3.69%. Found: C, 69.18; H,
5.77, N, 3.44%.
(2'fl,4S) and (TS ,45)-3,-Benzoyl-l-methyl-2'-phenylspiro[cyclohex-lene-4,4,-oxazolidin]-5,-one (29) and (30).

(29): M.p. 182-3 °C; [a]D27 +177.6 (c 0.5 in CHCI3). iH NMR 8 7.33
6.98 (m, 10H), 6.61 (s, IH, H2'), 5.37 (m, IH, H2), 3.38 (dd, J = 2.4, 17
Hz, IH, H3p), 3.21 (ddd, J = 5.6, 12.8, 18 Hz, IH, H6p), 2.58 (m, IH,
H6a), 2.38 (bd, J = 18 Hz, IH, H3a), 2.14 (m, 2H, H5a/5P), 1.77 (s, 3H,
CH3). 13C N M R 8 172.4 (CO), 169.3 (CO), 136.7, 136.4, 133.9 (CH),
130.1, 129.7, 128.6, 128.5, 126.7, 122.2, 116.2 (C), 89.2 (CH), 60.1 (C),
30.4 (CH 2 ), 28.5 (CH 2 ), 27.6 (CH 2 ), 23.2 (CH3). IR (nujol) 1782, 1650,
1401, 1175, 1036 cm-1. M S (CI) m/z 348 (MH+, 92%), 210 (49), 198 (29),
105 (100). Anal. Calcd for C 2 2H 2 iN03 : C, 76.06; H, 6.09; N, 4.03%.
Found: C, 76.14; H, 6.14; N, 3.87%.
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(30): lH N M R 87.35-6.98 (m, 10H), 6.62 (s, IH, H2'), 5.58 (m, IH, H2),
3.34 (bd, IH, H3p), 3.10 (ddd, J = 5.2, 12, 17.8 Hz, IH, H6P), 2.56 (m,
IH, H6a), 2.29 (m, IH, H5a), 2.24 (bd, IH, H3a), 2.12 (m, IH, H5P),
1.57(s,3H,CH3).
(15,25,2,/^,4S)-3,-Benzoyl-2,-phenylspiro[bicyclo[2.2.2]oct-5-ene-2,4,oxazolidin]-5'-one (11).

The two isomers (11) and (32) were separated by semi-preparative
(silica gel, 1 % ethyl acetate / hexane as eluent) or fractional crystallization
from ethyl acetate / hexane.
(11): M.p. 123-5 °C; [a] D 2 3 -92.0 (c 0.25 in CHC1 3 ). iH N M R 8 7.38-7.14
(m, 10H), 6.57 (s, IH, H2'), 6.25 (dd, J = 7.6, 8 Hz, IH, H6), 6.16 (dd, J =
7.4, 8 Hz, IH, H5), 3.12 (m, IH, HI), 2.90 (m, IH, H3P), 2.69 (m, IH,
H4), 2.23 (m, IH, H3a), 1.98 (m, IH, H7a), 1.72 (m, IH, H8p), 1.22 (m,
2H, H7p/8a). 13C N M R 8 173.5 (CO), 173.1 (CO), 138.7, 138.2, 137.3,
136.2, 130.7, 129.7, 129.2, 128.5, 127.9, 127.4, 89.7, 68.2, 37.4, 35.4,
30.2, 23.6, 21.1. IR (nujol) 1790, 1642, 1334, 1209, 1174, 1016, 714, 694
cm-l. M S (FAB) m/z 360 (11%, MH+), 226 (31), 210 (47), 165 (53), 148
(78), 127 (100). Anal. Calcd for C23H21NO3 : 76.86; H, 5.89; N, 3.90%.
Found: C, 77.06; H, 6.25; N, 3.78%.
(15,25,2,5,45,)-3,-Benzoyl-2,-phenylspiro[bicyclo[2.2.2]oct-5-ene-2,4,oxazo!idin]-5'-ene (32).
,
i

M.p. 40 °C; [ a ] D 2 3 -102 (c 0.3 CHCI3). J H N M R 8 7.4-7.26 (m, 10H),
6.78 (s, IH, H2'), 6.58 (dd, J = 7.2, 7.6 Hz, IH, H6), 6.24 (dd, J = 7.2, 7.4
Hz, IH, H5), 2.80 (m, 2H, H1/3P), 2.43 (m, IH, H4), 1.98 (m, IH, H3a),
1.86 (m, IH, H7a), 1.70 (m, IH, H8a), 1.25 (m, IH, H7P), 0.90 (m, IH,
H8P). 13C N M R 8 173.8 (CO), 168.5 (CO), 137.6, 137.4, 136.8, 136.23,
129.9, 129.4, 123.6, 128.6, 126.4, 125.7, 88.0, 66.9, 37.5, 34.1, 29.7, 24.3,
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20.3. IR (nujol) 1796, 1675, 1333, 1146, 1029 cm-1.

M

S (ES) m/z 398

(13%, M K + ) , 382 (15, M N a + ) 360 (100, MH+).
(l/?,25,2'/?,4S)-3,-Benzoyl-l-methoxy-2,-phenylspiro[bicyclo[2.2.2.]
oct-5-ene-2,4'-oxazolidin]-5'-one(37).
M.p. 159-60 °C; [a]D30 (on 90 : 10 mixture) +99.8 (c 0.54 in CHC1 3 ). lH
N M R (of mixture, in part) 8 7.26-6.80 (m, 10H), 6.54 (s, IH, H2'), [minor
isomer: 6.51(s, IH, H2')] 6.39 (m, 2H, H5/6), 3.57 (m, 4H, O C H 3 and H4),
[minor isomer 3.56 (s, 3H, OCH3)], 2.88 (m, IH, H3p), 2.34 (m, IH,
H3a), 2.07 (m, IH, H7a), 1.99 (m, IH, H7p), 1.62 (m, IH, H8P), 1.47 (m,
IH, H8a). 13C N M R 8 173.3 (CO), 171.8 (CO), 138.8, 137.7, 137.1,
135.8, 130.1, 129.3, 128.4, 128.2, 127;3, 126.3, 92.2, 84.9, 71.0, 51.8,
37.5, 30.7, 25.1, 23.5. IR (nujol) 1780, 1664, 1178, 1101, 1026, 769, 693
cm-1. M S (CI) m/z 390 (15%, M H + ) , 280 (12), 256 (19), 240 (30), 174
(28), 135 (93), 121 (100). Anal. Calcd for C24H23NO4 : C, 74.02; H, 5.95;
N, 3.60%. Found: C, 74.00; H, 6.00; N, 3.64%.
•

,

(l/?,25,2'i?,4S)-3 -Benzoyl-2-trimethyIsilyloxy-2'-phenylspiro[bicyclo
[2.2.2.]oct-5-ene-2,4'-oxazolidin]-5'-one(38).
M.p. 135-6 °C; [ a ] D 2 6 (on 93 : 7 mixture) +96.1 (c 0.52 in CHCI3). lH
N M R (of mixture) 8 7.2-6.8 (m, 10H), 6.51 (s, IH, H2') [minor isomer,
6.47 ( s, IH, H2')], 6.30 (m, J = 3.2, 8.8 Hz, IH, H5), 6.22 (d, J = 8.8 Hz,
IH, H6), 3.56 (m, IH, H4), 2.85 (bs, IH, H3p), 2.35 (m, IH, H7p), 2.31
(dd, J = 2,13.2 Hz, IH, H3a), 1.97 (m, IH, H7a), 1.46 (m, 2H, H8a/8p),
0.22 (s, 9H). 13C N M R 8 173.3 (CO), 171.8 (CO), 138.8, 137.1, 136.3,
134.4, 130.1, 129.3, 128.4, 128.2, 127.3, 126.3, 92.4, 82.4, 72.3, 36.9,
30.6, 29.4, 25.8, 2.34. IR (nujol) 1786,1667, 1251, 1217,1134,1099,754,
704. M S (CI) m/z 447 (42%, M+), 279 (73), 235 (29), 121 (26), 100 (100).
Anal. Calcd for C 2 6H 2 9N0 4 Si: C, 69.77; H, 6.53; N, 3.13%. Found: 69.56;
H, 6.59; N, 2.99%.
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(15,25,2,/?,45)-3,-Benzoyl-2,-phenylspiro[bicyclo[2.2.2.]oct-5-oneoxazolidin]-5'-one (40a).
Separation of the crude reaction mixture by column chromatography
pure (40a) and an inseparable mixture of three minor diastereoisomers.
Fractional crystallization of this mixture from ethyl acetate/hexane gave a
mixture (about 1 : 1) of (40a) and (40c), which could not be separated by
further crystallizations.
(40a): M.p. 212-14 °C; [ a ] D 2 2 +174.3 (c 0.35 in CHCI3). lH N M R 8
7.26-6.76 (m, 10H), 6.54 (s, IH, H2'), 3.63 (ddd, J = 2.4, 6, 14 Hz, IH,
H6p), 2.85 (ddd, J = 3, 6, 17 Hz, IH, H3P), 2.72 (m, IH, HI), 2.65 (m, IH,
H4), 2.57 (dd, J = 2.4, 14 Hz, IH, H6a), 2.50 (m, IH, H8a), 2.29 (dd, J =
2.4, 17 Hz, IH, H3a), 2.14 (m, IH, H7a), 1.88 (m, IH, H7P), 1.64 (m, IH,
H8P). 13C N M R 8 211.4 (CO), 172.9 (CO), 171.3 (CO), 137.0, 136.7,
130.3, 129.8, 128.7, 128.4, 126.6, 125.9, 90.3, 63.3, 43.0, 41.4, 39.9, 33.8,
22.4, 21.2. IR (nujol) 1780, 1718, 1660, 1205, 1170, 933, 871, 725 cm-1.
M S (FAB) m/z 376 (15%, M H + ) , 242 (40), 165 (47), 154 (100). Anal.
Calcd for C23H21NO4: C, 73.58; H, 5.64; N, 3.73%. Found: C, 73.35; H,
5.77; N, 3.35%.
(40b): lH N M R (in part) 8 6.86 (s, IH, H2')
(40c): lH N M R (in part) 8 6.51 (s, IH, H2').
(lS)-l-(l-Benzenecarboxamido-3,4-dimethyI-cyclohex-3-enyl)methanol
(21).

A mixture (97 : 3) of (17) and (18) (100 mg, 0.3 mmol) in dry meth
(10 m L ) was treated with

N a B H 4 (20 mg). After 16 hr at room

temperature the solution was then treated with acetone (2 m L ) at 0 °C for
10 min. The solvent was then evaporated and water was added and the
alcohol was extracted into C H 2 C I 2 (2x).

Short-path column

chromatography on silica gel gave (21) (32 mg, 41%). *H N M R 8 7.72-
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7.41 (m, 5H), 6.17 (bs, IH, O H ) , 5.14 (bs, IH, N H ) , 3.79 (m, 2H,
CHBHAOH),

2.22-2.00 (m, 5H), 1.78 (m, IH), 1.67 (bs, 6H). M S (CI) m/z

260 (53%, M H + ) , 138 (100), 122 (95), 105 (63).
M T P A ester of (21).

A solution of (21) (25 mg, 0.096 mmol) in CH2CI2 and two drops o
pyridine at 0 °C was treated with (fl)-(-)-a-methoxy-a-trifluoromethylphenylacetyl chloride (34 mg, 0.13 mmol). The solution was stirred for 3
hr at room temperature and then the solvent was evaporated. The solid
residue was dissolved in CH2CI2 (10 m L ) and the solution was washed
with 5 % aqueous HCI, 1 0 % aqueous N a O H , and then water. The CH2CI2
solution was then dried over MgS04, filtered and evaporated in vacuo to
give (22) as an oil (20 mg, 44%). The lH N M R spectrum was taken on
this oil. [ a ] D 2 5 -8.5 (c 0.2 in CHCI3). lH N M R 8 7.6-7.22 (m, 10H), 5.73
(s, IH, N H ) , 4.79 (d, J=11.2 Hz, IH) [minor isomer, 4.87 (d J=11.2 Hz,
IH)], 4.68 (d, J=11.2 Hz, IH) [minor isomer, 4.63 (d, J=11.2 Hz, IH)],
3.47 (s, 3H), 2.45-2 (m, 5H), 1.70 (m, IH), 1.62 (bs, 6H). M S (CI) m/z 476
(9%, M H + ) 445 (100). A n expanded section of the lH N M R spectrum of
(22) is shown in Figure 2.3.
(lS,2S,4S)-2-(2-Benzenecarboxamidobicyclo[2.2.2]oct-5-enyl)
methanol (33).
This compound was prepared from a mixture (76 : 24) of (11) and
(200 mg, 0.6 mmol) by treatment with N a B H 4 as described in the
preparation of (21). Purification of the crude reaction product by column
chromatography gave (33) (40 mg, 50%). lH N M R 8 7.68-7.4 (m, 5H),
6.45 (t, J = 7.2 Hz, IH, H6), 6.32 (t, J = 7.2 Hz, IH, H5), 5.94 (bs, IH,
N H ) , 5.64 (dd, J = 2.4, 9.2 Hz, IH, O H ) , 4.10 (dd, J = 2.4, 12, Hz, IH,
C H A C H R O H ) , 3.68 (dd, J = 9.2, 12 Hz, IH, C H A C H B O H ) , 3.32 (m, IH,

HI), 2.68 (m, IH, H3p), 1.94 (m, IH, H4), 1.71-1.23 (m, 5H). 13c N M R 8
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168.1 (CO), 135.7, 134.8, 132.9, 131.7, 128.7, 126.9, 68.9, 62.6, 42.3,
34.4, 30.0, 23.4, 20.6.
MTPAesterof(33).

This compound was prepared from (33) (10 mg, 0.04 mmol) as describe
in the preparation of (22). Short-path column chromatography gave (34) (8
mg, 46%). [ a ] D 2 6 -39.0 (c 0.2 in CHC1 3 ). lH N M R 8 7.53-7.22 (m, 10H),
6.42 (t, J = 7.2 Hz, IH, H6), 6.24 (t, J = 7.2 Hz, IH, H5), 5,63 (bs, IH,
N H ) , 5.24 (d, J = 11.2 Hz, IH) [minor isomer, 5.05 (d, J = 11.2 Hz, IH)],
4.50 (d, J = 11.2 Hz, IH) [minor isomer, 4.56 (d, J = 11.2 Hz, IH)], 3.47
(s, 3H, O C H 3 ) , 2.94 (m, IH, HI), 2.66 (m, IH, H3P), 1.75 (m, 3H), 1.51.26 (m, 3H). M S (CI) m/z 474 (37%, M H + ) , 394 (11), 240 (100). A n
expanded section of the lH N M R spectrum of (34) is shown in Figure 2.7.
Methyl
( 1 5 ,25,45)-2-benzamido-5-oxo-bicyclo[2.2.2]octane-2carboxylate (41) and
Methyl
(15,25,4/c)-2-benzamido-6-oxobicyclo[2.2.2]octane-2-carboxylate (42).
To a solution of (40a) or a mixture (1 : 1) of (40b) and (40c) (50 mg, 0.13
mmol) in dry methanol (10 m L ) under nitrogen was added powdered
anhydrous potassium carbonate (20 mg, 0.14 mmol). The mixture was
stirred at room temperature for 16 hr. The mixture was then diluted with
ethyl acetate (20 m L ) and washed with an aqueous solution of saturated
ammonium chloride. The aqueous layer was separated and extracted with
ethyl acetate (2x10 mL). The combined extracts were washed with water,
brine, dried (MgS04) and concentrated in vacuo. Starting from pure (40a),
the ester (41) was obtained in nearly quantitative yield. Starting with a
mixture of (40b) and (40c), then a 1 : 1 mixture of (41) and (42) was
obtained, these could be separated by preparative T L C using 4 0 % ethyl
acetate / hexane as eluent. In one experiment a mixture of (40b) and a
small amount of the fourth unidentified Diels-Alder diastereomeric product

Chapter 2

ng

was converted to mainly (41). The unidentified Diels-Alder diastere
product gave an ester that was different to both (41) and (42), but could not
be obtained in sufficient quantity or diastereomeric purity for structural
elucidation studies.
(41): lH NMR 8 7.75-7.42 (m, 5H), 6.47 (bs, IH, NH), 3.77 (s, 3H,
O C H 3 ) , 3.32 (dd, J = 2.8, 15 Hz, IH, H6a), 2.70 (ddd, J = 2.8, 5.6, 18.8
Hz, IH, H3p), 2.50 (m, IH, HI), 2.46 (m, IH, H4), 2.30 (dd, J = 2.8,18.8
Hz, IH, H3a), 2.04 (m, IH, H8a), 2.00 (ddd, J = 2.8, 12.8, 15 Hz, IH,
H6P), 1.80 (m, IH, H7a), 1.78 (m, IH, H7p), 1.64 (m, IH, H8p). M S
(ES) m/z 302 (100%, MH+).
(42): IH N M R 8 7.8-7.45 (m, 5 H), 6.68 (bs, IH, N H ) , 3.74 (s, 3H, OCH3),
3.20 (ddd, J = 2.6, 5.6, 15 Hz, IH, H5P), 2.50 (t, J = 2.8 Hz, IH, HI), 2.46
(m, IH, H4), 2.38 (ddd, J = 2.8, 3.2, 19 Hz, IH, H3P), 2.32 (m, IH, H7a),
2.26 (dt, J = 2.8, 19 Hz, IH, H3a), 2.20 (m, IH, H8a), 2.00 (m, IH, H8p),
1.97 (dd, J = 2.6, 15 Hz, IH, H5a), 1.70 (m, IH, H7p). M S (ES) m/z 302
(100%, M H + ) .
(25,2'/?,45)-3,-Benzoyl-2,-phenyIspiro[2.2.2]octane-2,4,-oxazoIidin]-5'one (57) and Benzyl (25,45)-2-benzamido-bicyclo[2.2.2]octane-2carboxylate (58).
A solution of (11) (1.8 g, 5 mmol) in ethyl acetate (30 mL) was
hydrogenated over 1 0 % palladium on carbon (360 m g ) for 10 hr at room
temperature under a hydrogen atmosphere (1 atm). The mixture was
filtered through celite, and the filtrate was evaporated to dryness under
reduced pressure to furnish a 80 : 20 mixture of (57) and (58) (1.5 g).
(57): lH N M R (of mixture, in part) 8 7.36-6.81 (m, 10H), 6.44 (s, IH, H2'),
3.60 (dt, J = 3, 5.4, 13.8 Hz, IH, H3p), 2.20 (dt, J = 2.4, 4.8, 13.8 Hz, IH,
H3a), 2.09-1.43 (m, 1 OH).
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Compound (58) was obtained in > 9 5 % purity after purification by column
chromatography on silica gel with ethyl acetate / hexane as the eluent.
(58): M.p. 125-7 °C; [ a ] D 2 4 +24.7 (c 0.15 in CHC1 3 ). lH N M R 8 6.917.80 (m, 10H), 6.36 (bs, IH, N H ) , 4.75 (d, J = 15.2 Hz, IH, C H A H B P I I ) ,

4.61 (d, J = 15.2 Hz, IH, C H A H B P I I ) , 3.04 (bs, 2H, Hl/H3a), 2.66 (bd,
IH, H3P), 2.54 (bs, IH, H4), 2.08 (bd IH, H8a), 1.87 (bd, IH, H8P), 1.76
(m, 2H, H7a/H7p), 1.68-1.40 (m, 4H, H5a/H5p/H6a/H6p). 13C N M R 8
174.8 (CO), 169.6(CO), 145.2, 143.1, 132.5, 132.1, 128.9, 128.8, 127.3,
127.2, 88.0, 62.3, 37.7, 29.7, 24.7, 24.0, 23.5, 21.6, 20.8. IR (nujol) 1712,
1600, 1505, 1290, 1206, 1160, 1061, 1028, 792, 712 cm-l. M S (ES) m/z
364 (10%, M H + ) , 296 (25), 274 (100).
(25,45)-2-Aminobicyclo[2.2.2]octane-2-carboxylic Acid (59)
A 90 : 10 mixture of (57) and (58) (250 mg, 0.69 mmol) in 6 N
hydrochloric acid (20 m L ) was heated to reflux for 24 hr. The solution was
then cooled, and extracted with CH2CI2 (50 mL). The aqueous layer was
purified on a Dowex 50-X8 ion exchange column that had been previously
conditioned with 1 M hydrochloric acid. The column was eluted with
water until the eluent became neutral. The free amino acid was then
obtained by eluting with 1.6 M aqueous ammonia. Pure (59) (115 mg,
99%) was obtained as a white solid.
M.p. 280-2 °C; [ a ] D 2 8 +12.40 (c 0.5 in H 2 0 ) . lH N M R (D 2 0) 8 2.42 (bd,
J = 14.4 Hz, IH, H3p) 1.90 (bt, J = 2.8, 5.6 Hz, IH), 1.75 (bt, J = 2.4, 5.6
Hz, IH, H4), 1.67-1.60 (m, 3H), 1.53 (m, 4H), 1.47 (m, 2H), 1.46 (bs, IH,
H3a). 13C N M R (D 2 0) 8 174.2 (CO), 61.3 (C), 33.6 (CH 2 ), 31.1 (CH),
23.5 (CH 2 ), 23.4 (CH), 22.9 (CH 2 ), 22.1 (CH 2 ), 19.8 (CH 2 ). M S (ES) m/z
170 (100%, M H + ) .
(25,2f/f,45)-2-Methoxy-3,-benzoyl-2,-phenyIspiro[2.2.2]octane-2,4,oxazolidin]-5f-one (60).
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A solution of (37a) (85 mg, 0.22 mmol) in ethyl acetate (7 m L ) was
hydrogenated at atmospheric pressure over 1 0 % palladium on carbon (17
mg) for 10 hr. A similar work up procedure to that described for (57) and
(58) gave (60) (75 mg, 87%) which was pure by lH N M R and T L C
analysis. Recrystallization from ethyl acetate / hexane gave clear needles.
M.p. 164-5 °C; [a] D 2 4 +188.3 (c 0.86 in CHC1 3 ). lH N M R 8 7.26-6.78
(m, 10H), 6.45 (s, IH, H2'), 3.78 (bd, IH, H3p), 3.36 (s, 3H, OCH3), 2.38
(m, IH, H4), 2.32 (dt, J = 2.8, 5.2, 13.6 Hz, IH, H3a), 2.06 (m, 2H), 1.951.82 (m, 4H), 1.73 (m, 2H). 13c N M R 8 173.9 (CO), 172.0 (CO), 138.4,
137.2, 129.8, 129.1, 128.3, 128.2, 127.1, 125.9, 91.8 (CH), 80.9 (C), 69.3
(C), 49.4 (CH 3 ), 34.5 (CH 2 ), 27.2 (CH 2 ), 25.3 (CH), 25,.2 (CH 2 ), 25.1
(CH 2 ), 24.3 (CH 2 ). IR (nujol) 1750, 1628, 1325, 1262, 1198, 1155, 1086,
1033, 989, 752, 718, 688 cm-1. M S (CI) m/z 392 (10%, M H + ) , 286 (30),
242 (85), 226 (80), 181 (90), 123 (86), 110 (100). Anal. Calcd for
C24H25NO4: C, 73.66; H, 6.39; N, 3.58%. Found: C, 73.76; H, 6.50; N,
3.41%.

99

CHAPTER THREE

Asymmetric Synthesis of A m i n o Acids Derivatives via 1,3Dipolar Cycloaddition Reactions of Nitrones and Nitrile
Oxides
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3-1. Introduction
A general principle for the synthesis of five-membered rings via 1,3dipolar cycloaddition was introduced by the monumental work of Huisgen
and coworkers in the early 1960s. 76 T h e 1,3-dipole with 4TC electrons is
defined as a species that is represented by zwitterionic octet structures and
undergoes 1,3-cycloadditions to a multiple-bond system, the dipolarophile
with 27i electrons (eq 3.1). 77
1,3-DipoIe (47te) Ub\. h

Dipolarophile (2ne)

a
ci
^
)
d==e

•

'
\

\
/

a

drr

(eq 3.1)

-e

A considerable number of 1,3-dipoles containing various combinations of
carbon and hetero atoms is theoretically possible and m a n y have been
made and their reactions with dipolarophiles studied.77 Huisgen has
classified the eighteen possibilities, six of the propargyl-allene type such as
nitrile oxides and twelve of the allyl type such as nitrones and azomethine
ylides.77
O
Nitrones

Azomethine Ylides
/

Nitrile Oxides

N+

X

8- + 5— C — N**0

Generally, it is agreed that 1,3-dipolar cycloadditions are concerted,
making them of great value in synthesis that require high degrees of regioand stereoselectivities.76-78 In most reactions the 1,3-dipole is not isolated
but is generated in situ in the presence of the dienophile, which is generally
an alkene or alkyne.

Reactions generally classified as 1,3-dipolar
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cycloadditions have been extensively employed in the synthesis of a
diverse array of heterocyclic compounds, including natural products.77"79
Nitrones and nitrile oxides react with D H A A s to produce geminally
functionalized heterocyclic amino acids.43 The 1,3-dipolar cycloaddition
of ethyl N-acetyl-a,p-dehydroalaninate (1) with nitrones and nitrile oxides
generally proceeded with remarkably high regioselectivity (Scheme 3.1).
C o m p o u n d (1) reacted with phenylnitrile oxide (2) to produce a single
regioisomer, A2-isoxazoline (3) (herein-after referred to as isoxazoline) in
8 5 % yield. Treatment of (1) with C,iV-diphenylnitrone (4) provided a
mixture of two stereoisomers of the isoxazolidine (5).
Scheme 3.1
<^.C0 2 C 2 H 5
Ph—C=N-0

r.t.

2hr/THF

C02C2H5

Ac

HN.
Ac

(D

(3)

(2)

Ph
Ph

(D

Ph
+,0"
,CFN X
Ph
H

50-60 °C
1

26hr/THF

C02C2H5
HN^

Ac
(4)

(5)

Since 1987 more than two hundred papers have been published on the
reaction of nitrile oxides with alkenes,80 thus highlighting the importance
of these types of reactions in organic synthesis.
Another application of the 1,3-dipolar cycloaddition of nitrile oxides is
medicinal chemistry.8!

Bromonitrile oxide ( B r C N O ) undergoes

cycloaddition with alkenes and alkynes with high regioselectivity to give
the 3-bromo-4,5-dihydroisoxazole ring system (6a) in good yield.8la This
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compound is an analogue of the amino acid antimetabolite antibiotic
Acivicin (6b).
C02H
H2N—\

C02H
H 2 N--\

%<^Br
(6a)

V^Cl
(6b)

Some of the heterocyclic systems produced through 1,3-dipolar additions
with dipolarophiles that contain hetero multiple bonds can be readily
converted into other synthetically useful compounds; ring-opening
reactions which result in the stereocontrolled formation of acyclic
compounds are particularly valuable.82 Nitrones, nitrile oxides and
azomethine ylides have been most widely used and the present Chapter
will be concerned with the reactions of two former compounds. In the next
Chapter the reactions of the latter compounds will be considered.
Nitrones are reactive 1,3-dipoles and with alkenes form isoxazolidines.
Reactions with alkenes are stereospecific as regards to the disposition of
substituents on the olefinic bond. These reactions are valuable in synthesis
because the nitrogen-oxygen bond of the adducts is easily cleaved and the
sequence of cycloaddition followed by ring cleavage provides a route for
the stereocontrolled synthesis of a variety of acyclic and substituted cyclic
compounds. These reactions have been extensively utilized as the key
feature in total synthesis of structurally diverse natural products,
particularly alkaloids.77-79' 83-86 There are some examples ofringopening
of nitrone cycloadducts to y-amino alcohols via reductive cleavage of the
nitrogen-oxygen bond. The isoxazolidine (8), which was produced by
cycloaddition reaction of nitrone (7) and propylene, was reduced with
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lithium aluminium hydride (LAH) in refluxing THF for 24 hr to give the
alkaloid d/-sedridine (9) in quantitative yield (Scheme 3.2).84
Scheme 3.2

,

T^

+

H 3 CCtt=CH 2

T0luene

»

no °c

(7)
LAH/THF

(8)
reflux
24 hr

'CH 3
(9)

The nitrogen-oxygen bond cleavage in the methiodide salt derived from
isoxazolidine (10) with zinc in the presence of acetic acid, afforded the
alkaloid darlinine (11) (Scheme 3.3).85
Scheme 3.3

(10)

(U)

Cleavage of the nitrogen-oxygen bond of isoxazolidines by hydrogenation
over palladium hydroxide (Perlmann's catalyst) has been used to prepare
natural products, including alkaloids79 and amino sugars.87 M o r e recently
Bravo et a/.88 reported that the hydrogenation of isoxazolidine (12) over
palladium hydroxide as a catalyst, afforded in 5 hr, the corresponding yamino alcohol (13) in high yield (Scheme 3.4).
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Scheme 3.4
CH2Ph

NH2 OH
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H
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3
H C02Et

82%
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S o m e of the k n o w n transformations of isoxazoline rings, which were
prepared from nitrile oxides, are summarized in Scheme 3.5. 1) Reductive
cleavage of the nitrogen-oxygen bond of isoxazolines followed by acid
hydrolysis leads to p-hydroxy ketones which are important in organic
synthesis because this functional group, called an aldol, can be further
transformed into a variety of related functionalities such as a,P-unsaturated
ketones, 1,3-diols and 1,3-dienes. Catalytic hydrogenation over Raney Ni
in aqueous methanol, 89 in the presence of boric acid 90 or aluminium
chloride,9! is most commonly employed for this purpose. 2) Reduction of
isoxazolines under severe conditions leads to a y-amino alcohol
functionality. In most cases L A H is employed as the reducing agent for
this purpose.92 3) p-Hydroxy nitriles are formed through a novel ring
opening reaction of 3-unsubstituted isoxazolines by the action of a base
such as sodium methoxide.93 4) P-Hydroxy acids and derivatives are
produced by catalytic hydrogenation over Raney Ni in the presence of
acetic acid.94
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Scheme 3.5
0

OH

0

XX

OH

/\

(3)
OH
NC

In this Chapter, the 1,3-dipolar cycloaddition reaction of nitrones and
nitrile oxides with the chiral oxazolidinone (14) is described and the
structure and stereochemistry of the cycloadducts is reported. Our attempts
to affect ring opening of some cycloadducts by catalytic hydrogenation
with the aim of preparing novel chiral amino acids will also be described.
CH2
PhOCN

,

H Ph
(14)
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3-2. 1,3-Dipolar Cycloaddition Reactions of (14) and Nitrones
3-2-1. 1,3-Dipolar Cycloaddition Reactions of (14) and C,NDiphenylnitrone (4)
When a solution of oxazolidinone (14) and nitrone (4) (1.1 molar
equivalents) in CH2CI2 was stirred at room temperature for 7 days, then a
70 : 30 mixture of two diastereomeric cycloaddition products, (15a) and
(15b) w a s formed in 9 4 % yield (Scheme 3.6). T h e same two
diastereomeric products were produced in a ratio of 62 : 38 when this
reaction was performed at 60 °C over 3 days (Table 3.1, page 110). The
diastereoisomers could be readily separated by fractional crystallization.
lH N M R analysis of both diastereoisomers indicated that these reactions
were highly regioselective and that both diastereoisomers had the 5,5disubstituted isoxazolidine rather than the 4,4-disubstituted isoxazolidine
structure. The relative stereochemistry of these compounds however,
could not be determined from N M R experiments. The stereochemistry of
the major diastereoisomer (15a) was unequivocally determined by a single
crystal X-ray structural determination (Figure 3.1). The X-ray structural
analysis indicated that the stereochemistry of (15a) arises from addition of
nitrone (4) to the 7t-face of the exo-cyclic 4-methylene group of (14) that is
anti to the C-2 phenyl substituent, via an endo type transition state.
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Scheme 3.6

P\

.
T+fl~

(14)

C=i\
H

CH2C12

Ph

(4)
Ph

,*

Ph -_^N.
«

s°y

ph
PhCON
•0

p/ V"X)
(enrfo transition state)

PhCON

(exo transition state)

Figure 3.1. Molecular projection of (15a) normal to the plane of the five membered
ring.
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To determine the stereochemistry at C-3 of the minor diastereoisomer, a 73
: 27 mixture of the minor (15b) and major (15a) diastereoisomers
respectively, was reduced with sodium borohydride 55 to give a 72 : 28
mixture of diastereomeric alcohols (Scheme 3.7). Treatment of this
mixture with (-)-(fl)-a-methoxy-a-trifluoromethylphenylacetyl chloride
( M T P A C 1 ) 5 6 and pyridine gave a mixture of four diastereomeric amethoxy-a-trifluoromethylphenylacetates ( M T P A ) (18), (19), (20) and
(21). The ratio of (20) + (21) : (18) + (19) was 70 : 30 (see Experimental
section for details). Clearly the above reduction reaction had produced a
mixture of (16) and its enantiomer ent-(16), and (17) and its enantiomer
ent-(\l). Thus epimerization at C-5 had occurred in the alcohol products.
W h e n this sequence of reactions was performed on diastereomerically pure
(15a) then only M T P A ' s (18) and (19) were formed, not necessarily
respectively, in a 55 : 45 ratio (Scheme 3.7). These experiments clearly
establish the stereochemistries at C-3 in the major (15a) and minor (15b)
diastereoisomers to be opposite. W e therefore suggest that the structure of
the minor diastereoisomer is (15b). The above experiments also show that
(15a) was obtained in high enantiomeric purity (e.e. > 9 8 % ) .
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Scheme 3.7
(15a) + (15b)
1. NaBH4, MeOH
2. MTPAC1, pyridine

(16)
(17)
(18)
(19)

; R1 = PhCONH, R 2 = CH 2 OH
; R1 = CH 2 OH, R2 = PhCONH
; R1 = PhCONH, R2 = CH 2 OMTPA
; R1 = CH 2 OMTPA, R 2 = PhCONH

ent-(16); R1 = CH2OH, R 2 = PhCONH
ent-(l7) ; R1 = PhCONH, R 2 = CH 2 OH
(20) ; R1 = CH2OMTPA, R 2 = PhCONH
(21); R1 = PhCONH, R2 = CH 2 OMTPA

MeOk /J*3
MTPA =

(15a)

OC

Ph

1. NaBH4, MeOH

(18) + (19)

2. MTPAC1, pyridine

Although the structure (15c), which could arise from an endo type
transition state, and addition of the nitrone to the more hindered side of the
exo-cyclic methylene group of (14), could not be ruled out for the minor
isomer, the lH N M R of this compound was significantly different to that of
(23b) (Scheme 3.8, page 112), the structure of which was established by
single crystal X-ray structural analysis.
Ph
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Table 3.1. 1,3-Dipolar cycloaddition products from the reactions of (14)
with nitrones and nitrile oxides.
Entry

Dipole

Time (days) /
Temp. (°C)

Yield

(Products)
(%) a
Diastereoselectionb
1 C, N-Diphenylnitrone
(15a), (15b)
7/r.t.
94
(4)
70:30
3/60
99
62: 38
2
C-Phenyl-iV-terr(23a), (23b)
butylnitrone
10/r.t.
36
88: 12
(22)
52
22/r.t.
88:12
31/r.t.
69
89:11
42
3/60
72:28
49
10/60
55:45
66
33:67
22/60
C-Phenyl-JV3
(25a),(25b),(25c),(25d)
methylnitrone
50
15/r.t.
28 :44 : 22 : 6
(24)
11:30:39:20
53
8 A60
4
(30), minor isomer
Pyrolidine nitrone
>98 : <2
(28)
27
2 / r.t.
33
2/40
92:8
(31), minor isomers
Piperidine nitrone
5
85 : 15
(29)
1.5/r.t.
25
70 : 15 : 15
30
1.5/40
(38a), (39a)
Phenylnitrile oxide
6
85 : 15
94
2 hr / r.t.
(2)
(38b), (39b)
7
Methylnitrile oxide
4ic
83:17
2 hr / r.t.
(37)
a
After purification.b Determined on the crude reaction mixture by !H N M R (400
MHz). c Yield of pure major diastereoisomer.
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W h e n a solution of diastereomerically pure (15a) in CH2CI2 was heated at
60 °C for 3 days no interconversion of (15a) to (15b) or the formation of
(4) and (14) was observed. Thus (15a) appears to be formed under
kinetically controlled conditions with no interconversion of (15a) to (15b)
occurring under the reaction conditions. In contrast, the cycloaddition
reactions of (14) and nitrones (22) and (24) were found to be reversible at
60 °C and furthermore, the starting compounds (14) and (22 or 24) were
always observed in the crude reaction mixtures.
3-2-2. 1,3-Dipolar Cycloaddition Reactions of (14) and C-PhenylN-tert-butylnitrone (22)
When a solution of (14) and nitrone (22) in CH2CI2 was stirred at room
temperature then a 88 : 12 mixture of (23a) and (23b) was obtained
(Scheme 3.8). The diastereomeric ratio of (23a) : (23b) remained
essentially unchanged over 31 days (Table 3.1, page 110). The structures
of (23a) and (23b) were elucidated by single crystal X-ray structural
determinations (Figure 3.2). The major diastereomeric product (23a) had
the same relative stereochemistry as (15a) and was the expected 'endo'
product.

The minor diastereoisomer (23b) had the unexpected

stereochemistry at C-4' of the oxazolidinone ring. This isomer arises from
addition of the nitrone (22) to the more sterically hindered 7t-face of the
e*o-cyclic 4-methylene group of (14), via an endo type transition state.
W h e n this reaction was performed at 60 °C however, the ratio of (23a) :
(23b) changed with the reaction time and after 22 days, (23b) was the
major diastereomeric product (Table 3.1, page 110). W h e n a solution of
diastereomerically pure (23a) was heated at 60 °C for 10 days then a 32 :
12 : 56 mixture of (23a), (23b) and (14) was obtained along with some
nitrone (22).
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Scheme 3.8

"O

CH2C12

(14)
+

N=<
Ph
(22)

N

A-*»»Ph

Ph
CO

'AA1

/Ph

•

_

Bu l
(ewrfo transition state / syn addition)

(23a)

(23b)

Figure 3.2. Molecular projection of (23a) and (23b) normal to the plane of five
membered ring.
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The above experiments clearly indicate that while diastereoisomer (23a
favoured kinetically, diastereoisomer (23b) is thermodynamically more
stable. Indeed molecular modelling of these diastereomeric molecules,
using the B I O S Y M molecular modelling program and the I N S I G H T II
forcefield,indicated that (23b) should be thermodynamically favoured
over (23a) by about 3 kcal m o H .

(23a) Total Energy = 103 kcal / mol

(23b) Total Energy = 100 kcal / mol

Figure 3.3. Energy minimized structures of (23a) and (23b) using the I N S I G H T II
force field of B I O S Y M .

3-2-3. 1,3-Dipolar Cycloaddition Reactions of (14) and C-Phenyl/V-methylnitrone (24)

When a solution of (14) and nitrone (24) in CH2CI2 was stirred at room
temperature for 15 days, then four diastereomeric 5,5-disubstituted
isoxazolidine products (25a), (25b), (25c) and (25d) were formed in 5 0 %
yield (Scheme 3.9). The ratio of these adducts remained essentially
unchanged throughout the course of the reaction (Table 3.1, page 110).
The two major diastereoisomers could not be obtained diastereomerically
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pure, however the two minor diastereoisomers (25c) and (25d) could be
isolated diastereomerically pure after partial separation by column
chromatography and then selective crystallisations. The single crystal Xray structures of (25c) and (25d) are shown in Figure 3.4.
Scheme 3.9
Me

\+
/ N

_

3L
= <

0

CH2C12
(14)

Ph

(24)

H
'lj-X-PIi

Me\

Mev
N

fh
I*-i-H

MeN

f
N—/.-Ph

™\

fh
N4-"H

6i
PhCON

PhCON3'

(25c)
Figure 3.4.

PhCON

(25d)

Molecular projection of (25c) and (25d) normal to the plane of five

membered ring.

Chapter 3

115

Both structures have the same stereochemistry at C-4' of the
oxazolidinone ring as (23b). Consequently (25a) and (25b) must have the
same stereochemistry at C-4' as the adducts (15a) and (23a). The
stereochemistry of (25a) and (25b) was based upon !H N M R analysis and
molecular modelling studies (Figure 3.5). The lH N M R spectrum of
(25b) showed that H 3 was highly shielded (5 3.30) compared to H 3 in the
IH N M R spectrum of (25a) (6 4.23). Molecular modelling (Figure 3.5)
of these compounds showed that H 3 in (25b) is in the shielding region of
the phenyl ring of the N-benzoyl group, while H 3 in (25a) is remote from
such influences. Thus based on these considerations w e tentatively assign
the structures (25a) and (25b). W h e n the reaction of (14) and (24) was
performed at 60 °C the ratio of the diastereomeric products favoured the
adducts (25c) and (25d) over (25a) and (25b) (Table 3.1, page 110 ).
H3(6 4.23 ppm)

(25a)

H3(6 3.30 ppm)

(25b)

Figure 3.5. Energy minimised structures of (25a) and (25b) using the INSI
force field of BIOSYM.
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3-2-4. Preparation of the Nitrones (4) and (24)

Nitrones are highly versatile synthetic intermediates and excellent sp
trapping reagents.95 Nitrones have been prepared by either condensation
of an aldehyde or ketone with a hydroxylamine,96 by the oxidation of
hydroxylamines,97 and by the direct and catalytic oxidation of secondary
amines.98 T h e oxidation methods have been routinely used for the
preparation of cyclic nitrones.98,99 The C,AT-diphenylnitrone (4) and Cphenyl-AT-methylnitrone (24) were prepared by condensation of
benzaldehyde with the appropriate iV-hydroxylamines.100,101 The Nphenylhydroxylamine (26) was produced by reduction of nitrobenzene
with zinc dust in a solution of a m m o n i u m chloride in water. Treatment of
the compound (26) with benzaldehyde in ethanol at room temperature
produced the nitrone (4) with 8 5 % yield (Scheme 3.10). The nitrone (24)
was prepared by treatment of N-methyl hydroxylamine hydrochloride (27)
with benzaldehyde in CH2CI2 and in the presence of sodium bicarbonate
(Scheme 3.10).
Scheme 3.10
NH4CI
C 6 H 5 N0 2 + 2Zn + H 2 0

•

C 6 H 5 NHOH + 2ZnO
(26)

(26) + PhCHO

V_=v/Ph
•
yC=j\
Ph
0~
(4)

HCl.MeNHOH + PhCHO

NaHC03
•
n„ n,
CH2C12

EtOH/r.t.

(27)

H

^r^^
/
N,
o~
Pn'
(24)
c
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3-2-5. 1,3-Dipolar Cycloaddition Reactions of (14) and Cyclic
Nitrones

The reactions of (14) and the pyrrolidine nitrone (28) (Scheme 3.11) w
highly diastereoselective at room temperature to 40 °C, but the isolated
yields of the major diastereomeric product were low (Table 3.1, page 110).
The reactions of (14) with the homologous (cyclic) piperidine nitrone (29)
(Scheme 3.11) were less diastereoselective and again the isolated yields of
the major diastereomeric product were low (Table 3.1, page 110). In
contrast, the reaction of (14) and (29) at 40 °C apparently gave three
diastereomeric adducts, however the stereochemistry of the two minor
adducts could not be determined. The single crystal X-ray structures of the
major diastereomeric adducts (30) and (31) from the reactions of (28) and
(29) respectively, are shown in Figure 3.6.
Scheme 3.11

(CH 2 ) n

CH 2 C1 2

(14)
N+
3
O"
(28);n=l

~

,, ,,
',;!

+ minor isomer(s)

4
PhCON^.
^
PhCONr 4 '>v^:0

Ph- ]{

(29) ; n=2
(30); n=l
(31) ; n=2

Both adducts (30) and (31) have the same relative stereochemistry. The
stereochemistry at C-4' of the oxazolidinone ring of these adducts suggests
that they are the thermodynamically favoured products that have been
formed from a reversible cycloaddition reaction. Both adducts arise from
an endo-like transition state.
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(30)

(31)

Figure 3.6. Molecular projection of (30) and (31) normal to the plane of five
membered ring.

The yields of these reactions were low (25-33 %) with the recovery of
some of the alkene (14) because of the competitive dimerisation of the
nitrones as shown in (eq 3.2). 1°2
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(eq 3.2)

(29)

(32)

3-2-6. Preparation of the Cyclic Nitrones (28) and (29)

The preparation of cyclic nitrones have been performed by reduction or
oxidation reactions. A n efficient synthesis of 5-membered cyclic nitrones
from y-nitro ketones (33) was introduced by R. Zschiesche et al. in
1988.1°3 In these reactions, substituted and functionalized pyrrolidine
nitrones (34) were obtained from a-nitro ketones by hydrogenation over Pd
/ C in the presence of ammonium formate (Scheme 3.12).
Scheme 3.12
,i

HC02NH4/MeOH^

R^

Pd/C

N02
(33)

N+
O(34)

Recently Murahashi et al." reported the preparation of cyclic nitrones
such as pyrrolidine and piperidine nitrones in high yields from the
oxidation of secondary amines. W e have prepared nitrones (28) and (29)
by oxidation of the secondary amines (35) and (36) respectively, with
hydrogen peroxide in the presence of sodium tungstate as a catalyst
following the Murahashi procedure (Scheme 3.13)".
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Scheme 3.13

CJ • „202 ~*°, (J"
H
n=l ;(35)
n =2 ; (36)

O
n =l ; (28)
n =2 ; (29)

3-3. 1,3-Dipolar Cycloaddition Reactions of (14) and Nitrile
Oxides
Treatment of (14) with phenylnitrile oxide (2) (Scheme 3.14) in
room temperature for 2 hr gave an 85 : 15 mixture of two diastereomeric
adducts (38a) and (39a) in excellent yield (94%) (Table 3.1, page 110).
The analogous reaction of (14) with methylnitrile oxide (37) (Scheme 3.14)
proceeded with a similar diastereoselectivity, however, the isolated yield of
the major diastereomerically pure product (38b) was low (41%) (Table 3.1,
page 110). The structure of the diastereoisomeric products (38a), (39a) and
(38b) were determined by single crystal X-ray structure determinations
(Figure 3.7) and (Figure 3.8).
Scheme 3.14
R

R
N = =

N=___/

(14) + R - C = N - 5 J S S S V

°<V"

+

4

PhCON XssssO

(2) ; R = Ph
(37);R = Me

kj0

PhCON

A

U

^V

(38)

^

O
Xss»0

L_/
^V
(39)

a ;R = Ph
b ;R = Me

Both the major diastereomeric adducts (38a) and(38b) had the exp
regiochemistry and stereochemistry at C-4'. These adducts arise from
addition of the nitrile oxides to the 7t-face of the exo-cyclic methylene
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group of (14) that is anti to the C2"-Ph substituent of the oxazolidinone ring
of (14). The minor isomers (39a) and(39b) were formed via addition of the
nitrile oxides to the more hindered 7C-face of the exo-cyclic methylene
group of (14).

(38a)

(39a)

Figure 3.7. Molecular projection of (38a) and (39a) normal to the plane of five
membered ring.
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PhCON
Ph

H
(38b)

Figure 3.8. Molecular projection of (38b) normal to the plane of five membered ring.

Analogous results have been reported by Pereira et al.104 in 1993 for the
addition of propionitrile oxide to the structurally related a-methylene-ybutyrolactones (40a-h) (Scheme 3.15). In this series of reactions the
product mixture contained two diastereoisomers, the major cycloadduct
(41) was formed by addition anti to the bulky R substituent, and the minor
cycloadduct (42) was formed from syn addition.
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Scheme 3.15
=N

+ O Et-C=N— 0
benzene / r.t.

R

R H

H
(40)

(42)

(41)
a
b
c
d

; R = methyl
; R = heptyl
; R = phenyl
; R = t-butyl

e ; R = 2-naphthyl
f ; R = 2-methoxyphenyl
g ; R = 4-methoxyphenyl
h ; R = 2,6-dichlorophenyl

Table 3.2. Relative proportions of syn a n d and additions of propionitrile
oxide to y-substituted oc-methylene-y-butyrolactones (40a) to (40h).l°4

Dienophile
(40)

Ami addition

Syn addition

Total yield (%)

(a)

81

19

54

(b)

86

14

72

(c)

89

11

86

(d)

90

10

80

(e)

87

13

79

(f)

82

18

83

fe)

86

14

66

(h)

100

0

65

To determine the enantiomeric purity of the nitrile oxide cycloadducts,
compound (38a) was reduced with sodium borohydride in methanol to give
the alcohol (43). Treatment of this alcohol with (-)-R-oc-methoxy-atrifluoromethylphenylacetyl chloride ( M T P A C 1 ) 5 6 and pyridine gave two
diastereoisomeric esters (44a) and (44b) in a ratio of 88 : 12 (Scheme
3.16). This experiment indicated that the enantiomeric purity of the (38a)
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was 76% and showed that ring opening of (43) is much less facile than th
in (16) and (17). This was not surprising since the extra double bond
(C=N) in (43) would be expected to retard the rate ofringopening.
Scheme 3.16
.Ph
(38a) N a B H 4 / M e O H >
PhCOHN-" X C H 2 O H
(43)
MTPAC1 / Pyridine
f
Ph

P

N=(
/
\

\J

FoC

Me CF3

\/

PhCOHN^ CH 2 -OCO
(44a) (44b)

+
Ph

X
Ph

PMe

>=N
/ \

y°
OCO-CHf%HCOPh

3-3-1. Preparation of Nitrile Oxides
Nitrile oxides are usually prepared in situ and not isolated. Generated
the presence of a dipolarophile they form the cycloadduct directly, often in
high yield.5! T w o general methods that have been used for their
preparation are dehydrochlorination of hydroxamoyl chlorides with triethyl
a m i n e 7 6 and dehydration of primary nitro compounds with an aryl
isocyanate. 104,105

They have also been conveniently obtained by

oxidation of aldoximes.90*!06 The phenylnitrile oxide (2) was prepared in
situ from benzohydroxamoyl chloride (46) which was available from the
chlorination of sy«-benzaldoxime (45) with N-chlorosucinimide (NCS) in
D M F (Scheme 3.17).!07
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Scheme 3.17
PhCHO + NH2OH.HCl

•

PhCH=NOH + H 2 0
(45)

a
PhCH=NOH +NCS — ^ P — •
25 30 C
- °

^C=N
Fh' \)H
(46)
Et3N

[ph—C=N-0 j
(2)

Methylnitrile oxide (37) was prepared in situ from the dehydration of
nitroethane (47) with triethylamine in the presence of phenyl isocyanate in
CH2CI2 (Scheme 3.18). 105a
Scheme 3.18
PhNCO
CH 3 CH 2 N0 2 + E13N CCH
H2
CC1
] 2/,n >
(47)

r
+ -1
[CH 3 —C=N-Oj
(37)

3-4. Regioselectivity of 1,3-Dipolar Cycloaddition Reactions of
Nitrones a n d Nitrile Oxides

1,3-Dipolar cycloadditions of nitrones and nitrile oxides are reversible
therefore subject to both thermodynamic and kinetic control. Both
electronic and steric factors are of importance in determining the
regiochemistry of these reactions. In general, in the reaction with the 1,1disubstituted electron deficient dienophiles with nitrones and nitrile oxides,
the oxygen of the dipole becomes attached to the more sterically hindered
end of the dienophile and therefore usually 5,5-disubstituted isoxazolidines
or isoxazoles are formed.80,108

T h e regiochemistry of 1,3-dipolar
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additions is controlled by the magnitudes of the atomic orbital coefficients
in the participatingfrontierorbitals. 1° 9 F r o m these generalizations and the
coefficient magnitudes, H o u k H ° has rationalised the regioselectivity of all
1,3-dipolar cycloadditions based on the model shown in Figure 3.9. In his
rationale, one frontier orbital interaction generally favours one regioisomer
while the other favours the opposite regioisomer. This is because the
larger H O M O coefficient is on "z", while the larger L U M O coefficient is
on "x" of the dipolarophile.
LUMO

:> **N

R

X

HOMO

R
5-substituted
isomer

}

R

R

\

+
+

4-substituted
isomer

:N—Z

C=NX_
Z
\
+

/

X=Y—Z
+
N=N—Z

/

/

Z =

1+

Z
/

— N

O

Figure 3.9. Frontier orbital interaction in 1,3-dipolar cycloadditions

The degree of regioselectivity in the cycloaddition of nitrones to electron
deficient alkenes has been investigated by A H et a l n i & and Bimanand and
H o u k . m b Ali et al. have reported the formation of 4- and 5-substituted
isoxazolidines (49) and (50) from the 1,3-disubstituted alkenes (48a-f) as
are shown in Scheme 3.19.
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Scheme 3.19
Ph..

-

y-K

+ CH2=<

— •

Ph.

/ v>x

+

.x

r^

(4) (48) (49) (50)
a ; x = Me
b ; x = Ph
c ; x = CN

d ; x = C02Et
e ; x = C0 2 Me
f ; x = CHO

Table 3.3. Reaction of C,N-diphenyl nitrone (4) with dipolarophile (48).!Ua
Dipolarophile 5-Substituted 4-Substituted
(48)
isomer (49) isomer (50)
a
b
c
d
e
f

(%)

(%)

98.4

1.6
-0
9
30
17
18

-100
91
70
83
82

It was observed that the ratio of 4-substituted to 5-substituted products
increased roughly with electron-deficiency of the dienophile (Table 3.3).
This is in general accord with the frontier orbital treatment of nitrone
cycloadditions.H2,l 13 According to this view most dipolarophiles should
undergo cycloaddition to afford predominantly 5-substituted adducts.
However, as the ionisation potential of the dipolarophile increase, i.e. as its
H O M O decreases in energy, an increasing tendency is expected towards
production of 4-substituted isoxazolidines. This is a consequence of the
HOMOdipole-LUMOdipolarophile interaction becoming more important than
the HOMOdipolarophile-LUMOdipole interaction in the generation of 4substituted adducts.

Following the above explanations it can be appreciated that the 1,3-dipol
cycloaddition reactions of dipolarophile (14) with nitrones (4), (22), (24),
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(28) and (29) produces 5,5-disubstituted isoxazolidinone adducts with high
(100%) regioselectivity.

T h e dienophile (14) with one electron

withdrawing group (lactone carbonyl group) and one electron releasing /
withdrawing group (benzamido group) would be expected to be moderately
electron deficient and therefore shows a similar regioselectivity in its
reactions as (48a) and (48b). Our observations are comparable with what
were observed by Ali et fl/.Hla in the reaction of (48b) with C,Ndiphenylnitrone.

The regiochemistry of nitrile oxides cycloadditions can be explained by th
F M O theory as mentioned above. In the majority of cases with 1,1disubstituted and trisubstituted alkenes, the more hindered end of the
dipolarophile adds to the nitrile oxide oxygen.114

T h e 1,3-dipolar

cycloaddition of captodative alkenes with arylnitrile oxides was considered
for the first time by Jimenez et al. in 1993.115 They observed the 5substituted isoxazoline adducts as the only regioisomer in their reactions.
Treatment of aryl nitrile oxides (51a-e) with alkenes (52) in dry benzene
gave the expected 5-acetyl-3-arylisoxazoles (53) in moderate to good
yields (66-96%) (Scheme 3.20).
Scheme 3.20
+ _ COMe
Ar—C=N— O +

II

=S
OCOC 6 H 4 N0 2 -p

(51)
a
b
c
d
e

\^OCOC 6 H 4 N0 2 -p

rjXOMe

(52)

; Ar = Ph
; Ar = 4-MeC6H4
; Ar = 3,4-(MeO)2C6H3
; Ar=3,4-(CH20)-C6H3
; Ar = 4-N0 2 C 6 H 4

(53)
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explained the regioselectivity of their reactions by

invoking a radicaloid transition state.

They have considered the

substituent effects that could stabilize the transition state that leads to the
major regioisomer (53). T h e most likely transition state was the one in
which allylic conjugative and captodative stabilizing effects were
maximized, as shown in Figure 3.10.

Figure 3.10. Conjugate and captodative effect in 1,3-dipolar addition of arylnitrile
oxides with alkene (52).

A similar explanation can be used to understand the regioselectivity of 1,3dipolar additions of nitrile oxides (2) and (37) with dienophile (14). A s it
was explained in Chapter T w o , the alkene (14) has captodative properties.
The transition state that lead to the major regioisomers observed in our
reactions could be stabilized by similar allylic conjugative and captodative
effects as described by Jimenez et al 115 (Figure 3.11).
R.

Figure 3.11. Conjugative and captodative effect in 1,3-dipolar addition of nitrile
oxides (2) and (37) with alkene (14).
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Additionally, the regiochemistry of 1,3-dipolar cycloaddition m a y be
influenced by steric effects. Steric factors have been discussed by Pereira
et al.104 (Section 3.3) and others.! 16 Martin et al.116* stated that "the
regiochemical course of the 1,3-dipolar cycloadditions of nitrile oxides
with unactivated and unsymmetrical alkenes was subject to steric effects
alone".
Besides the electronic factors the steric interaction can be considered to
explain the regioselectivity of our 1,3-dipolar cycloadditions with nitrones
and nitrile oxides. The repulsion between the C-substituent on carbon in
nitrones or nitrile oxides with the bulky benzamido group of (14) could be
responsible for the non-existence of 4-substituted isoxazolidine or
isoxazoline adducts (Figure 3.12).

r
'N—Ph
R

X=K JH j
Ph '

Ph J

|

N^J^
prt

PI/

V*\.

Figure 3.12. Steric interactions between the C-substituent on carbon in nitrones or
nitrile oxides with the benzamido group in alkene (14).

3-5. Stereoselectivity of the 1,3-Dipolar Cycloaddition of Nitrones

Dipolar cycloadditions of nitrones, like the Diels-Alder reactions, proceed
through exo or endo transition states. In most cases the endo cycloadduct
is favoured due to a stabilizing secondary orbital interaction. This was
explained by P a d w a et alMl in the reaction of C-phenyl-Af-methylnitrone
(24) with acrylonitrile to produce a mixture of cis (23%) and trans (77%)
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5-cyano-substituted isoxazolidines (54) and (55) respectively (Scheme
3.21).
Scheme 3.21
Me
Ph

Plw ,N.

H

CN

Me

Me

Ph

Vj°
VCN

(24)

(54)

(55)

23%

77%

The endo transition state w a s suggested to be favoured because of a
stabilizing

secondary

orbital interaction in the participating

HOMOdipolarophile-LUMOnitronefrontiermolecular orbitals to produce the
trans isomer (55) (Figure 3.13).

LUMO
secondary orbital
interaction

HOMO
N

C

(endo transition state)
Figure 3.13. Secondary orbital interaction in the endo transition state of C-phenyl-Nmethylnitrone and acrylonitrile.

A similar secondary orbital interaction in the endo transition state is
possible for the dipolar cycloaddition of dienophile (14) with nitrones
(Figure 3.14a). A n alternate possibility is that steric repulsion between the
alkyl group on nitrogen of the nitrone and the benzamido substituent on the
dipolarophile destabilize the exo transition state (Figure 3.14b) and
therefore the endo adduct is favoured.
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Ph

H
LUMO

PhCON
a)

secondary orbital
interaction
HOMO

O

C O

b)

PhCON
Ph
(exo adduct)

Figure 3.14. a) Endo and b) exo transition state structures for the reaction of (14) and
nitrones.

While steric and orbital interactions can explain the preference for endo
type cycloadducts in the reactions of (14) with 1,3-dipoles, some of the
major (eg.(30) and(31)) and most of the minor adducts appear to be formed
under reversible, thermodynamically controlled conditions.
The formation of the exo adducts (25b) and (25c) from the reaction of (14)
with C-phenyl-N-methyl nitrone (24) m a y be due to the possibility that the
more stable (Z)-form of the nitrone is in equilibrium with a small amount
of the less stable (^-isomer. 1° 8 Adducts (25b) and (25c) m a y be derived
from the reaction of the (ZT)-form of the nitrone with (14) via an endo
transition state. (Z) to (E) isomerization of the nitrones (4) and (22) would
be expected to be less likely for steric reasons, while such an isomerization
is not possible for cyclic nitrones (28) and (29).
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From the above considerations, the endo/exo ratio of dipolar cycloadducts
with our nitrones would be expected to vary according to the following
series, which is consistent with our experimental findings.
p

\

+/°

H

Me

P

\

+

'°

H

Ph

> = \

N+

t

Bul

H

I
(24)

(4)

(22)

O"
(28)
endo selectivity

Ph

R

3-6. Attempted Synthesis of y-Amino-a-Amino Acids
As it was mentioned in Section 3-1. there are various methods to reduce
the nitrogen-oxygen bond in isoxazolidines to give synthetically useful
compounds. Catalytic hydrogenation of the cycloadduct (15a) was carried
out over palladium on carbon in acetic acid and ethyl acetate solution
under an atmosphere of hydrogen with the aim of preparing y-amino-ocamino acid (56) (Scheme 3.22). Unfortunately these reaction conditions
gave a mixture of compounds that were difficult to separate and
characterise.
Scheme 3.22
PhHR

(15a)

Pd/C/H2
EtoAc/AcOH

Ph

-H20
Red."

PhCON

PhCOHN

NHPh
Ph

H0 2 C
(56)

Ph

The reaction of (15a) with methanol and potassium carbonate produced the
methyl ester (57) (Scheme 3.23) as a mixture of two diastereoisomers.
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Catalytic hydrogenation of compound (57) over palladium on carbon or
with zinc in the presence of acetic acid with the purpose of preparing a yamino-a-amino acid (Scheme 3.23) was also disappointing. Likewise,
hydrogenation of a mixture of (16) and (17) gave a complex mixture of
products.
Scheme 3.23

(15a)

MeOH/K2CQ3

%

PhCOHN

C0 2 Me

(57)
PhHN(57)

Pd/C/H2
or) Zn / AcOH

1. -H20

PhCOHN

2.W*R02C

NHPh
.*

Ph

C02R

However, treatment of (15a) under catalytic hydrogenation /
hydrogenolysis conditions with palladium hydroxide on carbon under an
atmosphere of hydrogen gave the unexpected ds-l,4-diphenyl-2benzoylazethane (58) in 3 0 % yield and N-benzylbenzamide (59) in 4 7 %
yield (Scheme 3.24).
Scheme 3.24

Ph
(15a)

Pd(OH) 2
H 2 , EtOAc

V-i
+ PhCONHCH2Ph

m

NNH
HCOPh
(58)

(59)

The structure of (58) was evident from J H and 1 3 C N M R and M S and
H R M S spectral analysis. The c/s-stereochemistry of (58) was determined
by analysis of the coupling constants for H 2 , H3oc, H30, H 4 in the J H
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NMR spectrum of (58) using the known coupling constants of cis- and
rra«5-2,3-dimethyloxetanes as reference c o m p o u n d s . H 8

In these

heterocyclic 4-membered ring c o m p o u n d s vicinal coupling constants for
cis protons are generally larger (7.25-8.65 H z ) than those for trans protons
(5.61-6.65 H z ) . T h e geminal coupling constant J3a,3p in (58) is consistent
with that typically found oxetanes (10.77-11.15 H z ) . H 8 T h e selected l H
N M R data for (58) in C D C I 3 solution are outlined in S c h e m e 3.25.
Scheme 3.25
H4

H2

jT
H3p1
Ph-^XT^^NCOPh
Ph~N\
H3a

(58)

chemical
shifts
H2, 5.27
H3a,3.30
H3p, 2.00
H4 4 27
' -

coupling
constant (Hz)
J2/3a 6.4
J23p 9.6
J3a/3p 12.8
J3a,47.6
J3p,4 10-4

A possible mechanism for the formation of (58) is given in S c h e m e 3.26.
The proposed m e c h a n i s m involves, hydrogenolysis of (15a), followed by
ring closure to the azethanium ion (60). Carboxy-hydroxy-eliminationll 9
then gives the azethenium ion (61) which undergoes addition of hydrogen
from the least hindered 7C-face of the iminium group of (61) to give the cis1,4-disubstituted product (21) (Scheme 2.26). Unfortunately related
azethane products could not b e isolated u p o n hydrogenolysis /
hydrogenation of the adducts (23a) and (30).
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Scheme 2.26
Ph
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Ph

Ph

Ph
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PhCONH

Ph

C02H
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\+
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« — P
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) C02H

+
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O

(61)

NHCOPh
(60)

3-7. Conclusions
The 1,3-dipolar cycloaddition reactions of (14) and nitrones generally
occur under equilibrating conditions to give the more stable adducts that
result from addition to the exo-cyclic methylene of (14) from the sterically
more hindered 7i-face. These reactions are highly regioselective and only
5,5-disubstituted isoxazolidines are formed. The regiochemistry of these
reactions can be explained by electronic and steric factors. The endo
adducts are generally kinetically and thermodynamically favoured. In one
case the novel azethane (58) was formed from the treatment of the adduct
(15a) with palladium hydroxide on carbon under a hydrogen atmosphere.
The major adducts from the reaction of (14) and nitrile oxides (2) and (37)
had the expected stereochemistry, addition of the 1,3-dipole occurred from
the least hindered 7t-face of the exo-cycUc methylene of (14).
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General experimental procedures were as described in the Experimental
Section of Chapter T w o .
The nitrones (4) and (24) were prepared by condensation of benzaldehyde
with the appropriate N-hydroxyl amine. 100,101 N-Phenylhydroxylamine
(26) and syrc-benzaldoxime (45) were prepared following the procedures
from 'Vogel's Practical Organic

Chemistry'. 107a

Pyrrolidine and

piperidine nitrones (28, 29) were prepared by oxidation of their related
secondary cyclic amines with hydrogen peroxide." All N M R spectra
were measured in CDCI3 solution. lH N M R of some of compounds have
been run at high temperature because at ambient temperature the N M R
signals were very broad due to restricted rotation about the amide C-N
bond. All crystalline compounds were crystallized from ethyl acetate /
hexane unless otherwise stated.
X-ray Structure Determinations.
Unique diffractometer data sets were measured at ~ 295 K; ( 2 0 m a x , as
specified; 20/0 scan mode; monochromatic M o K a radiation, X = 0.71073
A ) yielding N independent reflections, N 0 of these with I > 3o(7 ) being
considered 'observed' and used in the full matrix least squares refinement
without absorption correction. Anisotropic thermal parameters were
refined for the non-hydrogen atoms; (x, y, z, Ui S0 )H were included
constrained at estimated values. Conventional residuals R, R w on IFI at
convergence are given (statistical weights, derivative of G2(I) = o2(/diff)
+0.0004 G4(/diff)- Neutral atom complex scattering factors were used;
computation used the X T A L 3.2 program system, implemented by S. R.
Hall. Individual variations in procedure or anomalous features are noted
where applicable ('variata'). Pertinent results are given in the Figures (20%
thermal ellipsoids for the non-hydrogen atoms; arbitrary radii of 0.1 A for
H). The c o m m o n (crystallographic) numbering adopted for the molecular
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core is as follows, with a c o m m o n chirality for the oxazolidinoneringand
substituents, the 2-Ph substituent lying away from the reader. Where the
material is optically active, the chirality adopted is drawn from the
chemistry.
Crystal / refinement data.
(15a). C3oH24N204,M = 476.5. Monoclinic, space group P2\ (C22,
No.4); a = 10.06(1), b = 5.79(1), c = 21.398(7) A, p = 95.42(7)°, V = 1241
A3. Dc (Z = 2) = 1.28 g.cm.-3; F(000) = 500. U M 0 = 0.9 cm-1; specimen:
0.25 x 0.85 x 0.42 m m , 2 0 m a x = 50°; N = 2401, N0 = 1633; R = 0.065, Rw
= 0.067.
'Variata'. -Linewidths were very broad, and the optimum specimen from
recrystallized material was used without cutting.
(23a). C28H28N2O4. 1/3 C H 3 C O 2 C 2 H 5 , M = 485.9. Trigonal, space
group P 3 2 (C33, (No.145); a = 15.023(6), c=10.656(6) A, V = 2084 A3. Dc
(Z = 3) = 1.16 g.cm.-3; F(000) = 774. U M O = 0.8 cm-1; specimen: 0.80 x
0.50 x 0.38 m m . 2 0 m a x = 45°; N = 3193, N0 = 1908; R = 0.055, Rw =
0.052.
'Variata'. - Steady deterioration of the periodic standards of, ultimately,
- 6 % was compensated for by appropriate scaling. The solvent comprises a
disordered array about the symmetry axis.
(23b). C28H28N2O4, M = 456.6. Monoclinic, space group P2\lc (C2/15,
No.14); a = 12.005(6), b = 7.906(6), c = 26.73(1) A, p = 105.08(4)°, V =
2450 A 3 . Dc (Z = 4) = 1.24 g.cm.-3; F(000) = 968. U M O = 0.8 cm-1;
specimen: 0.75 x 0.38 x 0.21 m m . 2 0 m a x = 50°; N = 4311, N 0 = 2619; R =
0.041,^ = 0.042.
'Variata'. -Cc, y, z, UiSo)u were all refined.
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(25c). C25H22N2O4, M = 414.5 Orthorhombic, space group P2\2\2\ (D24,
No.19); a = 16.215(6), b = 12.913(5), c = 10.198(5) A, V = 2135 A3. D c
(Z = 4) = 1.29 g.cm.-3; F(000) = 872. U M O = 0.9 cm-1; specimen: 0.60 x
0.45 x 0.40 m m . 2 0 m a x = 60°; N = 3477, N0 = 1647; R = 0.039, Rw = 0.036.
'Variata\-(x, y, z,

£ASO)H

were all refined.

(25d). C25H22N2O4, M = 414.5. Triclinic, space group F\ (Q7, No.2); a
12.11(1), b = 10.361(4), c = 10.133(4) A, a = 94.91(3), p = 108.24(5)°, y =
112.26(5)°, V = 1087 A3. Dc (Z = 2) = 1.27 g.cm.-3; F(000) = 436. U M O =
0.8 cm-1; specimen: 0.30 x 0.32 x 0.40 m m . 2 0 m a x = 50°; N = 3810, N0 =
2424; R = 0.041, Ry, = 0.042.
'Variata'. -(x, y, z, £/iso)H were all refined.
(30). C21H20N2O4, M = 364.4. Orthorhombic, space group P2i2i2r, a =
16.868(4), b = 13.294(2), c = 8.006(2) A, V= 1795 A3. Dc (Z = 4) = 1.35
g.cm-3; F(000) = 768.

JIMO

= 0.9 cm-1; specimen: 0.065 x 0.60 x 0.27 m m .

20max = 60°; N = 2963, N0 = 2342; R = 0.038,flw= 0.040.
' Variata'.-(x, y, z, £/iso)H were all refined.
(31). C22H22N2O4, M

= 378.4. Monoclinic, space group P2i; a =

9.408(4), b = 8.610(3), c = 11.720(2) A, p = 90.19(2)°, V= 949.2 A3. Dc
(Z = 2) = 1.32 g.cm.-3; F(000) = 400. U M O = 0.9 cm-1; specimen: 0.38 x
0.27 x 0.08 m m . 2 0 m a x = 45°; N= 1348, N0 = 95l;R = 0.045,flw= 0.033.
'Variata'.-Distinction between the nitrogen atom at N(8) and possible
alternative sites was made on the basis of refinement behaviour.
'Observed' criterion : 7>2o(7).
(38a). C 2 4 H i 8 N 2 0 4 , M = 398.4. Monoclinic, space group P2i; a =
12.820(4), b = 7.994 (5), c = 10.111 (7) A, p = 102.17 (4)°, V = 1013 A3.
Dc (Z = 2) = 1.31 g.cm.-3; F (000) = 416. UMo = 0.9 cm"1; specimen: 0.45
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x 0.27 x 0.15 m m . 2 0 m a x = 50°; N = 1992, N0 = 1236; R = 0.039, /? w =
0.037.
'Variata'.-(x, y, z, £/iso)H were all refined.
(39b). C24H18N2O4, M= 398.4. Orthorhombic, space group P2i2i2i; a =
16.38 (1), b = 15989 (7), c = 7.631 (3) A, V = 1998 A3. Dc (Z = 4) = 1.32
g.cm.-3; F(000) = 832. U M O = 0.9 cm-i; specimen: 0.40 x 0.11 x 0.75 m m .
20max = 50°; N= 2018, N0 = 1361; R = 0.042, Rw = 0.043.
'Variata'.-(x, y, z, £/iso)H were all refined.
(38b). C19H16N2O4, M = 336.4. Orthorhombic, space group P2i2i2i; a =
12.298 (5), b = 12.274 (4), c = 10.824 (5) A, V = 1634 A3. Dc (Z = 4) =
1.37 g.cm.-3; F(000) = 704. U M O = L O cm-1; specimen: 0.35 x 0.32 x 0.18
m m . 2 0 m a x = 50°; N= 1656, No = 1262; R = 0.049, Rw = 0.051.
'Variata'.-(x, y, z, £/iso)H were all refined'.

Structural commentary. The results of the room temperature single cry
X-ray studies are presented above, and in summary in Figures 3.1, 3.2, 3.4,
3.6 and 3.7. In all cases, the asymmetric unit is a single molecule, with
stoichiometrics and connectivities consistent with the above formulations;
in most cases hydrogen atoms have been located and refined in (x, y, z,
Uiso). The crystals of (23b) and (25d), belonging to centro symmetric
space groups are racemic, presumably consequent of relative insolubility
and less than 1 0 0 % optical purity of the sample; the remainder crystallize
in polar space groups, so that, at least within the single crystal studied, all
molecules have the same chirality. Presentation of the results follows
adoption of the c o m m o n chirality of the parent oxazolidinone (14) with the
ad hoc c o m m o n numbering scheme for the c o m m o n bicyclic core given
above; in cases, ring 21 lies away from the reader and is assigned a
negative sign in the description of deviations from the associated
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heterocycle, while substituents of the other fused ring are assigned positive
deviations if directed toward 0(5). The following comments m a y be
made:
The parent oxazolidinone ring is effectively planar throughout the series of
compounds studied, the higher y2 values lying generally among the more
precisely determined members; in no case does the deviation of any
defining atom from the ring plane exceed 0.065 A. Distances within the
ring do not vary non-trivially although it m a y be no accident that C(2)-N
(3) in (38a,b) and (39a) exhibit the longest values associated with this
parameter; the endocyclic angles are similarly uniform. The exocyclic
angles at N(3) are essentially equivalent in (31) and (38a); in the
remainder, in which the carbonyl disposition is reversed, they become
quite unsymmetrical, C(4)-N(3)-C(3) being m u c h the larger. At C(5), the
exocyclic angle C(4)-C(5)-0(5) is slightly larger than 0(l)-C(5)-0(5)
throughout the series. C(6)-C(4)-0(9) varies over a range of about 3°,
being smallest in (38a,b) and (39a) (and, perhaps, (15a)); variations of
similar magnitude are found among the other exocyclic angles at C(4).
S o m e variation is observed in the deviation of 0(5) from the ring plane,
also in that for C(21); the plane of phenyl 2 lies effectively to the ring
throughout the series. Carbonyl 3 plane lies quasi-coplanar with the ring,
while the associated phenyl ring lies quasi-normal and quasi-parallel to the
fused ring ((31) and (39a) excepted). Angles about C(3) vary only slightly
throughout the series N(3)-C(3)-C(37) being consistently just less than
120°, as might be expected from electron pair repulsion theory, while the
others are slightly greater.
The other ring plane lies quasi-normal to thefirst,as might be expected, in
most cases (excluding (38a,b) and (39a)) adopting a quasi 'envelope'
conformation with C(7) the deviant atom; the fused ring in 31 is a chair,
while in 30 it is a pseudo envelope, with C(10) deviant. About C(7), the
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non-hydrogen angle sum is generally close to 326°, as also N(8), where
(excepting 38a,b, 39a) the spread is rather greater (323-331°).
C, iV-Diphenylnitrone (4)
A solution of N-phenylhydroxylamine (19.85 g, 0.18 mol) and
benzaldehyde (18.3 g, 0.18 mol) in the minimum amount of ethanol was
allowed to stand at room temperature overnight.

The crystalline

precipitates werefilteredand recrystallized from benzene to afforded the
nitrone (4) (32 g, 9 0 % ) , as white crystals. M.p. 114 °C (lit.l00a>b 114-115
°C).
C-Phenyl-N-methylnitrone (24)
Freshly distilled benzaldehyde (5 g, 47.1 mmol) was added to a solution of
N-methyl hydroxylamine hydrochloride (27) (4.97 g, 59.5 m m o l ) in
C H 2 C I 2 (60 m L ) . Sodium bicarbonate (12.43 g) was added and the
reaction mixture was refluxed at 80 °C for 10 hr. The mixture was cooled,
filtered and washed with CH2CI2 (10 m L ) . After evaporating the solvent
the yellow crystals that remained were recrystallized from ethyl acetate /
hexane (4.5 g, 7 1 % ) . M.p. 83-85 °C (lit. 101 84-86 °C). lH N M R 5 8.21
(dd, J = 3.6, 7.6 Hz, 2H), 7.42 (m, 3H), 7.37 (s, IH, C H = N ) , 3.9 (s, 3H,
CH3).
Preparation of Pyrolidine nitrone (28) and Piperidine nitrone (29)."

The secondary cyclic amine (100 mmol) was added to a solution of sod
tungstate dihydrate (1.32 g, 4 mmol) in water (20 m L ) under nitrogen. The
mixture was then cooled to -5 °C and a solution of aqueous hydrogen
peroxide (34%, 20 m L , 200 mmol) was added dropwise over a period of 60
min. During the period of addition the reaction mixture was kept below 20
°C. The mixture was stirred at room temperature for 3 hr. Excess
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hydrogen peroxide was decomposed by addition of sodium hydrogen
sulfite (1.5 g) with ice cooling. (The presence of hydrogen peroxide was
detected with potassium iodide-starch test paper). The solution was
saturated by sodium chloride (15 g) and extracted with ten portions (100
m L ) of CH2CI2. The combined organic extracts were dried over M g S 0 4 .
The drying agent was removed by filtration, and the solvent was removed
by a rotatory evaporator keeping the temperature at 40 °C to give a pale
yellow oil.
(28): 3.5 g (41%), lH NMR 8 6.93 (s, IH, CH=N), 3.95 (m, 2H), 3.41 (m,
4H).
(29): 4.5 g (45%), lH NMR 5 7.29 (s, IH, CH=N), 3.81 (m, 2H), 3.42 (m,
2H), 2.50 (m, 4H).
1,3-Dipolar Cycloaddition Reactions of (14) and Nitrones, A General
Procedure:
A solution of (14) (225 mg, 0.8 mmol) and the nitrone (0.88 mmol) in
dichloromethane (3 m L ) under nitrogen was stirred at room temperature or
60 °C in a sealed tube under an atmosphere of nitrogen for several days, as
reported in Table 3.1, page 110. The solution was then cooled and
evaporated to dryness. The crude products were purified by column
chromatography on silica gel using ethyl acetate / hexane (10-20 / 90-80)
as the eluent or by fractional crystallisation. The diastereoselection of
these reactions were determined from lH N M R (400 M H z ) analysis of the
crude reaction product.
(2^,35,55) and (2,/?,3/?,55)-2,3-Diphenylisoxazolidine-5-spiro-4,-(3'benzoyl-2'-phenyl)oxazoIidin-5'-one (15a) and (15b).
The two diastereoisomers were separated by fractional crystallization
ethyl acetate / hexane.
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(15a): M.p. 160-1 °C dec; [ot]D27 -44.6 (c 0.55 in CHCI3). lH N M R 8
7.53-6.97 (m, 20H), 6.95 (s, IH, H2'), 4.93 (dd, IH, J = 6.0, 11.4 Hz, H3),
3.32 (IH, bt, J = 11.4, 12.6 Hz, H4), 2.99 (dd, IH, J = 6.0, 12.6 Hz, H4).
13C N M R 8 170.5 (CO), 170.1 (CO), 149.2, 137, 135.9, 135.7, 130.2,
130.1, 128.9, 128.7, 128.6, 128.4, 128.3, 127.5, 127.4, 126.4, 125, 119.6,
89.6 (C2'), 88.8 (C5), 72.1 (C3), 47.5 (C4). IR (nujol) 1765, 1660, 1580,
1470, 1338, 1283, 1178, 1135, 1075, 1003, 743, 690 cm-1. M S (ES) m/z
477 (16%, M H + ) , 268 (100). Anal. Calcd for C30H24N2O4: C, 75.6; H,
5.1; N, 5.9%. Found: C, 75.85; H, 4.95; N, 5.65%.
(15b): M.p. 145-6 °C dec; [cc]D27 +198.7 (c 0.23 in CHCI3). X H N M R 8
(at 55 °C) 7.46-6.96 (m, 15H), 6.77 (s, IH, H2'), 4.29 (bt, J = 8.4 Hz, IH,
H3), 3.53 (dd, J = 7.6, 12.8 Hz, IH, H4), 3.23 (dd, J = 9.6, 12.8 Hz, IH,
H4). 13C N M R 8 170 (CO), 169.7 (CO), 148.1, 138.3, 135.7,135.5,130.6,
130.1, 128.84, 128.8, 128.44, 128.4, 128.2, 127.9, 126.7, 126.6, 124.8,
119.7, 89.5 (C2'), 87.7 (C5), 69.4 (C3), 47.4 (C4). IR (nujol) 1778, 1655,
1580, 1482, 1333, 1160, 1010, 758, 687 cm-1.

M

S (ES) m/z Ml (70%,

M H + ) , 314 (37), 268 (100).
(2'fl,3S,5S) and (2'S,35,55)-2-^^-ButyI-3-phenylisoxazolidine-5-spiro4'-(3,-benzoyl-2,-phenyl)oxazolidin-5'-one (23a) and (23b).
(23a): M.p. 112 °C; [oc]D24 -84.6 (c 1.0 in CHCI3). ! H N M R 8 7.61-6.84
(m, 15H), 6.95 (s, IH, H2'), 4.67 (dd, J = 6.0, 11.6 Hz, IH, H3), 2.94 (bt, J
= 11.6, 12.6 Hz, IH, H4), 2.78 (dd, J = 6.0, 12.6 Hz, IH, H4), 0.95 (s, 9H,
3CH3).

13

C N M R 8 170.8 (CO), 170.3 (CO), 140, 136.3, 135.7, 130,

129.9, 128.9, 128.33, 128.27, 127.9, 127.6, 127.2, 126.3, 89.0 (C2'), 87.8
(C5), 64.7 (C3), 60.0 (C(CH3)3), 50.0 (C4), 26.4 (C(£H3)3). IR (nujol)
1785, 1642, 1368, 1342, 1251, 1222, 1140, 1012, 761, 732, 692 cm-1. M S
(ES) m/z 457 (100%, M H + ) . Anal. Calcd for C28H28N2O4: C, 73.7; H,
6.2; N, 6.1%. Found: C, 74.0; H, 6.2; N, 5.8%.
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(23b): M.p. 146-7 °C; [ot]D24 -4.0 (c 0.4 in CHC1 3 ). lH N M R 8 (at 55 °C)
7.84-6.81 (m, 15H), 6.93 (s, IH, H2'), 4.73 (dd, J = 6.0, 11.0 Hz, IH, H3),
2.65 (dd, J = 11, 13.2 Hz, IH, H4), 2.56 (dd, J = 6.0, 13.2 Hz, IH, H4),
1.05 (s, 9H, 3CH 3 ). 13C N M R 8 170.2 (CO), 170.1 (CO), 139.6, 135.9,
134.8, 131.6, 130, 129.5, 128.7, 128.5, 128.3, 127.6, 127.2, 127.1, 88.9
(C2'), 87.5 (C5), 64.6 (C3), 60.0 (C(CH3)3), 48.5 (C4), 26.4 (C(£H3)3). IR
(nujol) 1768, 1627, 1446, 1350, 1255, 1226, 1142, 1025, 721, 687 cm-1.
M S (ES) m/z 457 (100%, M H + ) , 284 (14).
(2'fl,3S,5S), (2'RJR,5S), (2'R,3S,5R) and (27?,3#,5#)-2-Methyl-3phenyIisoxazolidine-5-spiro-4'-(3'-benzoyI-2,-phenyl)oxazolidin-5f-one
(25a), (25b), (25c) and (25d).

(25a): lH NMR 8 (in part) 7.72-6.96 (15H, m), 6.82 (s, IH, H2'), 4
J = 5.6, 11.2 Hz, IH, H3), 3.45 (bt, J = 12.6 Hz, IH, H4), 2.87 (dd, J = 5.6,
12.8 Hz, IH, H4), 2.63 (s, 3H, CH3).

(25b): lH NMR 8 (in part) 7.72-6.96 (15H, m), 6.77 (s, IH, H2'), 3
J = 6.0, 12.0 Hz, IH, H3), 3.1.0 (bt, J = 12.0 Hz, IH, H4), 2.90 (m, IH,
H4), 2.56 (s, 3H, CH3).

(25c): M.p. 166-8 °C; [a]D25 +30.2 (c 0.42 in CHCI3). lH NMR (at 60 °
8 7.53-7.24 (m, 15H), 6.75 (s, IH, H2'), 3.38 (bs, IH, H3), 2.94 (dd, J =
10.4, 13.0 Hz, IH, H4), 2.84 (dd, J = 6.8, 13.0 Hz, IH, H4), 2.68 (s, 3H,
CH3).

13

C N M R 8 170.2 (CO), 169.6 (CO), 137, 135.5, 135.1, 131.2,

130.1, 128.7, 128.6, 128.42, 128.41, 128.1, 127.8, 127.2, 89.1 (C2'), 86.7
(C5), 72.4 (C3), 46.2 (C4), 42.8 (CH3). IR (nujol) 1780, 1648, 1475, 1350,
1268, 1145, 1035, 697 cm-1.

M

S (ES) m/z 415 (100%, M H + ) , 288 (37),

210 (75). Anal. Calcd for C25H22N2O4: C, 72.5; H, 5.35; N, 6.8%.
Found: C, 72.9; H, 5.4; N, 6.5%.
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(25d): M.p. 150-2 °C; [cc]D26 -16.7 (c 0.15 in CHC1 3 ). J H N M R (at 55 °C)
8 7.72-6.96 (m, 15H), 6.88 (s, IH, H2'), 4.28 (dd, J = 6.0, 11.8 Hz, IH,
H3), 2.92 (bt, J = 11.8, 12.6 Hz, IH, H4), 2.71 (s, 3H, CH3), 2.64 (dd, J
6.0, 12.8 Hz, IH, H4). 13c N M R 8 170.7 (CO), 170.0 (CO), 136.0, 135.7,
134.8, 131.45, 130.1, 128.72, 128.71, 128.6, 128.5, 128.4, 127.8, 127.2,
89.5 (C2'), 88.8 (C5), 73.8 (C3), 46.1 (C4), 44.3 (CH3). IR (nujol) 1779,
1635, 1480, 1345, 1315, 1268, 1145, 1035, 692 cm-1.

M

S (ES) m/z 415

(100%, M H + ) , 341 (9), 288 (8), 136 (20).
(2i^3a/^,2,/^)2,3,3a,4,5,6,-Hexahydropyrrolo[l,2-b]isoxazole-2-spiro-4,(3,-benzoyl-2,-phenyl)oxazoIidin-5'-one(30).
M.p. 142-4 °C dec; [oc]D25 +35.5 (c 0.2 CHCI3). lH N M R (at 55 °C) 8
7.42-7.25 (m, 10H), 6.67 (s, IH, H2'), 3.70 (bs, IH, H3a), 3.51 (m, IH,
H6), 3.25 (m, IH, H6), 2.87 (dd, J = 8.0, 13.6 Hz, IH, H3), 2.66 (dd, J =
7.6, 13.6 Hz, IH, H3), 2.12 (m, IH, H4), 1.90 (m, 2H, H5), 1.71 (m, IH,
H4). 13C N M R 8 171.2 (CO), 169.3 (CO), 135.4, 135.1, 131.1, 130.1,
128.7, 128.5, 127.3, 127.2, 92.7 (C2), 89.7 (C2'), 65.9 (C3a), 56.5 (CH 2 ),
45.3 (CH 2 ), 29.3 (CH 2 ), 22.0 (CH 2 ). IR (nujol) 1772, 1646, 1380, 1268,
1150, 1025, 718, 692 cm-1.

M

S (ES) m/z 365 (100%, M H + ) , 86 (20).

Anal. Calcd for C21H20N2O4: C, 69.2; H, 5.5; N, 7.7%. Found: C, 68.8;
H, 5.6; N, 7.5%.
(2/?,3a/?,2'/?)3,3a,4,5,6,7-Hexahydro-2H-isoxazolo[2,3-a]-pyridine-2spiro-4,-(3'-benzoyl-2,-phenyl)oxazolidin-5'-one (31) and minor
isomer.

The two diastereoisomers were separated by fractional crystallisa
ethyl acetate / hexane and or by column chromatography on silica gel using
ethyl acetate / hexane as eluent.
(30): M.p. 155-7 °C dec; [a]D27 +77.7 (c 0.3 in CHCI3). lH NMR (at 55
°C) 8 7.41-7.25 (m, 10H), 6.63 (s, IH, H2'), 3.52 (m, 1 H), 2.7 (m, 2H),
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2.57 (bs, IH), 1.9-1.6 (m, 6H), 1.25 (t, J = 7.2 Hz, IH). 13c N M R (broad
signals were observed) 8 170.1 (CO), 169.5 (CO), 135.9, 135.5, 130.2,
130.1, 128, 127.9, 127.5, 127.4, 89.0, 86.1, 66.0, 55.2, 42.0, 28.8, 24.0,
23.8. IR (nujol) 1770, 1658, 1340, 1285, 1160, 1021, 758, 690 cm-1. M S
(ES) m/z 379 (100%, M H + ) , 288 (16), 209 (11). Anal. Calcd for
C22H22N2O4: C, 69.8; H, 5.9; N, 7.4%. Found: C, 69.5; H, 5.85; N, 7.1%.

minor isomer: M.p. 46-8 °C; [a]D29 -10.0 (c 0.15 in CHCI3). !H NMR (at
55 °C) 8 7.35-7.00 (m, 10H), 6.67 (s, IH, H2'), 3.43 (m, IH), 2.93 (dd, J =
6.0, 12.0 Hz, IH), 2.68 (bs, IH), 2.58 (m, IH), 2.41 (m, IH), 1.87 (m, IH),
1.71 (m, 4H), 1.27 (bs, IH). 13C N M R (broad signals were observed) 8
170.1 (CO), 169.4 (CO), 136.3, 135.4, 129.9, 128.7, 128.6, 128.3, 127.3,
126.7, 103.4, 89.3 (CH), 65.8, 54.9, 42.1, 28.9, 24.6, 23.6. IR (nujol)
1780, 1660, 1320, 1240, 1155, 1080, 1015, 770, 680 cm-1. M S (FAB) m/z
379 (15%, M H + ) , 247 (80), 230 (71), 188 (90).
(35,5S)
and
(35 , 5#)-5-Benzamido-5-hydroxymethyl-2,3diphenylisoxazolidine (16) and (17).
To a solution of (25a) (80 mg, 0.17 mmol) in dry methanol (10 m L ) and
dichloromethane (2 m L ) was added sodium borohydride (20 mg). After
stirring 16 hr at room temperature the solution was then treated with
acetone (3 m L ) at 0 °C for 10 min. The solvent was then evaporated.
Water (10 m L ) was added and the products were extracted into
dichloromethane (2 x 10 mL). The extracts were dried (MgS04) and
evaporated. Short-path column chromatography on silica gel gave a 61 :
39 mixture of diastereoisomers (16) and (17) (40 mg, 60%).
lH N M R (major isomer, in part) 8 7.65-6.98 (m, 15H), 6.66 (bs, IH, N H ) ,
4.91 (dd, J = 7.2, 9.6 Hz, IH, H3'), 4.20 (m, IH, C H A H B O H ) , 4.01 (m, IH,
C H A H B O H ) , 3.68 (bs, IH, O H ) , 3.65 (dd, J = 7.6, 12.8 Hz, IH, H4'), 2.60
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(dd, J = 9.6, 12.8 Hz, IH, H4'). (minor isomer, in part) 8 7.65-6.98 (m,
15H), 6.89 (bs, IH, N H ) , 4.63 (dd, J = 6.0, 8.8 Hz, IH, H3'), 4.18 (m, IH,
CHAHBOH),

4.02 (m, IH, C H A H B O H ) , 3.27 (dd, J = 8.8, 13.6 Hz, IH,

H4'), 3.08 (bs, IH, O H ) , 2.98 (dd, J = 6.4, 13.6 Hz, IH, H4'). 13C N M R 8
(major isomer, in part) 167.19 (CO), 151.9, 140.3, 133.7, 132, 129.05,
128.9, 128.6, 127.8, 126.9, 126.7, 122.6, 115.3, 94.5, 69.5, 65.4, 45.8.
(minor isomer, in part) 8 167.23 (CO), 149.4, 140.1, 133.7, 132.0, 129.02,
128.7, 128.6, 127.8, 126.9, 126.8, 123.5, 117.0, 93.7, 69.8, 65.6, 47.2. M S
(ES) m/z 375 (35%, M H + ) , 254 (100), 180 (25).
M T P A esters (18) and (19) of alcohols (16) and (17).

A solution of (16) and (17) (10 mg, 0.03 mmol) in dichloromethane
m L ) and two drops of dry pyridine at 0 °C was treated with R-(-)-amethoxy-a-trifluoromethylphenylacetylchloride (12 mg, 0.04 mmol). The
solution was stirred for 2 hr at room temperature and then the solvent was
evaporated. The residue was dissolved in dichloromethane (10 m L ) and
the solution was washed with 5 % aqueous hydrochloric acid, 1 0 % aqueous
sodium hydroxide, and then water. The organic layer was dried over
M g S 0 4 , filtered and evaporated under reduced pressure to leave an oil.
Short-path column chromatography on silica gel gave a 55 : 45 mixture of
two diastereoisomers (18) and (19) (10 mg, 61%).
lH N M R (major isomer, in part) 7.68-6.87 8 (m, 15H), 6.28 (s, IH, N H ) ,
4.99

(d, J =

CHAHBOR),

12.0

Hz, IH, C H A H

B

O R ) , 4.88

(d, J = 12.0 Hz, IH,

4.23 (t, J = 8.8 Hz, IH, H3'), 3.54 (s, 3H, O C H 3 ) , 3.09 (bd, J

= 8.0 Hz, 2H, H47H4'); (minor isomer, in part) 8 7.68-6.87 (m, 15H), 6.73
(s, IH, N H ) , 5.05 (d, J = 11.6 Hz, IH, C H A H B O R ) , 4.87 (d, J = 12.0 Hz,
IH, H3'), 4.79 (d, J = 11.6 Hz, IH, C H A H R O R ) , 3.72 (dd, J = 7.2, 13.0 Hz,

IH, H4'), 3.56 (s, 3H, OCH3), 2.53 (dd, J = 10.0 Hz, 13.0 Hz, IH, H4').
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(3S,5S), (3R,5R), (3S,5R) and (31?^)-5-Benzamido-5-hydroxymethyl2,3-diphenylisoxazolidine (16), ent-(16), (17), ent-(17).
The title compounds were prepared from a 73 : 27 mixture of (15b) and
(15a) (50 m g , 0.1 m m o l ) by treatment with sodium borohydride as
described above. Purification of the crude reaction product by column
chromatography gave 25 m g ( 6 4 % ) of a 7 2 : 28 mixture of
diastereoisomers that were identical by lH N M R to the major and minor
diastereoisomers, respectively as described above from (15a).
M T P A esters (18), (19), (20) and (21) of alcohols (16), ent-(16), (17) and
ent-(Yl).
The title compounds were prepared from the mixture of alcohols
(16), (17) and ent-(\l) (15 mg, 0.04 mmol) as described above.
Purification of the crude reaction mixture by column chromatography gave
a mixture of four diastereoisomers (15 mg, 69%).
IH N M R (major isomer, in part) 8 5.08 (d, J = 11.6 Hz, IH,

CHAHBOR),

4.80 (d, J = 11.6 Hz, IH, C H A H B O R ) , 4.36 (t, J = 8.0 Hz, IH) 3.56 (s, 3H,

OCH3). (second most prominent diastereoisomer, in part) 8 4.95 (d, J =
11.6 Hz, IH, C H A H B O R ) , 4.86 (d, J = 11.6 Hz, IH, C H A H B O R ) .

MS

(ES) m/z 591.7 (35%, M H + ) , 470.5 (23), 102.3 (100). The other two
diastereoisomers were (18) and (19).
Preparation of Benzohydroxamoyl Chloride (46).l°7b'c
To a stirred solution of syn-benzaldoxime (45) (19g, 0.16 mol) in D M F
(150 m L ) at 25-30 °C was added about one-tenth of 21.3 g (0.16 mol) of
solid N C S . The initial N C S addition resulted in a slight temperature
decrease. Because the reaction did not self initiate within 10 min. (It
should be initiated with a slight temperaturerise)10 m L of gas from the
head space of a concentrated hydrochloric acid reagent bottle was collected
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in a syringe and then bubbled into the D M F solution. The reaction
initiated after 5 min. The rest of the N C S was added at 25-30 °C by
cooling in ice bath. Completion of the reaction was indicated by cessation
of the exotherm. The solution was poured into four volume of ice water.
The mixture was extracted twice with ether. The combined ether extracts
were washed three times with water, dried (MgS04), concentrated under
reduced pressure. The almost colourless residual liquid was dissolved in
hexane (100 m L ) and cooled in an ice-acetone bath, whereupon a
colourless crystalline solid started separating. The cooling was continued
for 30 min and the solid was thenfilteredand washed with cold hexane.
The residual solid was dried in desiccator. The yield of benzohydroxamoyl
chloride (46) was 12.5 g (50%) with m.p. 48-50 °C (lit. 107c m.p. 4g-52 °C).
IH N M R 8 9.25 (bs, I H N O H ) , 7.7-6.83 (m, 5H). M S (FAB) m/z 156
(95%, M + ) .
(TR£S) and (2,^^)-3-Phenyl-A2-isoxazolidine-5-spiro-4'-(3,-benzoyl2'-phenyl)oxazolidin-5'-one (38a) and (39a).

To a solution of (14) (225 mg, 0.8 mmol) and triethylamine (0.11 mL
m m o l ) in dry C H 2 C I 2 (10 m L ) was added dropwise a solution of
benzohydroxamoyl chloride (128 mg, 0.8 mmol) in CH2CI2 (5 m L ) under
nitrogen at room temperature. After stirring for 2 hr the solution was
washed with water (2 x 20 m L ) , the organic layer was dried over M g S 0 4 ,
and the solvent was removed under reduced pressure. lH N M R analysis of
the crude product revealed a 85 : 15 mixture of diastereoisomers that were
separated by column chromatography on silica gel ( 2 0 % ethyl acetate /
hexane) to furnish a mixture of (38a) and (39a) (300 mg, 94%).
(38a): M.p. 130-2 °C; [a ] D 2 6 +30.2 (c 0.5 in CHCI3). lH N M R 8 7.6-7.05
(m, 15H), 6.83 (s, IH, H2'), 4.13 (d, J = 17.0 Hz, IH, H4), 4.04 (d, J = 17.0
H z , IH, H4). 13C N M R 8 169.9 (CO), 168.5(CO), 155.5 (CN), 135.2,
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134.8, 130.7, 130.5, 130.4, 128.9, 128.7,128.4, 127.9, 127.0, 126.6, 126.2
91.9 (C5), 89.9 (C2), 43.6 (C4). IR (nujol) 1768, 1655, 1385, 1305, 1255,
1020, 880, 855, 685 cm-1.

M S

(ES) m/z 399 (100%, M H + ) , 277 (15), 210

(49), 130 (53). Anal. Calcd for C24H18N2O4: C, 72.3; H, 4.6; N, 7.0%.
Found: C, 72.6; H, 4.7; N, 7.0%.
(39a): M.p. 222-3 °C; [ocfo26 +89.5 (c, 0.45 in CHCI3). lH N M R 7.5a
7.20 8 (m, 15H), 6.87 (s, IH, H2'), 3.86 (d, J = 17.6 Hz, IH, H4), 3.54 (d, J
= 17.6 Hz, IH, H4). 13C N M R 8 169.1 (CO), 168.4 (CO), 150.6 (CN),

134.8, 134.7, 134.1, 132.3, 131.5, 131.2,129.5, 128.1,127.8, 126.5, 126.2,
126.0, 91.6 (C5), 89.3 (C2*), 42.5 (C4). IR (nujol) 1775, 1640, 1580, 1370,
1340, 1265, 1010, 880, 850, 694 cm-1. M S (ES) m/z 399 (45%, M H + ) , 316
(44), 288 (100).
(5S)-5-Benzamido-5-hydroxymethyl-3-phenyl-A2-isoxazoline (43).
Thetitlecompound was prepared from (38a) (150 mg, 0.37 mmol) by
treatment with sodium borohydride as described for the preparation of (16)
and (17). Purification of the crude reaction product by column
chromatography gave (43) (120 mg, 51%).
M.p. 72-3 °C; [ a ] D 2 8 -111.2 (c 0.2 in CHCI3). !H N M R 8 7.77-7.34 (m,
10H), 7.15 (s, IH, N H ) , 4.14 (d, J = 11.1 Hz, IH, H4'), 4.00 (d, J = 17.4
Hz, IH, C H A H B O H ) , 3.92

(bd, IH, H4'), 3.55

C H A H B O H ) , 3.44 (bs, IH, O H ) .

13C N M R

(d, J = 17.4 Hz, IH,

8 167.3 (CO), 158.2

(CN),

132.1, 130.5, 128.7, 128.6, 128.5, 127.2, 126.9, 126.8, 96.2, (C5'), 65.4
(C4'), 41.2 (Cl). M S (ES) m/z 319 (83%, MNa+), 297 (27%, M H + ) , 176
(100). Anal. Calcd for C17H16N2O3: C, 68.92; H, 5.40; N, 9.46%. Found:
C, 68.61; H, 5.59; N, 9.06%.
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M T P A ester (44) of alcohol (43).
The title compound was prepared from (43) (10 mg, 0.034 mmol) as
described for the preparation of (18) and (19). Short-path column
chromatography gave a 88 : 12 mixture of two diastereoisomeric M T P A
esters (15 mg, 86%).
[CX]D23

-48 (c 0.2 in CHCI3). lH NMR (major isomer, in part) 8 7.71-

(m, 15H), 6.71 (bs, IH, N H ) , 4.97 (d, J = 11.6 Hz, IH, C H A H B O R ) , 4.83
(d, J = 12 Hz, IH, C H A H B O R ) , 4.38 (d, J = 18.0 Hz, IH, H4'), 3.53 (d, J =

18.0 Hz, IH, H4'), 3.53 (s, 3H, OCH3). (minor isomer, in part) 7.71-7.26 8
(m, 15H), 6.73 (bs, IH, N H ) , 4.90 (d, J = 11.2 Hz, IH, C H A H B O R ) ,

4.82

(bd, IH, C H A H B O R ) , 4.00 (d, J = 17.6 Hz, IH, H4'), 3.52 (m, 4H, H4',

OCH3). M S (ES) m/z 535 (100%, M N a + )
(2'/^,51S)-3-Methyl-A2-isoxazolidine-5-spiro-4,-(3,-benzoyl-2,phenyl)oxazolidin-5'-one (38b).

To a solution of (14) (225 mg, 0.8 mmol), nitroethane (150 mg, 2 mmol
and triethylamine (0.11 m L , 0.8 mmol) in of dry CH2CI2 (5 m L ) at room
temperature under nitrogen was added a solution of phenyl isocyanate (380
mg, 3.2 mmol) in dichloromethane (3 m L ) by syringe over a 2.5 hr period.
The reaction mixture was stirred for an additional 2 hr. Water (6 m L ) was
then added and the mixture was stirred for 3 hr, and then filtered. The
layers were separated and the aqueous phase was extracted with
dichloromethane. The combined extracts were dried over M g S 0 4 and
concentrated. lH N M R analysis of the crude product revealed a 83 : 17
mixture of diastereoisomers. Purification of the mixture by column
chromatography on silica gel (30% ethyl acetate / hexane) furnished
diastereomerically pure (38b) (110 mg, 41%).
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(38b): M.p. 182-3 °C; [ a ] D 2 7 +52.0 (c 0.2 in CHC1 3 ). lH N M R 8 7.397.00 (m, 10H), 6.75 (s, IH, H2'), 3.71 (d, J = 17.6 Hz, IH, H4), 3.61 (d, J =
17.6 Hz, IH, H4), 1.94 (s, 3H, C H 3 ) . 13C N M R 8 169.8 (CO), 168.6 (CO),
154.3 (CN), 135.2, 134.9, 130.5, 130.3, 128.8, 128.4, 126.6, 126.2, 91.2
(C5), 89.8 (C2'), 46.6 (C4), 12.4 (CH3). IR (nujol) 1777, 1657, 1408,
1345, 1320, 1241, 1155, 1005, 740, 685 cm-1.

M

S (ES) 337 (100%,

M H + ) , 288 (40), 210 (28). Anal. Calcd for C19H16N2O4: C, 67.85; H, 4.8;
N, 8.3%. Found : C, 67.5; H, 4.9; N, 7.95%.

(39b) (in part): lH NMR 8 7.39-7.00 (m, 10H), 6.8 (s, IH, H2'), 3.8
= 17.6 Hz, IH, H4), 3.61 (d, J = 17.6 Hz, IH, H4), 2.08 (s, 3H, CH3).
Methyl (3S,5S)-5-benzamido-2,3-diphenylisoxazolidine-5-carboxyIate
(57a) and Methyl (3S,5/?)-2-benzamido-2,3-diphenylisoxazolidine)-5carboxylate (57b).
To a 0 °C solution of (15a) (150 mg, 0.31 mmol) in dry methanol (10 m L )
under nitrogen was added powdered anhydrous potassium carbonate (43.5
mg, 0.31 mmol). The mixture was stirred at room temperature for 13 hr.
The mixture was then diluted with ethyl acetate (20 m L ) and washed with
an aqueous solution of saturated ammonium chloride. The aqueous layer
was separated and extracted with ethyl acetate (2x10 m L ) . The combined
extracts were washed with water, brine, dried (MgS04) and concentrated in
vacuo to give 100 m g (83%) of the two isomers (57a) and (57b) in a ratio
of 56:44.
IH N M R (major isomer, in part) 8 7.91-6.92 (m, 15H), 4.94 (dd, J = 7.6,
9.6 Hz, IH, H3'), 3.91 (s, 3H, CH3), 3.51 (dd, J = 7.2, 13.2 Hz, IH, H4'),
3.2 (dd, J = 9.8, 13.2 Hz, IH, H4'); (minor isomer, in part) 8 7.91-6.92 (m,
15H), 4.81 (bt, J = 7.6 Hz, IH, H3'), 3.83 (s, 3H, CH3), 3.68 (dd, J = 7.6,
13.2 Hz, IH, H4'), 3.02 (dd, J = 9.8, 13.2 Hz, IH, H4'). M S (ES) m/z 403
(19%, M H + ) , 282 (100).
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(2J?,45)-l,4-Diphenyl-2-benzoylazethane(58).

A solution of (15a) (150 mg, 0.3 mmol) in ethyl acetate (10 mL) w
stirred at room temperature under an atmosphere of hydrogen (1 atm.) for 5
hr in the presence of 2 0 % palladium hydroxide on carbon (50% water)
(100 mg). The catalyst was removed by filtration through celite and the
solvent was evaporated under reduced pressure. Purification of the crude
reaction mixture by column chromatography (silica gel, 2 0 % ethyl acetate /
hexane) afforded 1,4-diphenyl-2-benzoylazethane (58) (30 mg, 30%) and
AM>enzylbenzamide (59) (30 mg, 47%).
(58): M.p. 175-7 °C; [CX]D 26 +71.1 (c 0.18 in CHCI3). ! H N M R 8 7.387.00 (m, 15H), 5.27 (dd, J = 6.4 Hz, IH, 9.6, H2), 4.73 (bs, IH, N H ) , 4.27
(dd, J = 7.6 ,10.4 Hz, IH, H4), 3.30 (ddd, J = 6.4, 7.6, 12.8 Hz, IH, H3a),
2.00 (ddd, J = 9.6, 10.4, 12.8 Hz, IH, H3P). 13C N M R 8 173.1 (CO),
147.3, 139.8, 137.1, 129.3, 128.8, 128.6, 128, 126.7, 125.6, 123.3, 118.6,
113.8, 60.8 (C2), 55.9 (C4), 40.7 (C3). M S (ES) m/z 329 (100%, M H + ) ,
182 (15). H R M S found: 329.1647 +/- 0.007. Calcd for C22H20N2O+H:
329.1653.
(59): M.p. 97-100 °C dec (lit. 120 105-6 °C). lH N M R 8 7.80-7.30 (m,
10H), 6.48 (bs, IH, N H ) , 4.66 (d, J = 5.2 Hz, 2H, C H 2 ) . 1 3 C N M R 8 167.3
(CO), 138.1, 134.3, 131.5, 128.8, 128.6, 127.9, 127.6, 126.9, 44.1. M S
(ES) m/z 212 (3%, M H + ) , 182 (12), 91 (100).
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CHAPTER FOUR

Asymmetric Synthesis of Proline Derivatives via ExoDiastereoselective 1,3-Dipolar Cycloaddition Reactions of
Azomethine Ylides
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4-1. Introduction

1,3-Dipolar cycloaddition reactions to alkenes have found wide syn
application in organic chemistry, as they open

access to

polyfunctionalized five membered heterocyclic rings, often in a highly
regio- and stereoselective fashion.77 A m o n g the variety of 1,3-dipoles
available, the chemistry and stereochemistry of nitrone and nitrile oxide
cycloadditions has been more intensively investigated, with particular
focus on the variant of these reactions that secures control of the absolute
stereochemistry of the products (Chapter Three).

1,3-Dipolar cycloaddition reaction of azomethine ylides (1) to alk
become a powerful method for constructing the pyrrolidine ring system
(2). (Scheme 4.1).77,121 Several natural products with highly substituted
pyrrolidine ring systems have been synthesised by utilization of the 1,3dipolarringforming reaction as a key step. I 2 2
Scheme 4.1
H

H
1+

JU^N^R

R 3 CB=CH 2

I
V " N < R1

R1

H
(1)

(2)

Azomethine ylides are generated in situ and not isolated. The preparation
of stabilized azomethine ylides with a wide range of electron withdrawing
substituents on the carbon atom bearing the negative charge was first
described by Grigg et alA2^ in 1978. These intermediates undergo 1,3dipolar cycloaddition reactions to give a wide range of novel
polyfunctionalized pyrrolidines (Scheme 4.2).I24
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Scheme 4.2
H

M = Ag(I), T1(I), Mg(II), Mn(II)
E W G = CO2R, C(0)R, CN, P(0)(OEt)2, 2-pyridyl, 2-thiazolyl, Y=CQ 2 R, C(0)R
1,3-Dipolar cycloaddition reaction of azomethine ylides derived from Narylidene a-amino acids l 2 5 and a-amino acid esters to electron deficient
alkenes is an extremely powerful method for the synthesis of
polyfunctional prolines. 1 2 6 _ 130 Recent attention in this area has focused
on devising methods for preparing optically active

1,3-dipolar

cycloaddition products from azomethine ylides.i28-130 Three general
approaches for the asymmetric version of these reactions have been
realized by employing a chiral auxiliary attached to either the azomethine
ylide I 2 8 or the dipolarophile I 2 9 or by utilization of a chiral metal
complex as catalyst. 130 Besides these three approaches there is another
report in which a chiral azomethine ylide and a chiral dipolarophile
reacted to give chiral adducts with double asymmetric induction.131
There are five issues which need to be considered w h e n evaluating the
utility of such systems for asymmetric synthesis: 1) availability of the
auxiliary; 2) diastereofacial selectivity; 3) endo/exo

selectivity; 4)

geometry of 1,3-disubstituted ylides and 5) auxiliary removal / recovery.

Chapter 4

159

Suffice it to say none of the chiral systems reported so far appears to
satisfy all of these requirements. While good stereocontrol has been
achieved in the asymmetric version of these reactions by attaching chiral
auxiliaries to the dipolarophile component, the development of a general
chiral auxiliary for azomethine ylides is ongoing. i28 In 1994 Garner et
fl/.128h

demonstrated that Oppolzer's sultam could serve as an effective

recoverable chiral auxiliary for 1,3-dipolar cycloadditions of carbonylstabilized azomethine ylides. Thermolysis of aziridine (3a,b) produced
the corresponding A7-substituted azomethine ylides (4a,b) which
underwent 1,3-dipolar cycloaddition to dimethyl maleate (5) as a
dipolarophile. Cycloadducts (6a,b) (proline derivatives) were obtained as
the major products, with facial selectivity of 9 : 1 and 1 1 : 1 respectively,
and arose via the exclusive endo cycloaddition to the Z-ylide (4a,b)
(Scheme 4.3).
Scheme 4.3

180 °C

H2

S+
(4a, b)

(3a) ; R = Bn
(3b) ; R = p-MeOC 6 H 4

^CC^Me
^C02Me

Me02«

C0 2 X<

(6a, b)
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Utilization of a chiral metal complex in 1,3-dipolar cycloadditions of
azomethine ylides was reported for the first time by All way et al. 130 j n
1991. They explored the use of anhydrous C0CI2 in the presence of (IR,
2S)-Ar-methylephedrine (8) for the reaction of (7) with methyl acrylate to
give (9) (Scheme 4.4). The best results ( 8 4 % yield, 9 6 % e.e.) were
reported with a mole equivalent of C0CI2 and a 1 : 2 metal salt to ligand
ratio.
Scheme 4.4
Me

Ar'

*nr

OMe

%

HO'
^

N(Me) 2

(8)

C0 2 Me

CoCl2, 45 min.

0

Me0 2 C^

(7) Ar = 2-naphthyl

H

Ar**"^N^***C02Me
H
(9)

The suggested model (10) for the asymmetric induction shows that the
ds-arrangement of the methyl and phenyl groups of the chiral ligand
results in a pseudo-equatorial conformation for the phenyl group and
effective blockade of one 7C-face of the imine of the dipole.
OMe
H

r /Me
/

O* I _»NH

w W Me
Me

(10)
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In 1991, Annunziata et al.l29e

reported the cycloaddition of

enantiomerically pure (£)-y-alkoxy-a,p-unsaturated esters (lla-c) and
azomethine ylides derived from the glycine imines (12) and (13) in the
presence of LiBr and D B U (Scheme 4.5). From these reactions proline
derivatives (14)-(17) were prepared.

These reactions were highly

regioselective and only two diastereoisomers were obtained (Table 4.1).
The major diastereoisomers (14a)-(17a) arose from addition of the ylide
to the 7t-face of the dipolarophile that was anti to the y-alkoxy or yhydroxy substituent via an endo type transition state.
Scheme 4.5
QR
Ar.> s ^ N v / C 0 2 M e

'C02Me

(12) ; Ar = Ph
(13) ; Ar = p-MeOC6H4

(11a) ; R = Bn
(b) ; R = TBDMS
(b) ; R = H

LiBr/DBU -78 °C / THF

''

fJR
^-<

Me02Cx

>c£02Me

Y

Ar

^:

Me0 2 C

m

JC02Me

*

N

Ar

H

H

(14a)-(17a)

(14b)-(17b)
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Table 4.1. Diastereoselective synthesis of pyrrolidines (14)-(17) from esters
(lla-c).128e
Entry

Imine

1

Ester
(11)
a

2

a

(12)

3

b

(12)

4

b

(12)

5

c

(12)

(12)

Dipole : Alkene Yield%
(Products)
ratio
Diastereoselection
1: 1
40
(14a): (14b)
78:22
3: 1
58
(14a) : (14b)
77:23
1: 1
65
(15a) : (15b)
9 0 : 10
3: 1
77
(15a) : (15b)
88: 12
1: 1
24
(16a) : (16b)

96:4
6

a

1: 1

(13)

52

(17a) : (17b)
79:21

Similar observations were reported by Patzel et al.l29f in 1993 with
different a,p-unsaturated ketones (enones) (18) bearing a chiral alkoxy
or amino substituent in the y-position (Scheme 4.6). Again the major
diastereoisomer (20) arose from addition of the ylide to the 7t-face of
(18) that was anti to the y-oxygen substituent via an endo type transition
state.
Scheme 4.6

THF, catalyst
+

Ph^N^CO.Et

DBUs_78oc>4hr>

5

(19)

(18)

Catalyst

Yield

LiBr
AgOAc

53%
91%

Diastereoselection
85 : 15
>95 : 5

> C \ y .COMe
Et0
2
Ph
H
(20)
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Compared with LiBr / D B U , the use of A g O A c / D B U gave higher
stereoselectivity.i29 f
In all of the above series of reactions the geometry of the azomethine
ylides has been proposed to be (21b), for the following two reasons: 1)
Intramolecular chelation of the metal ion would favour structures (21a)
and (2lb) 132 and 2) Steric effects favour (21b), because of an
unfavourable steric interaction between Ar and R in (2la) 133 (eq 4.1).

r+~ff

M

i?

•

Ar

CL 'OR

OR

Ar jj R

H
(21a)

eq (4.1)

R
(21b)

In this Chapter, the 1,3-dipolar cycloaddition reaction of azomethine
ylides with the chiral oxazolidinone (22) is described as a method for the
asymmetric synthesis of polyfunctional proline derivatives. The structure
and stereochemistry of the cycloadducts will also be considered.
CH2
PhOCN

,

)r°
H

Ph
(22)
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4-2. 1,3-Dipolar Cycloaddition Reactions of (22) and Azomethine
Ylides

In this study the azomethine ylides (24a-e) were generated in si
(23a-e) in the presence of (22) by treating a T H F or C H 3 C N solution of
(23) with a metal salt (LiBr or A g O A c ) and a base ( D B U or Et3N) at -78
°C. The reactions were performed via three different methods that are
indicated in Scheme 4.7. Methods I, II, III involved the salt, base, solvent
combinations (LiBr / D B U / THF), (LiBr / Et 3 N / C H 3 C N ) and (AgOAc /
D B U / THF), respectively. The reaction mixtures were maintained at -78
°C for several hours or warmed to the temperature specified in Table 4.2
(page 171) before being quenched with saturated aqueous NH4CI solution.
Scheme 4.7
2

n>L^C0 2 R'

. ..
+ t
base/M

P hou

i+

^^l>vr^(

R1

^A.l>2

R1

(23a); R = CH2CH(CH3)2, R2 = CH 3
, R 2 = CH 2 CH 3
(b); R = CH2Ph
, R 2 = CH 3
(c); R = Ph
, R2 = CH 3
(d); R = CH 3
(e) ; R1 = H
, R2 = CH 2 CH 3

(24a-e)

method I : LiBr / DBU / THF
method II : LiBr / Et3N / CH 3 CN
method III : AgOAc / DBU / THF

; M = Li, Ag
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4-2-1. 1,3-Dipolar Cycloaddition Reactions of (22) and Methyl
A/-Benzylidene Leucinate (23a)
When a solution of oxazolidinone (22) and methyl N-benzylidene
leucinate (23a) was treated according to Method I, at -78 °C for 2 hr and
then at -20 °C for 30 hr, a 94 : 6 mixture of two diastereomeric
cycloaddition products (25a) and (25b) was formed in 6 1 % yield (Scheme
4.8). The same two diastereomeric products were produced in a ratio of
88 : 18 when this reaction was performed according to Method II at 0 °C
for 10 hr. W h e n this reaction was performed using Method III, at -78 °C
for 2 hr and then at to room temperature for 30 hr, the reaction
proceeded with a poorer diastereoselectivity and a small amount of the
regioisomer (25c) was also obtained. The ratio of diastereoisomers (25a)
: (25b) : (25c) was 58 : 37 : 5 as determined by lH N M R on the crude
reaction mixture (Table 4.2, page 170). The diastereoisomers were
readily separated by column chromatography. The structures of (25a)
and (25b) were elucidated by single X-ray structural determinations
(Figure 4.1).

The X-ray structural analysis indicated that the

stereochemistry of (25a) and (25b) arose from addition of the azomethine
ylide (24a) to the 7C-face of the exo-cyclic 4-methylene group of (22) that
is anti to the C-2 phenyl substituent, via an exo and endo type transition
state, respectively.
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CH 2
C 0 2 CH 3

PhCON

f

THF or C H 3 C N
(M = Li or Ag)

H Ph
(22)
Ph

(24a)

M
V ...*N,„. .^C02CH3

Phcq^ H *

^

V

C0 2 CH 3

'f

PhOC

(«JCO,

(endo, minor isomer 25b)

major isomer 25a)

Ph

4\£HP
H3C02C^ S<* *J?
PhOCN
H

Ph

(regioisomer 25c)
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(25a)

(25b)

Figure 4.1. Molecular projection of (25a) and (25b) normal to the plane of fivemembered ring.

C O S Y and N O E S Y N M R experiments were used to assign the lH N M R
spectra of the cycloadducts. In the N O E S Y spectrum of the major isomer
(25a), strong cross peaks between H2' (5 4.91) and the signal at 8 2.79 (d,
J = 14 Hz) identified this resonance as being associated with H4'a rather
than H4'p (8 3.54, d, J = 14 Hz) in (25a). Similar cross peaks in the
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N O E S Y spectrum of the minor isomer (25b) were observed between H2'
(8 5.45) and the resonance at 8 3.57 (d, J = 13.2 Hz), which identified this
resonance as being associated with H4'P rather than H4'a (8 2.90, d, J =
13.2 Hz). These observed N O E S Y cross peaks were consistent with the
close proximity of H2' and H4*a and also H2' and H4*p in (25a) and
(25b) respectively, from the energy minimized structure of these
compounds (Figure 4.2).

(25a)

(25b)

Figure 4.2. Energy minimized structures of (25a) and (25b) using the I N S I G H T II
force field of B I O S Y M .

The lH NMR of these two diastereoisomers were useful in determining
the stereochemistry of the other cycloadducts in this study. A s it is shown
in Figure 4.3, the H 2 signal in the exo isomer (25a) is observed upfield (8
5.80) of the H 2 signal in the endo isomer (25b) (8 6.04) (Table 4.3, page
173). In the exo isomer (25a), two relatively upfield 'ortho'-aromatic
proton signals are observed at 8 6.60 and 8 6.08. While in the endo
isomer (25b) only one upfield aromatic signal is observed at 8 6.71
(Figure 4.3).
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^

_JC02CH3

N

NOE

r

\KL_JI
Figure 4.3. 400 M H z *H N M R spectrum of (25a) and (25b) in CDCI3.
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The structure of the regioisomer (25c) was evident from its lH N M R
spectrum. While the lH N M R spectrum of the (25a) and (25b) showed
both H4'a and H4'P as doublets, these protons were observed as a doublet
of doublets in the l H N M R spectrum of (25c).

The relative

stereochemistry of (25c) however, could not be determined.
Table 4.2. 1,3-Dipolar cycloaddition products from reactions of (22) and
azomethine ylides (24a-e).
Entry
1

2

3

4

5

a

Imine

Method Time(hr)/ Yield
(Products)
T e m p f C ) (%)a Diastereoselection15
Methyl _V(25a): (25b): (25c)
I
benzylideneleucinate
30 / -20
61
94 : 6 : 0
(23a)
10/0
62
82 :18 : 0
n
30/r.t.
58 :37 : 5
67
m
Ethyl AT-benzylidene
(26a): (26b)
i
9/-78
85: 15
alaninate
45
78:22
(23b)
3/0
51
n
64:36
30/r.t.
51
m
(27a): (27b)
Methyl N83:17
i
20 / -78
50
benzylidene
93:7
20/0
59
phenylglycinate
n
NRc
(23c)
m
(28a): (28b)
Methyl N82: 18
52
i
6/-78
benzylidenealaninate
76:24
69
8/0
(23d)
n
58:42
20/r.t.
83
m
Ethyl Af-benzylidene
glycinate
(23e)

i

15/0

32

H

6/0

44

m

6 / r.t.

88

(30a): (29b)
82: 18
(30b): (31)
50:50
(29b): (29a)
55 : 45

Combined yield of products after purification. b Determined on the crude reaction

mixture by *H N M R . c N o reaction.
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4-2-2. 1,3-Dipolar Cycloaddition Reactions of (22) and A7Benzylidene oc-Amino Acid Esters (23b)-(23e)
The 1,3-dipolar cycloaddition reactions of (22) and N-benzylidene aamino acid esters (23b)-(23e) were performed via Methods I, II and m ,
for the period of time and reaction temperature indicated in Table 4.2,
page 170 (Scheme 4.9). The diastereomeric adducts were separated by
column chromatography. The cycloadducts (26a)-(29a) and (26b)-(29b)
were determined to have the exo and endo stereochemistry respectively,
by comparison of their lH N M R spectra with that of the compounds (25a)
and (25b) respectively, whose stereochemistry was established by single
crystal X-ray structural determinations (Figure 4.1). The chemical shifts
for the two upfield aromatic protons in the l H N M R

spectra of

compounds (25a) and (26a)-(29a) were almost identical (Table 4.3, page
173). Likewise, the chemical shifts for the single upfield aromatic proton
in compound (25b) and (26b)-(29b) were essentially the same. In
addition, the signals for H 2 in compounds (26a)-(29a) were observed
upfield of H 2 in compounds (26b)-(29b), similar to what was observed in
(25a) and (25b) respectively (Table 4.3, page 173). The stereochemistry
of (26a) was further evident from a single crystal X-ray structure
determination of its proline derivative (50) that is described later in this
Chapter (Figure 4.7).

The structure of compound (26b) was

unequivocally established by a single crystal X-ray structure
determination (Figure 4.4). This X-ray structure confirmed what was
deduced about the stereochemistry of (26b) from lH N M R analysis.
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Scheme 4.9

M
Ph
(22)

V*Jd

Y

Co2R

2

T H F or C H 3 C N
-•

(M = Li or Ag)

R1
(24b-e)

PhOCN

(26b)-(29b)
(26): R 1 = CH 2 Ph
(27) : R 1 = Ph
(28) : R 1 = C H 3
(29) : R 1 = H

, Rz = C H 2 C H 3
, R2 = C H 3
, R2 = C H 3
,R 2 = C H 2 C H 3

Figure 4.4. Molecular projection of (26b) normal to the plane of five-membered ring.
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The assignment of the lH N M R spectra of (26a)-(29a) and (26b)-(29b)
were aided by C O S Y and N O E S Y N M R experiments. In the N O E S Y
spectra strong cross peaks were observed between H2' and H4'a in (26a)(29a) and between H2' and H4'P in (26b)-(29b) (Table 4.3).
Table 4.3. Chemical shifts 8 (ppm) of H2o, H4'o, H4'P and 'ortho-aromatic'
protons ('ortho'-ArH) of the cycloaddition adducts (25)-(29).
Cycloadduct

a

H4*a

Exo isomer (a)
H4'p H 2
o-ArHa

(25)

2.79

3.54

5.80 6.60, 6.08 2.90

3.57

6.04

6.71

(26)

3.02

3.67

5.80 6.62, 6.12 3.31

3.51

6.04

6.73

(27)

3.53

4.18

5.76 6.64,6.21 3.19

3.78

6.35

6.78

(28)

2.85

3.65

5.80

6.61,6.11 2.98

3.59

6.06

6.71

(29)

3.10

3.41

5.88 6.64,6.10 2.70

3.57

6.25

6.72

Endo isomer (b)
H4'a H4'P
H 2 o-ArHa

'ortho'-aromatic protons

In the case of imine (23c), the use of Method in or using the metal salt /
base / solvent combination of A g O A c / Et3N / C H 3 C N were unsuccessful
and only starting imine (23e) and alkene (22) were recovered.
For entries 1,2,4 and 5 (Table 4.2, page 170), Method I gave cycloadducts
with the highest exo : endtf-diastereoselectivity. In general, Method II
gave cycloadducts with poorer exo : encfo-diastereoselectivity except in
the case of (23c) (Entry 3, Table 4.2, page 170), where an enhanced exodiastereoselectivity (93 : 7) over Method I was realised. W h e n Method
HI was employed, the diastereoselectivity was in general much lower than
that for Method I or II (64-55 : 36-45) and the reactions did not proceed
at an appreciable rate below 0 °C.
W h e n the reaction of the glycine derivative (23e) (Entry 5, Table 4.2,
page 170) was performed using Method I, at -78 °C for 15 hr and then 0

Chapter 4

\ 74

°C for 8 hr, the cycloadduct (29b) and the tricyclic product (30a) w
obtained, in 10 and 2 5 % yields, respectively. The structure of (30a) was
determined from lH, 13C N M R , C O S Y and H E T C O R N M R and mass
spectrometric analysis. The details of the lH and i 3 C N M R spectra of
(30a) are outlined in the Experimental Section of Chapter Four.** The
similarity of the proton resonances for the aromatic and H 2 (8 6.45)
protons in the l H N M R of (30a) with those of (29b) showed this
compound had the stereochemistry at C2' and C4'a indicated in structure
(30a). In the C O S Y experiment, H6' (8 5.26) had a strong cross peak
with two hydrogens at (8 3.41) and (8 2.42). This showed that H6' is
next to two hydrogens on C5\ A H E T C O R experiment showed that H 2
(8 6.45), H 2 ' (8 6.08) and H6' (8 5.26) are on C2, C2* and C6\
respectively. Also from this experiment it was found that there are two
hydrogens on C4' (H4'a (8 3.35, d, J = 12.8 Hz) and H4'p (8 3.76, d, J =
12.8 Hz)) and two hydrogens on C5' (H5a (8 3.41) and H 5 P (8 2.42))
(Figure 4.5).
NHCOPh

C02CH2CH3
PhOCN
-O

PhOCN
H

Ph

(31)
(30a) ; (Stereochemistry at C-6' unknown)
(30b) ; (Stereochemistry at C-6' opposite to that of (30a))

**The numbering used here for compounds (30a) and (30b) is not systematic. This
numbering scheme has been used to allow a direct comparison of the structural and
stereochemical features of (30a) and (30b) with those of the related compounds (2529a,b). The systematic number system is used in the Experimental Section, Chapter
Four.
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NHCOPh

CO2CH2CH3

CHj

t'

C41
C5"

C6'
CHj

c

a

fc.s

i.a

s.s

s.«

*.*

3.1

).«

z.s

e.«

I.I

rr (pp.1

Figure 4.5. The H E T C O R spectrum of tricyclic (30a).

When the reaction of (22) and (23e) was performed using Method II,
°C for 6 hr, then compound (30b) and the Michael adduct (31) were
obtained. lH N M R analysis showed compound (30b) is the C6' epimer of
(30a) (Experimental Section, Chapter Four). A possible mechanisms for
the formation of the tricyclic compounds (30a) and (30b) is given in
Scheme 4.13. The proposed mechanism (mechanism a) involves,
nucleophilic attack of the initially formed lithiated cycloadduct (32a) to
the carbonyl lactone of (22), followed by ring opening of the
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oxazolidinone ring to release P h C H O and to generate intermediate (33).
Anion (34), which m a y be formed from intramolecular or intermolecular
deprotonation of compound (33), undergoes a Michael type addition to
produce the tricyclic compound (30a) or (30b) (Scheme 4.10). Another
possible mechanism for the formation of the tricyclic compounds (30a)
and (30b) involves first Michael addition of (32b) to (22) and then
nucleophilic attack on the lactone carbonyl group (mechanism b).
Compounds (30a) and (30b) may also be interconverted, by epimerization
at C6', by base.
Scheme 4.10

NCOPh
C02Et

-78 °C

(22)

(32a)
mechanism
b

(30a) or'
(30b)
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Mechanism b would seem unlikely since, treatment of a mixture of the
cycloadducts (29a) or (29b) and alkene (22) with D B U / LiBr, at -78 °C
to room temperature, resulted only in the recovery of unreacted starting
materials and the products (30a) and (30b) could not be detected.
Another compound formed from the reaction of (22) and (23e) using
Method II was the Michael adduct (31). Unfortunately isolation of this
compound

after purification by column

chromatography

was

unsuccessful. Compound (31) was converted to the lactam (35) when the
crude reaction products were separated on silica gel (Scheme 4.11). This
conversion most likely occurs via first hydrolysis of the C = N bond and
then cyclization by nucleophilic attack of nitrogen to the lactone carbonyl
of the oxazolidinone ring. Lactam (35) was a single diastereoisomer and
the structure of this compound was evident from lH, 13C, C O S Y N M R
and mass spectroscopic analyses (Experimental Section, Chapter Four).
The stereochemistry of (35) was not determined.
Scheme 4.11
Li
Ph.

N+

C02Et
H

_7g o c

+
(22)

J

silica gel

Ph

y3~l\ co2Et
O ^ ^ H
H
(35)
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4-2-3. Preparation of Imines (23a)-(23e)
The AT-benzylidene-a-amino acid esters (23a)-(23e) were prepared by
condensation of benzaldehyde with the appropriate a-amino acid ester
hydrochloride (36a-e) in the presence of sodium carbonatel32a (Scheme
4.14). These reactions were performed in water initially at 40 °C and
then at room temperature overnight. Compound (36c) was prepared by
treatment of 2-phenylglycine (37) with thionyl chloride in dry methanol
(Scheme 4.12).
Scheme 4.12
R1 H
HCI. NH 3 -^C0 2 R 2

+ PhCHO

Na2C

H20
(36a-e)
P h

yH
NH2-X^C02H
(37)

°V Ph^N^CO.R2

T>
R
(23a-e)

Ph H
S Cl2
°
>- nn. M U / \ ~ n r H
HC1 N H
CH 3 OH
- 3
C0 2 CH 3
(36c)

4-3. Cycloaddition vs. Michael Addition in the Reactions of (22)
with Azomethine Ylides

Imines of a-amino esters undergo regio- and stereospecific cycloaddit
to electron deficient alkenes in T H F , C H 3 C N or other polar solvents in
the presence of a metal salt (silver, lithium or zinc) and D B U or
Et3N.l 2 6 - l 3 0 They also undergo regiospecific Michael addition to
electron deficient alkenes in the presence of a suitable base. 134 Barr et
al. 135 presented evidence which indicated there was a fine balance
between Michael addition and cycloaddition of the species generated from
imines in the presence of metal salts and base. Reaction of methyl Nbenzylidene alaninate (23d) with methyl acrylate under various conditions

Chapter 4

179

gave different ratios of cycloadduct (41) and Michael adduct (40) (Table
4.4, page 180).127e The proposed transition state for these reactions is
shown in structure (38a) in which the metal ion is chelated to the oxygen
and nitrogen atoms of both reaction partners (Scheme 4.13).

Bond

formation at the p-carbon of the acrylate precedes that at the a-carbon to
give (38b).

Quenching of (38b) with a proton source, presumably

triethylammonium bromide, leading to the Michael adduct (40) competes
with intramolecular cyclization producing the metal amide cycloadduct
(39).

Ready quenching of (39) with the a m m o n i u m salt produces

cycloadduct (41). T h e direct formation of (39) from (38a) via a
concerted cycloaddition m a y also be involved.
Scheme 4.13
O

x0CH3

O

;;CH3^fe

Ph-Vv .*>
H 3 CO

Ph

x 0CH 3

1V ^ C H

3

^N.HB

"^a>3

H 3 CO

.

V

Ph^

N >

^ s ^C0 2 CH 3

H3C C 2 C H 3

°

(38b)
(40)
H

Ph^.Nv^COzCH, EhN.HBr^

I

P h ^ N ^ C O ^

\_T'CH3

\J"'C*
H 3 C0 2 C

H 3 C0 2 C
(39)

(41)
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Table 4.4. Metal halide / amine-induced reactions of imine (23d) with
methyl acrylate at room temperature.127e
Entry Metal halide Et3N D B U Time Solvent Yield(%) Ratio
(equivalent)
(hr)
(40)+(41) (40): (41)
1

LiBr,

1.5

1.2

49

THF

95

1:5

2

LiBr,

1.5

1.2

1

CH3CN

79

1.4:1

3

LiBr,

1.5

1.2

92

3.3:1

4

LiBr,

1.5

-

3 CH 2 C1 2
1
THF
min

96

1:1.8

5

MgBr2,1.5

1.2

99

0:1

1

7

THF

The ratio of cycloadduct (40) to Michael adduct (41) was dependent upon
the reaction conditions (Table 4.4). Replacement of T H F by C H 3 C N or
C H 2 C I 2 favoured the Michael addition product (40) (Entries 2,3). The
polar solvent ( C H 3 C N ) would be expected to stabilize the polar Michael
addition transition state more effectively than the relatively non-polar
cycloaddition transition state, thus favouring the formation of Michael
adduct (40). i36 The effect of C H 2 C I 2 on the product ratio is more
difficult to rationalize since reactions in this solvent are heterogeneous
and probably occur at a solid-liquid interface. W h e n D B U was employed
as a stronger base, the reaction was complete within 1 min at room
temperature, indicating high acceleration of the deprotonation step
leading to the lithiated anion intermediate (Entry 4). With D B U as base,
the relative amount of Michael product (40) increased relative to that of
the cycloadduct (41) (compare Entries 1 and 4 in Table 4.4). W h e n a
magnesium salt was employed the cycloadduct was the only identified
product (Entry 5). The tendency of the small 'hard' lithium cation to
complex with oxygen donor groups and of the 'soft' (magnesium,
aluminium, silver) cation to complex with nitrogen donor groups m a y
form the basis for the differences observed. I 3 5
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In contrast, the analogous reactions of (23a-e) and (22) produced only
cycloadducts, except in the reaction of (23e) and (22) in the presence of
LiBr / Et3N. This reaction gave the tricyclic compound (30b) and the
Michael adduct (31) in a 1 : 1 ratio.
4-4. Regio- and Stereoselectivity of 1,3-Dipolar Cycloaddition
Reactions of (22) a n d Azomethine Ylides
It has been observed experimentally that azomethine ylides show a high
regioselectivity in their reactions with electron deficient alkenes. 126-130
Calculation of the energies of the various orbitals involved for different
types of cycloadditions by Houkl37 and Padwa et al.11 revealed that the
azomethine ylides are all electron rich species characterized by relatively
high energy H O M O s and L U M O s . From these calculations it has been
concluded that such species react preferentially with electron deficient
alkenes to give products via a transition state that favours 4-substituted
adducts because of a more favourable HOMOdipole-LUMOdipolarophile
interaction. This explanation can be used to explain the regiochemistry of
the 1,3-dipolar cycloaddition of alkene (22) and azomethine ylides (24ae). In all cases w e observed exclusively 2',3',3,,5',5'-pentasubstituted
pyrrolidine cycloadducts except in the case of (23a) using Method III
where a small amount ( 5 % ) of the 2',2',3,,3',5'-pentasubstituted
pyrrolidine cycloadduct (25c) was observed.
While endo cycloaddition adducts are generally favoured in 1,3-dipolar
cycloaddition reactions of azomethine ylides, 126,127(a,e,g),128(a,c-e,g),
129(b,c,g,h) ejco-diastereoselective azomethine ylide cycloadditions are not
u n c o m m o n . 129e,138 Garner et a/.138 reported the intermolecular
cycloaddition of azomethine ylide (42) to Oppolzer's chiral acryloyl
sultam (43) gave cycloadducts (44)-(47) with high exo-diastereoselectivity
(Scheme 4.14).
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Scheme 4.14
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(44) + (45) : (46) + (47) = 5:1

The preference for exo cycloaddition adducts in the reaction of (22) and
azomethine ylides (24a)-(24d) can be rationalized by assuming chelation
between the metal cation and Af-benzoyl carbonyl group in alkene (22)
and the azomethine ylide, as shown in the possible transition state
structure (48).
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A secondary orbital interaction between the nitrogen of the azomethine
ylide a n d the b e n z a m i d o nitrogen in the alkene (22) in the H O M O d i p o l e LUMOdipolarophile pair (Figure 4.6) is another possible reason for the
formation of exo cycloadducts in these series of reactions.
k *C0 2 R

2

HOMO
secondary orbital
interaction

PhC
LUMO

Figure 4.6. Orbital interactions between dipolarophile (22) and azomethine ylides in
exo transition state.
4-5. Synthesis of Proline Derivatives
The polyfunctional proline derivatives (49) and (50) were prepared by
based catalysed methanolysis of the oxazolidinone moiety of the major
dipolar cycloadducts (25a) a n d (26a), respectively ( S c h e m e 4.15).
Treatment of the cycloadducts (40) and (50) in methanol solution with
anhydrous potassium carbonate at r o o m temperature for 13 hr and then
purification of the products b y c o l u m n chromatography gave the proline
derivatives (49) and (50) in high yields ( 8 6 - 9 5 % ) . T h e structures of (49)
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and (50) were evident from their spectral analysis and both compounds
were a single diastereoisomer. The structure of (50) was elucidated by a
single crystal X-ray structural determination (Figure 4.7). This X-ray
structure also confirmed the stereochemistry of the cycloadduct (26a) as
being exo.
Scheme 4.15

(25a) or (26a) K 2 C 0 3 / C H 3 O H
r.t.

H

C Q

^

(49); R = CH^r* ([a] D 25 + 69.0, c 0.3 in CHC1 3 )
(50); R = CH 2 Ph ([a] D 28 + 82.8, c 0.6 in CHC1 3 )

Figure 4.7. Molecular projection of (50) normal to the plane of five-membered ring.
The enantiomeric purity of (25a) was determined to be 92% based on lH
N M R analysis of its diastereomeric carbamate derivatives (52) from
treatment with (£)-(+)-1-phenylethylisocyanate (51) (Scheme 4.16).
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Integration of the resonances for the diastereotopic methylene protons
H 3 a and H 3 p for the major and the minor diastereoisomers of (52)
showed that these diastereoisomers were in a ratio of 96 : 4. This
allowed the enantiomeric purity of (25a) to be calculated as 9 2 % .
Scheme 4.16
NHCOPh

"H%_;£-C02CH3
H3C02C„. It 4\ ..Ph

S-(+)-PhCH(CH3)NCO
r*n
(51)

(49)

^

(52)
4-6. Conclusions
In this Chapter, a n e w method for the synthesis of poly functional
prolines, through the 1,3-dipolar cycloaddition reactions of the chiral
dipolarophile (22) and AT-benzylidene amino acid esters have been
presented. The cycloadducts resulted from addition to the exo-cyclic
methylene of (22) from the less hindered Tt-face. It was found that these
reactions proceeded with good to high e*0-diastereoselectivity and they
were highly regioselective to produce only 2',3',3',5',5'-pentasubstituted
pyrrolidines. W h e n Method I (LiBr / D B U / T H F ) was employed the
diastereoselectivities were m u c h higher than that for Method II (LiBr /
Et3N / C H 3 C N ) or Method III ( A g O A c / D B U / T H F ) . The regio- and
stereoselectivity of these reactions can be explained byfrontiermolecular
orbital theory.

The stereochemistry of the cycloadducts has been

elucidated by single crystal X-ray structural determinations and I D and
2 D lH N M R analysis. The highly functionalized prolines (49) and (50) of
cycloadducts (25a) and (26a) were synthesised in high enantiomeric
purity ( 9 2 % e.e.) by methanolysis of the oxazolidinone moiety.
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For general experimental procedures see the Experimental Section of
Chapter Two.
Crystal / refinement data.
(25a). C31H32N2O5, M = 512.6. Monoclinic, space group P2i; a =
11.605 (5), b = 10.422 (9), c = 11.286 (8) A, p = 100.38 (5)°, V = 1343
(2) A3. Dc (Z = 2) = 1.27 g.Cm.-3; F (000) = 544
(25b). C31H32N2O5, M = 512.6. Orthorhombic, space group P2i2i2i
(D2 4, No. 19), a = 17.43 (2), b = 13.988 (4), c = 11.278 (4) A, V =
2750 (3) A3. D c (Z = 4) = 1.24 g.Cm.-3; F (000) = 1088.
(26b). C35H32N2O5, M = 560.7. Monoclinic, space group P2i, a =
9.627 (6), b = 9.06 (1), c = 16.76 (1) A, p = 90.39 (6)°, V = 1461 (2)
A3. Dc (Z = 2) = 1.27 g.cm.-3; F (000) 592.
(49). C28H28N2O5, M = 472.6. Monoclinic, space group P2i, (C22, No.
4) a = 10.612 (4), b = 9.384 (s), c = 13.134 (9) A, P = 91.83 (4)°, V =
1307 (1) A3. Dc (Z = 2) = 1.20 g.cm.-3; F (000) 500.
Preparation of 2-Phenylglycine methyl ester hydrochloride
(36c).
To a magnetically stirred solution of 2-phenylglycine (37) (3.4 g, 22.5
mmol) in dry methanol (20 m L ) at 0 °C was slowly added thionyl
chloride (3.0 g, 2.5 mmol). The homogeneous solution was left to stand
for 16 hr. The methanol was then evaporated in vacuo to furnish a white
solid, 4.3 g (95%). IH N M R 8 7.52-7.46 (m, 5H), 5.27 (s, IH, CHPh),
3.78 (s, 3H, CH3).
General Method for the Preparation of Imines (23a-e).132a
1

The amino acid ester hydrochloride (9.25 mmol) and sodium carbonate
(9.25 mmol) were dissolved in water (25 mL). Benzaldehyde (1 g, 9.25
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mmol) was added to the clear solution while stirring. The reaction
mixture was heated to 40 °C and stirred for 1 hr and then at room
temperature for a further 20 hr. The mixture was then extracted with
chloroform (3 x 100 m L ) and the combined chloroform extracts were
washed with water (2 x 100 mL), dried (MgS04) and evaporated under
reduced pressure to afford the crude imine.
Methyl AT-benzylideneleucinate (23a). (70%) Colourless liquid. lH
N M R 5 8.29 (s, IH, CH=N), 7.87-7.38 (m, 5H), 4.09 (dd, J = 6, 8.8 Hz,
IH, C H C O 2 C H 3 ) , 3.73 (s, 3H, CO2CH3), 1.85 (m, 2H, C H 2 ) , 1.58 (m,
IH, CH(CH 3 )2), 0.95 (d, J = 6.8 Hz, 3H, CH3), 0.9 (d, J = 6.6 Hz, 3H,
CH 3 ). M S (CI) m/z 234 (24%, M H + ) , 174 (43), 131 (65), 105 (100).
Ethyl N-benzylidenephenylalaninate (23b). (85%) Colourless
semisolid. lH N M R 5 7.92 (s, IH, CH=N), 7.69-7.15 (m, 10H), 4.17 (m,
3H, CHCO2CH2CH3), 3.36 (dd, J = 5.6, 13.6 Hz, IH, C H A H B P I I ) , 3.14
(dd, J = 8.8, 13.6 Hz, IH, CHAHBPh), 1.22 (t, J = 7.2 Hz, 3H, CH3). M S
(CI) m/z 282 (8%, M H + ) , 208 (55), 190 (65), 116 (100).
Methyl A^-benzylidenephenylglycinate (23c). (80%) Colourless
solid, m.p. 47-8 °C. lH N M R 5 8.32(s, IH, CH=N), 7.82-7.80 (m, 10H),
5.20 (s, IH, C H C O 2 C H 3 ) , 3.71 (s, 3H, CH3). M S (CI) m/z 254 (17%,
M H + ) , 194 (100).
Methyl N-benzylidenealaninate (23d). (80%) Colourless liquid. lU
N M R 5 8.30 (s, IH, CH=N), 7.89-7.39 (m, 5H), 4.15 (q, J = 6.6, 13.5 Hz,
IH, CHCO2CH3), 3.73 (s, 3H, CO2CH3), 1.52 (d, J = 6.6 Hz, 3H, CH3).
M S (CI) m/z 192 (29%, M H + ) , 132 (100).
Ethyl N-benzylideneglycinate (23e). (83%) Colourless liquid. lH
NMR

5 8.29 (s, IH, C H = N ) , 7.89-7.39 (m, 5H), 4.40 (s, 2H,
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C H 2 C O 2 C H 2 C H 3 ) , 4.23 (q, J = 7.2 Hz, 2H, CH2CH3), 1.30 (t, J = 7.2 Hz,
3H, CH2CH3). M S (CD m/z 192 (90%, M H + ) , 116 (100).
General Procedure for Preparing Cycloadducts:

To a solution of the irnine (0.91 mmol) and metal salt (AgOAc or L
0.91 mmol) in either dry T H F or C H 3 C N (10 m L ) was slowly added, by
the aid of syringe at -78 °C under N2, a solution of the alkene (22) (0.225
mg, 0.8 mmol) in the same solvent as the imine / metal salt (5 m L ) and
then D B U or Et3N (0.91 mmol).

The mixture was stirred at the

temperature and for the period of time as reported in Table 4.2, page 170
(the progress of the reaction was monitored by TLC). The mixture was
quenched with a solution of saturated aqueous ammonium chloride (20
m L ) and the products were extracted into diethyl ether (3 x 20 mL). The
combined extracts were dried (MgS04) and evaporated in vacuo. The
residue was chromatographed over silica gel using ethyl acetate / hexane
(20-30 / 80-70) as an eluent to give the products. The diastereoselection
of these reactions were determined from lH N M R analysis of the crude
reaction mixture.
(2#,2'S,4S,5'S) and (2ix\2'fl,4S,5'fl)-3-Benzoyl-2-phenyIoxazolidin-5-one-4-spiro-3'-[5'-methoxycarbonyl-5,-(2methyl-l-propyl)-2'-phenyl]pyrrolidine (25a) and (25b).
(25a): M.p. 142-3 °C; [ a ] D 2 0 +166.5 (c 0.8 in CHCI3). lH N M R 5 7.466.07 (m, 15H), 5.80 (s, IH, H2), 4.91 (s, IH, H2'), 4.23 (bs, IH, N H ) ,
3.88 (s, 3H, CO2CH3), 3.54 (d, J = 14 Hz, IH, H4'p), 2.79 (d, J = 14 Hz,
IH, H4'a), 2.25 (dd, J = 8, 17.4 Hz, IH, C H A H B C H ( C H 3 ) 2 ) , 1.98 (m, 2H,
C H A H B C H ( C H 3 ) 2 ) , 1-02 (d, J = 6.4 Hz, 3H, C H 3 ) , 0.91 (d, J = 6 Hz, 3H,

CH3). 13C N M R 8 175.2 (CO), 174.6 (CO), 169.8 (CO), 136.2, 136.1,
136.0, 129.8, 129.7, 128.8, 128.5, 128.1, 128, 126.3, 126.2, 125.4, 90.6
(C2), 73.7 (C4), 72.9 (C5'), 70.7 (C2'), 52.4 ( C 0 2 £ H 3 ) , 50.8 (C4'), 46.5

Chapter 4

JOQ

(£H2CH(CH3)2), 24.8 (CH2£H(CH3)2), 24.4 (CH3), 22.7 (CH3). IR
(nujol) 3250 1747, 1705, 1631, 1306, 1213, 1192, 1151, 1134, 1018,
1007, 851, 690 Cm-1.

M

S (ES) m/z 513 (100%, MH+). Anal. Calcd for

C31H32N2O5: C, 72.66; H, 6.25; N, 5.45%. Found: C, 72.87; H, 6.35; N,
5.32%.

(25b): M.p. 220 °C; [a]D24 +189.6 (c 0.5 in CHCI3). lH NMR 8 7

6.70 (m, 15H), 6.04 (s, IH, H2), 5.45 (s, IH, H2'), 3.86 (s, 3H, CO2CH3

3.80 (bs, IH, NH), 3.57 (d, J = 13.2 Hz, IH, H4'p), 2.90 (d, J = 13.2 Hz,
IH, H4'a), 2.24 (dd, J = 6.4, 13.6 Hz, IH,

CHAHBCH(CH3)2),

1.99 (dd, J

= 6.8, 13.6 Hz, IH, C H A H B C H ( C H 3 ) 2 ) , 1.87 (m, IH, CH 2 CH(CH 3 )2),
1.02 (d, J = 6.8 Hz, 3H, CH3), 0.89 (d, J=6.8 Hz, 3H, CH3). 13C N M R 8
175.6 (CO), 172.1 (CO), 169.2 (CO), 136.2, 135.9, 135.0, 130.2, 129.9,
128.9, 128.8, 128.7, 128.6, 127.3, 126.2, 125.9, 90.0 (C2), 72.1 (C4),
67.5 (C5'), 62.9 (C2'), 52.5 (C02£H3), 49.0 (C4'), 44.4 (£H2CH(CH3)2),
25.3 (CH2£H(CH3)2), 24.5 (CH3), 22.9 (CH3). IR (nujol) 3258 1770,
1701, 1625, 1318, 1257, 1209, 1150, 1128, 1021, 818, 770, 731, 690
cm-l. M S (ES) m/z 513 (100%, MH+). Anal. Calcd for C31H32N2O5: C,
72.66; H, 6.25; N, 5.45%. Found: C, 73.05; H, 6.31; N, 5.47%.
3-Benzoyl-2-phenyl-oxazolidin-5-one-4-spiro-3'-[2,-methoxy
carbonyl-2,-(2-methyl-l-propyI)-5,-phenyl]pyrrolidine (25c).
M.p. 149-51 °C dec; [a]D24 +93.3 (c 0.12 in CHCI3). lH N M R 8 7.586.8 (m, 15H), 6.63 (s, IH, H2), 4.91 (bs, IH, H5'), 3.96 (dd, J = 6.8, 12.8

Hz, IH, H4'), 3.84 (s, 3H, CO2CH3), 3.12 (bs, IH, NH), 2.54 (dd, J = 10,
12.8 Hz, IH, H4'), 2.35 (dd, J = 6.4, 13.6 Hz, IH, C H A H B C H ( C H 3 ) 2 ) ,
2.06

(dd, J = 5.2, 13.6 Hz, IH, C H A H B C H ( C H 3 ) 2 ) , 1.79

(m, IH,

CH 2 CH(CH 3 )2), L04 (d, J = 6.8 Hz, 3H, CH 3 ), 0.88 (d, J = 6.8 Hz, 3H,
CH 3 ). 13C N M R 8 175.4 (CO), 173.6 (CO), 171.4 (CO), 140.9, 137.3,
136.6, 130.5, 129.7, 128.7, 128.6, 128.59, 127.7, 127.1, 126.9, 126.2,
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91.7 (C-2), 81.7 (C-4), 75.4 (C2'), 60.6 (C5% 52.8 (C02£H3), 44.0
(C4'), 41.3 (£H 2 CH(CH 3 )2), 25.5 (CH 2 £H(CH 3 ) 2 ), 24.4 (CH 3 ), 23.8
(CH 3 ). IR (nujol) 3250 1750, 1717, 1632, 1129, 1208, 1153, 1020, 745,
690 cm-1. M S (ES) m/z 513 (100%, MH+), 71 (94).
(2^,2'5,4S,5'S) and (2/?,2*/?,45,5,/?)-3-Benzoyl-2-phenyloxazolidin-5-one-4-spiro-3,-(5'-benzyl-5'-ethoxycarbonyl-2'phenyl)pyrrolidine (26a) and (26b).
(26a): M.p. 201-2 °C; [a]D24 +191.4 (c 1.3 in CHCI3). lH N M R 8 7.56.1 (m, 20H), 5.8 (s, IH, H2), 5.1 (d, J = 12.4 Hz, IH, H2'), 4.24 (m, 2H,
CO2CH2CH3), 4.11 (d, J = 12.4 Hz, IH, N H ) , 3.67 (d, J = 14 Hz, IH,
H4'P), 3.52 (d, J = 13,6 Hz, IH, C H A H B P I I ) , 3.26 (d, J = 13.6 Hz, IH,
CHAHBPII),

3.02 (d, J - 14.4 Hz, IH, H4'a), 1.22 (t, J = 7.2 Hz, 3H,

CH3). 13C N M R 8 174.6 (CO), 173.6 (CO), 169.8(CO), 136.7, 136,
135.6, 135.5, 130.4, 129.85, 129.81, 128.9, 128.6, 128.2, 128.1, 128.0,
126.7, 126.5, 126.4, 125.5, 90.7 (C2), 74.0 (C4), 72.9 (C2'), 72.6 (C5'),
61.4 (CO2CH2CH3), 49.0 (£H2Ph), 44.1 (C4'), 14.1 (CH3). IR (nujol)
3278 1750, 1716, 1639, 1335, 1310, 1175, 1155, 1073, 1020, 689 cm-1.
M S (ES) m/z 561 (100%, MH+). Anal. Calcd for C35H32N2O5: C, 75.00;
H, 5.71; N, 5.00%. Found: C, 74.74; H, 5.81; N, 4.91%.
(26b): M.p. 212-13 °C; [ a ] D 2 4 +173.7 (c 0.27 in CHCI3). lH N M R 8
7.52-6.72 (m, 20H), 6.04 (s, IH, H2), 5.58 (d, J = 9.6 Hz, IH, H2'), 4.19
(m, 2H, CO2CH2CH3), 3.76 (d, J = 13.6 Hz, IH, CHAH B Ph), 3.61 (d, J =
10.8 Hz, IH, N H ) , 3.51 (d, J=14 Hz, IH, H4'p), 3.31 (d, J=13.6 Hz, IH,
H4'a), 3.01 (d, J = 13.6 Hz, IH, C H A H B P 1 I ) , 1.24 (t, J = 7.0 Hz, 3H,
CH 3 ). 13C N M R 8 173.8 (CO), 171.9 (CO), 169.3 (CO), 137.0, 136.2,
136.0, 135.2, 130.3, 130.2, 129.9, 128.93, 128.9, 128.7, 128.6, 127.9,
127.4, 126.7, 126.4, 125.8, 90.0 (C2), 72.2 (C4), 69.0 (C5'), 62.9 (C2'),
61.5 ( C 0 2 £ H 2 C H 3 ) , 46.4 (£H 2 Ph), 42.9 (C4'), 14.1 (CH 3 ). IR (nujol)
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3280 1765, 1708, 1639, 1359, 1337, 1324, 1210, 1180, 1151, 1109,
1021, 721, 692 cm-1. M s (ES) m/z 5 6 1 ( 1 0 0 % ) M H + ) > 2 8 g ( 1 5 )
(2/?,2'5,45,5'/?) and (2/?,2'/?,45,5,5)-3-Benzoyl-2-phenyIoxazolidin-5-one-4-spiro-3'-(5,-methoxycarbonyl-2,,5'diphenyl)pyrrolidine (27a) and (27b).
(27a): M.p. 100-101 °C, [ a ] D 2 6 +178.3 (c 0.6 in CHC1 3 ). lH N M R 8
7.91-6.20 (m, 20H), 5.76 (s, IH, H2), 4.76 (bd, J = 9.9 Hz, IH, H2'), 4.54
(bs, IH, N H ) , 4.18 (d, J = 14.4 Hz, IH, H4'p), 3.80 (s, 3H, CH 3 ), 3.53 (d,
J = 14.4 Hz, IH, H4'a). 13c N M R 8 173.8 (CO), 173.5 (CO), 170.5
(CO), 141.4, 135.9, 135.5, 135.4, 129.9, 129.8, 128.9, 128.6, 128.5,
128.3, 128.2, 127.9, 126.5, 126.4, 126.2, 125.5, 90.5 (C2), 74.5 (C4),
73.8 (C2'), 73.1 (C5'), 53.1 (CH 3 ), 51.3 (C4'). IR (nujol) 3275, 1742,
1710, 1616, 1340, 1225, 1195, 1155, 1010, 685 cm-1- M S (CI) m/z 533
(7%, M H + ) , 323 (18), 253 (100). Anal. Calcd for C33H28N2O5: C,
74.44; H, 5.26; N, 5.26%. Found: C, 74.40; H, 5.40; N, 4.97%.
(27b): M.p. 70-2 °C; [ a ] D 2 3 +40.95 (c 0.4 in CHCI3). lH N M R 8 7.916.76 (m, 20H), 6.35 (s, IH, H2), 6.21 (bs, IH, H2'), 5.17 (bs, IH, N H ) ,
3.78 (d, J = 11.7 Hz, IH, H4'p), 3,70 (s, 3H, CH3), 3.19 (d, J = 12.3 Hz,
IH, H4'a). 13C N M R 8 174 (CO), 172.3 (CO), 171.0 (CO), 136.7,
135.5, 135.1, 134.4, 129.4, 129.2, 129.1, 128.9, 128.7, 128.6, 128.3,
127.4, 127.1, 127.0, 126.8, 126.3, 91.3 (C2), 77.1 (C2'), 73.5 (C4), 70.1,
(C5'), 52.5 (CH3), 41.6 (C4'). IR (nujol) 3277, 1750, 1705, 1619, 1350,
1250, 1180, 1140, 1020, 689 cm-1.

M

S (ES) m/z 533 (90%, M H + ) , 339

(100).
(2R,2'S,4S,5'S) and (2/?,2,/?,45,5'/?)-3-BenzoyI-2-phenyloxazolidin-5-one-4-spiro-3'-(5,-inethoxycarbonyl-5,-methyI2'-phenyl)pyrroIidine (28a) and (28b).
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(28a): M.p. 156-7 °C; [a]D26 +158.8 (c 1 in CHC13). lH N M R 8 7.486.10 (m, 15H), 5.80 (s, IH, H2), 5.03 (s, IH, H2'), 4.36 (bs, IH, NH),
3.90 (s, 3H, CO2CH3), 3.65 (d, J = 13.8 Hz, IH, H4'p), 2.85 (d, J = 14.1
Hz, IH, H4'a), 1.78 (s, 3H, CH 3 ). 13c N M R 8 175.3 (CO), 174.4 (CO),
170.0 (CO), 135.9, 135.5, 135.4, 129.8, 128.8, 128.5, 128.2, 128.1,
126.4, 126.2, 126.1, 125.4, 90.6 (C2), 74.0 (C4), 72.6 (C2'), 67.5 (C5'),
52.6 (C0 2 £H 3 ), 46.6 (C4'), 25.9 (CH3). IR (nujol) 3245, 1751, 1701,
1625, 1310, 1200, 1117, 1010, 738, 685 cm-1. M S (CI) m/z 471 (20%,
M H + ) , 321 (10), 261 (60), 202 (55), 191 (100). Anal. Calcd for
C28H26N2O5: C, 71.49; H, 5.53; N, 5.96%. Found: C, 71.66; H, 5.61: N,
5.72%.
(28b): M.p. 168-9 °C; [a]D28 +204.2 (c 0.8 in CHCI3). lH N M R 8 7.486.7 (m, 15H), 6.06 (s, IH, H2), 5.59 (s, IH, H2'), 3.88 (s, 4H, NH,
CO2CH3), 3.59 (d, J = 12.8 Hz, IH, H4'p), 2.98 (d, J = 12.8 Hz, IH,
H4'a), 1.84 (s, 3H, CH3). J3C N M R 8 175.6 (CO), 171.9 (CO), 169.1
(CO), 136.1, 135.8, 134.7, 130.2, 129.8, 128.8, 128.7, 128.6, 128.5,
127.1, 126.3, 125.8, 90.0 (C2), 72.3 (C4), 64.2 (C5'), 62.6 (C2'), 52.7
(C0 2 £H 3 ), 43.6 (C41), 28.1 (CH3). IR (nujol) 3245, 1760, 1770, 1628,
1330, 1210, 1190, 1120, 730, 689 cm-1. M S (CI) m/z 471 (10%, MH+)
321 (10), 261 (50), 202 (62), 191 (100). Anal. Calcd for C28H26N2O5:
C, 71.49; H, 5.53; N, 5.96%. Found: C, 71.30; H, 5.55: N, 5.77%.
(2R,2'S,4S,5'S) and (2i?,2,/?,45,5,/2)-3-Benzoyl-2-phenyloxazolidin-5-one-4-spiro-3'-(5'-ethoxycarbonyI-2'-phenyI)
pyrrolidine (29a) and (29b).
(29a): M. p. 154-6 °C; [a] D 2 4 +257.7 (c 0.3 in CHCI3). lH N M R 8 7.476.09 (m, 15H), 5.88 (s, IH, H2), 4.81 (d, J = 9.6 Hz, IH, H2'), 4.36 (m,
3H, H5', CO2CH2CH3), 4.05 (bs, IH, NH), 3.41 (dd, J = 9.6, 13.2 Hz,
IH, H4'p), 3.10 (dd, J = 8.8, 13.6 Hz, IH, H4'a), 1.38 (t, J = 7.2 Hz, 3H,
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CH3). 13C NMR 8 174.5 (CO), 171.2 (CO), 169.9 (CO), 135.9, 135.5
135.3, 129.9, 129.8, 128.8, 128.6, 128.2, 128.1, 126.3, 126.2, 125.3,
90.6 (C2), 74.4 (C5'), 72.8 (C4), 61.9 (C2'), 61.4 ( C 0 2 £ H 2 C H 3 ) , 42.8
(C4'), 14.2 (CH 3 ). IR (nujol) 3300, 1752, 1711, 1621, 1218, 1193, 1151,
1020, 690 cm-1.

M

S (ES) m/z 471 (100%, MH+), 153 (7), 102 (10).

(29b): M.p. 53.5 °C; [a] D 2 4 +144.4 (c 0.9 in CHCI3). J H N M R 8 7.496.71 (m, 15H), 6.25 (s, IH, H2), 5.20 (s, IH, H2'), 4.60 (bs, IH, H5'),
4.32 (m, 2H, CO2CH2CH3), 3.57 (dd, J = 8.4, 12.4 Hz, IH, H4'P), 3.27
(bs, IH, N H ) , 2.70 (dd, J = 8.4, 12.8 Hz, IH, H4'a), 1.36 (t, J = 7.2 Hz,
3H, CH3). 13C N M R 8 172.4 (CO), 171.9 (CO), 168.9 (CO), 136.2,
135.8, 135.1, 130.3, 129.9, 128.8, 128.7, 128.5, 128.4, 126.9, 126.4,
125.9, 90.1 (C2), 71.4 (C4), 66.5 (C5'), 61.4 (C0 2 £H 2 CH3), 58.9 (C2'),
39.6 (C4'), 14.2 (CH3). IR (nujol) 3250 1761, 1691, 1628, 1325, 1210,
1148, 1022, 848, 725, 690 cm-1. M S (ES) m/z 493 (95%, MNa+), 471
(100, M H + ) , 316 (15), 288 (38). Anal. Calcd for C28H26N2O5: C, 71.50;
H, 5.53; N, 5.96%. Found: C, 71.71; H, 5.89; N, 5.61%.
(55,65,85,2'/c)-2-Benzamido-8-ethoxycarbonyI-hexahydro-3Hpyrrolizin-3-one-6-spiro-4,-(3l-benzoyl-2'-phenyI)oxazoIidin5'-one (30a) and (30b).
NHCOPh

C0 2 CH 2 CH 3

(30a) and (30b)

(30a): M.p. 103-5 °C; [a] D 2 6 +108.7 (c 6.45 in CHCI3). J H N M R 8 7.826.77 (m, 20H), 6.45 (s, IH, H2'), 6.08 (s, IH, H5), 5.26 (m, IH, H2),
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4.47 (q, J = 7.2, 10.8 Hz, IH, C02CHAHBCH3), 4.36 (q, J = 7.2, 10.8 Hz,
IH, C 0 2 C H A E B C H 3 ) , 3.76 (d, J = 12.8 Hz, IH, 7p), 3.41 (dd, J = 7.6,

12.8 Hz, IH, HI), 3.35 (d, J = 12.8 Hz, IH, H7a), 2.42 (t, J = 12.4 Hz,
IH, HI), 1.43 (t, J = 7.2 Hz, 3H, CH 3 ). 13C N M R 8 174.4 (CO), 171.8
(CO), 169.3 (CO), 169.1 (CO), 167.5 (CO), 135.4, 135.15, 135.1, 133.3,
131.6, 130.5, 130,1, 128.7, 128.68, 128.6, 128.4, 128.38, 127.0, 126.3,
126.1, 125.6, 90.5 (C2'), 74.0 (C), 69.5(C), 62.5 (CO2CH2CH3), 61.8
(C5), 53.0 (C2), 45.7 (Cl), 41.7 (C7), 14.0 (CH3). M S (ES) m/z 666
(21%, MNa+), 644 (91, MH+), 281 (56), 195 (100), 142 (86).
(30b): M.p. 110-113 °C; [a]D29+33.0 (c 0.1 in CHCI3). 1HNMR87.876.80 (m, 20H), 6.49 (s, IH, H2'), 6.00 (s, IH, H5), 5.21 (bt, J = 8.1 Hz,

IH, H2), 4.40 (dd, J = 7.2, 10.8, Hz, IH, CO2CHAHBCH3), 4.29 (dd, J =
7.5, 10.5 Hz, IH, CO2CHAHBCH3), 3.82 (d, J = 12.6, Hz, IH, H7P), 3.29
(d, J = 12.3 Hz, IH, H7a), 2.8 (dd, J = 8.1, 14.4 Hz, IH, HI), 2.53 (d, J =
14.1 Hz, IH, HI), 1.29 (t, J = 7.2 Hz, 3H, CH3). i3 C N M R 8 174.5 (CO),
173.7 (CO), 169.7 (CO), 169 (CO), 166.5 (CO), 135.6, 135.2, 135.0,
133.3, 131.7, 130.6, 130.2, 128.9, 128.8, 128.7, 128.5, 127.0, 126.4,
126.3, 125.8, 90.7 (C2'), 78.8 (C), 71.3 (C), 62.8 (C0 2 £H 2 CH3), 62.3
(C5), 53.9 (C2), 43.3 (Cl), 41.2 (C4), 13.9 (CH3). M S (ES) m/z 644
(33%, MH+), 2.11 (25), 193 (30), 192 (100).
5-Ethoxycarbonyl-3-phenylpyrrolidin-2-one (35).
M.p. 135-6 °C; [a] D 29 -12.0 (c 0.15 in CHCI3). lH N M R 8 7.80-7.37 (m,
5H), 7.06 (d, J = 4.8 Hz, IH, NH), 6.65 (bs, IH, NH), 4.56 (m, IH), 4.25
(m, 3H), 2.98 (m, IH, H4), 2.42 (m, IH, H4), 1.31 (t, J = 7.2, 3H, CH 3 ).
1 3 C N M R 8 175.7 (CO), 171.8 (CO), 167.8 (CO), 133.2, 131.8, 128.4,
127.1, 62.0 (CH2), 53.2 (CH), 49.8 (CH), 32.9 (CH2), 14.1 (CH3). M S
(ES) m/z 299 (47%, MNa+), 277 (55, MH+), 141 (57).
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Preparation of Proline Derivatives, A General Procedure:
To a solution of (25a) or (26a) (117 mmol) in dry methanol (10
under nitrogen was added powdered anhydrous potassium carbonate (17
mg, 117 mmol). The mixture was stirred at room temperature for 13 hr.
The mixture was then diluted with ethyl acetate (20 m L ) and washed with
a saturated aqueous solution of ammonium chloride. The aqueous layer
was extracted with ethyl acetate (2 x 10 mL). The combined organic
extracts were washed with water and brine, then dried over M g S 0 4 and
concentrated in vacuo. Short path column chromatography on silica gel
using ethyl acetate / hexane (20 / 80) as eluent gave the proline
derivatives (49) or (50).
Methyl (25,35,55)-2-(2-methyl-l-propyl)-4-benzamido-4methoxy carbonyl-5-phenylprolinate (49).
White solid (86%). M.p. 75-6 °C; [ a ] D 2 5 +69.0 (c 0.3 in CHC1 3 ). lH
N M R 8 7.57-7.35 (m, 10H), 6.14 (s, IH, N H C O P h ) , 4.78 (s, IH, H5),
3.71 (s, 3H, C O 2 C H 3 ) , 3.52 (d, J = 14 Hz, IH, H3p), 3.46 (s, 3H,
CO2CH3), 3.1 (bs, IH, N H ) , 2.92 (d, J = 14 Hz, IH, H3a), 1.92 (dd, J =
6,13.2 Hz, IH,

CHAHBCH(CH3)2),

1.70 (m, 2H, C H A H B C H ( C H 3 ) 2 ) , 0.96

(d, J = 6.4 Hz, 3H, CH3), 0.88 (d, J = 6.4 Hz, 3H, CH 3 ). 13C N M R 8
178.3 (CO), 171.3 (CO), 167.0 (CO), 135.7, 133.9, 131.7, 129.2, 129.1,
128.5, 127.1, 126.8, 70.3,(C-4), 67.7 (C2), 66.9 (C5), 52.6 (C0 2 CH 3 ),
52.3 (CO2CH3), 48.9 (C3), 46.0 (CH 2 CH(CH 3 )2), 25.5 (CH2£H(CH3)2),
23.9 (CH3), 23.3 (CH 3 ). IR (nujol) 3355, 3310, 1698, 1640, 1572, 1550,
1490, 1460, 1270, 1240, 1200, 1140, 1112, 1060, 710, 693 cm-1.

M

S

(CI) m/z 349 (100%, M H + ) , 258 (6), 233 (100). Anal. Calcd for
C25H30N2O5: C, 68.49; H, 6.84; N, 6.39%. Found: C, 68.08; H, 6.95; N,
5.97%.
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Methyl (25,45,55)-2-benzyl-4-benzamido-4-methoxycarbonyI5-phenylprolinate (50).

White solid (95%). M.p. 140-2 °C; [a]D28 +82.8 (c 0.6 in CHC1
N M R 8 7.53-7.20 (m, 15H), 6.11 (bs, IH, NHCOPh), 4.74 (s, IH, H5),
3.71 (s, 3H, CO2CH3), 3.54 (d, J = 13.8 Hz, IH, H3p), 3.43 (s, 3H,
CO2CH3), 3.23 (d, J = 13.2 Hz, IH, H3a), 3.10 (m, 3H, CH2PI1, NH).
13C N M R 8 177.0 (CO), 171.1 (CO), 166.9 (CO), 136.5, 135.7, 133.9,

131.7, 129.8, 129.2, 129.1, 128.5, 128.2, 127.2, 126.9, 126.8, 70.1 (C
68.9 (C4), 67.0 (C2), 52.6 (CO2CH3), 52.2 (CO2CH3), 45.4 (C3), 44.6
(CH2Ph). IR (nujol) 3352, 1695, 1640, 1572, 1550, 1480, 1240, 1178,
1080, 1030, 690 cm-1. M S (ES) m/z 473 (100%, MH+). Anal. Calcd for
C28H28N2O5: C, 71.18; H, 5.93; N, 5.93%. Found: C, 70,78; H, 6.05; N,
5.59%.
Synthesis of Urea (52) to determine the enantiomeric purity of
proline methyl ester (49).

A solution of the proline methyl ester (49) (18 mg, 0.04
CH2CI2 (2 mL) was treated with (5)-(+)-l-phenylethylisocyanate (0.082
mmol, 0.012 mL) and the mixture was heated at reflux for 2 hr. Removal
of the volatiles under vacuum left a mixture of the two diastereoisomers

of urea (52) in a ratio of 96 : 4fromlH N M R analysis. After purification
on a 0.2-mm PTLC plate (silica gel) pure urea (52) was isolated (16 mg,
(63%)). IH N M R 8 7.50-7.12 (m, 15H), 6.44 (s, IH, NHCOPh), 5.40 (s,

IH, H5), 4.76 (q, J = 6.9 Hz, IH, PI1CHCH3), 4.50 (bs, IH, NH), 3.75 (s,
3H, CO2CH3), 3.58 (d, J = 14.4 Hz, IH, H3p), 3.45 (s, 3H, CO2CH3),
3.08 (d, J = 13.8 Hz, IH, H3a), 2.17 (m, 2H, CH 2 CH(CH 3 ) 2 ), 1.83 (m,
IH, CH2CH(CH3)2), 1.40 (d, J = 6.9 Hz, IH, PhCHOfc), 0.99 (d, J = 6.6
Hz, 3H, CH 2 CH(CH 3 )2), 0.98 (d, J = 6.9 Hz, 3H, CH2CH(CH3)2). M S
(ES) m/z 586 (100%, MH+), 439 (10), 291 (20), 269 (80).
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